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Over! the! last! 30! years,! since! the! first! cases! of! what! is! now! recognized! as! HIV! infection! were!
identified!in!1981,!the!rise!of!the!number!of!HIV;infected!women!of!childbearing!age!in!developing!
countries! resulted! in! the! increased!number!of! children! infected!with!HIV.!During! the!past!decade,!
many!national!HIV!epidemics!have!changed!dramatically.!Although!HIV!remains!one!of!the!world’s!
most! serious! health! challenges,! global! solidarity! in! the! HIV! response! during! the! past! decade!
continues!to!generate!health!gains.!!
In!2011,!92%!of!pregnant!women!living!with!HIV!resided!in!sub=Saharan!Africa,!but!the!majority!of!
countries! continue! to! achieve! dramatic! results! in! the! AIDS! response! –! in! lives! saved! and! new!
infections!averted.!The!percentage!of!pregnant!women! living!with!HIV!who!received!antiretroviral!
therapy!or!prophylaxis!is!now!59%![53–66%]!and!the!number!of!children!newly!infected!fell!by!24%!
from!2009!to!2011! [1].! In! these!three!years,!antiretroviral!prophylaxis!prevented!409!000!children!
from! acquiring! HIV! infection! in! low;! and! middle;income! countries.! ! Still,! recent! estimates! from!
UNAIDS! are! that!worldwide! an! estimated!3.4!million! children! younger! than! 15! years! of! age! are!
infected! with! HIV! [2],! about! 91%! of! whom! reside! in! Africa.!With! that! Sub;Saharan! Africa! is! the!
epicenter!of!the!pediatric!HIV!epidemic. 
!
The! scaling! up! of! antiretroviral! therapy! in! low;! and! middle;income! countries! has! transformed!
national! AIDS! responses! and! generated! broad;based! health! gains.! In! countries! with! generalized!





Zambia! was! also! among! the! 6! sub;Saharan! African! countries! where! between! 2009! and! 2011! the!
number!of!children!newly!infected!with!HIV!declined!by!40=59%,!compared!to!the!overall!reduction!
of!24%!in!sub;Saharan!countries.!This!is!a!combined!effect!of!decreasing!incidence!in!women!and!the!
introduction!of!the!PMTCT!program.! In!Zambia,!the!estimated!number!of!new!infections! in! infants!
and!children!aged!1;4!years!was!2,946!in!2011![3].!
In!2011,!an!estimated!56%!of!people!eligible! for!HIV!treatment! in!sub;Saharan!Africa!received! it!–!
compared! to! a! global! average! of! 54%.! Five! countries! in! the! region! had!achieved!more! than! 80%!
coverage!of!HIV!treatment,!among!which!was!Zambia![1].!However,!the!estimated!coverage!is!much!





Although! much! of! the! news! on! HIV/AIDS! is! encouraging,! challenges! remain.! Despite! the! gains,!
HIV/AIDS! is! affecting! the! health! and!welfare! of! children! and!undermining! hard;won! gains! in! child!
survival! in! some! highly! affected! countries! [4].! Sub=Saharan! Africa! still! accounted! for! 71%! of! the!






Macha! Mission! Hospital! was! established! in! 1957.! The! 208;bed! hospital! is! administered! by! the!
Zambian!Brethren! in! Christ! Church! that! functions!within! the! healthcare! system!of! the!Ministry! of!
Health.!Macha! Hospital! serves! as! a! referral! hospital! for! at! least! 13! rural! health! centers,! bringing!
patients!in!from!an!80!km!radius. The!catchment!area!of!Macha!Hospital!is!populated!by!traditional!
villagers! living! in! small,! scattered! homesteads,! characteristic! of!much! of! rural! sub;Saharan! Africa,!
with!an!estimated!population!size!of!over!150,000!persons.!Overall!population!density!in!this!area!is!
25!per!km2!and!roughly!50%!of!the!population!is!under!12!years!of!age![5].!Other!specific!data!for!
the! local! population! are! not! reliable,! but! country;wide! the! crude! birth! rate! is! 45.6! per! 1,000!
population,!with!an!infant!mortality!of!68.9!per!1,000!live!births,!and!an!under;5!mortality!of!111!per!




at!Macha! (MIAM)! in!2003,!officially!opened! in!2005.!Whereas! initial! research! focused!on!malaria,!
soon! the! institute! expanded! it’s! range! of! activities! further! to! Tuberculosis! and! HIV/AIDS! related!
research! and! programs,! and! changed! the! name! into! Macha! Research! Trust! (MRT). The! Macha!
Research!Trust! is!a!unique!place!;!both! in!the!sense!that! it! is!one!of!the!few!research! institutes! in!
sub;Saharan! Africa! established! in! a! remote! rural! area! and! is! in! the!midst! of! an! area! traditionally!
endemic! to! malaria,! HIV! and! tuberculosis.! ! A! relationship! with! the! Erasmus! Medical! Center! was!





Antiretroviral! treatment! (ART)! provision! at! the! hospital! became! available! in! 2005,! through! the!
Government! of! Zambia's! antiretroviral! treatment! program,! with! additional! support! from! the!




HIV/AIDS! is! not! just! a! health! issue! but! also!a! development! issue.! Its! impact! extends!well! beyond!
typical! health! indicators! (e.g.! infant! mortality! rate,! life! expectancy! and! death! rate)! to! key!
development! indicators! (e.g.! per! capita! income,! literacy! and! GDP! growth! rates)! [7].! Successful!
antiretroviral! treatment! programs! in! rural! sub;Saharan! Africa! face! different! challenges! than!
programs! in!urban!areas.!Although! the! level!of! the!epidemic! in! rural! areas! is! lower! than! in!urban!
areas,!the!population!affected!is!quite!high!since!about!65!per!cent!of!the!population!lives!there.!At!
this!stage!of!dealing!with!the!epidemic,!lessons!have!been!learnt!and!capacities!have!been!improved!
;! both! in! terms! of! human! resources! and! institutional! capacities! for! a!multi;sectorial! approach! of!
interventions.!The!generalized!HIV!epidemic!in!Zambia!is!such!that!all!prongs!of!interventions!should!
be! at! full! scale,! and!half!measures! in! some!areas!would! cause! little! overall! impact! to! be!made! in!
reversing!the!epidemic.!The!availability!of!clinical!management!resources!as!well!as!the!application!
of!prevention,!diagnosis!and!treatment!standards!are!necessary!to!reach!that!goal.!
Besides! our! scientific! knowledge,! appropriate! service! delivery! requires! understanding! of! the! local!
situation! clients! are! in,! and! it’s! complexity.! Treating!HIV! in! a! rural!African! setting! requires!holistic!
care,!addressing! the!different!aspects! involved.! It! requires!a!continuum!of!care.!For!sustained!and!
holistic! action! against! HIV/AIDS,! it! is! essential! that! the! community! is! involved! and! takes! up! a!






Janneke! van! Dijk! (Macha! Research! Trust,! Zambia)! initiated! the! paediatric! ART! (PART)! study,! a!
prospective!cohort!study!of!HIV;infected!children!cared!for!by!the!HIV!clinic!at!Macha!Hospital,!and!











care! and! treatment! of!HIV;infected! children! in! this! region.!Our! review!of! the! published! literature!
showed!that!children!in!sub;Saharan!Africa!achieved!comparable!outcomes!to!those!in!high;income!
settings! although! they! enrolled! in! care! at! older! ages! and! more! advanced! stages! of! disease.! The!
findings!emphasised!the!need!for!low;cost!diagnostic!tests!that!allow!for!earlier!identification!of!HIV!
infection! in! infants! living! in! sub;Saharan! Africa,! improved! access! to! antiretroviral! treatment!






the!care!of!HIV;infected!children!unique! to! rural! settings,! specifically! long! travel! times!and! lack!of!
transportation,! but! are!encouraging! in! that! age! at! clinic! enrolment! and! immunologic!outcomes! in!


















prevalence! of! undernutrition,! and! identify! characteristics! at! ART! initiation! that! influence! growth!
trajectories.!!!
!
In! part! four,! issues!regarding!HIV!service!delivery!are!addressed.!We!reviewed!mortality!rates!and!
clinical!predictors!of!mortality!during!the!period!prior!to!ART!initiation![chapter!7],!underscoring!the!
need! to! increase! efforts! to! identify! HIV;infected! children! at! an! earlier! age! and! stage! of! disease!
progression.!! !
Antiretroviral!treatment!options!for!young!children!co;infected!with!HIV!and!tuberculosis!are!limited!
in! resource;poor! settings! in! sub;Saharan! Africa,! where! the! dual! burden! of! HIV! infection! and!
tuberculosis! represents! a! significant! threat! to! the! health! of! children.! Using! available!
pharmacokinetic! data,! an! efavirenz! (EFV)! dosing! schedule! was! developed! for! young! co;infected!
children! and! implemented! as! the! standard! of! care! at! Macha! Hospital! in! Zambia.! Treatment!
outcomes! in! children!younger! than!3! years!of! age!or!weighing! less! than!10!kg! receiving!either! an!
EFV;based!ART!plus!anti;tuberculous!treatment!or!nevirapine;based!(NVP)!ART!were!compared,!and!
are!presented!in!chapter!8.!
Repeatedly! decentralization! is! mentioned! as! one! of! the! strategies! to! scaling;up! access! to!
antiretroviral!treatment,!but!few!such!programs!have!been!evaluated.!We!compared!outcomes!for!
children! receiving! care! in! mobile! and! hospital;based! HIV! clinics! in! rural! Zambia! [chapter! 9].! In!
chapter! 10,! we! describe! the! feasibility! and! challenges! in! providing! antiretroviral! treatment! to!
children! in! Sub;Saharan!Africa,! highlighting! some!of! the! successful! practices! and!developments! in!
service!delivery!and!care.!!
!












































We! review! the! effectiveness! of! paediatric! antiretroviral! treatment! programmes! in! sub;Saharan!
Africa! and! discuss! the! implications! of! these! findings! for! the! care! and! treatment! of! HIV;infected!
children!in!this!region.!!
!
Available! reports! indicate! that! programmes! in! sub;Saharan! Africa! achieve! treatment! outcomes!




HIV! infection! in! infants! living! in! sub;Saharan! Africa,! improved! access! to! antiretroviral! treatment!









infected! children! aged! under! 15! years,! representing! 90%! of! all! HIV;infected! children! globally! [1].!
Without! treatment,!more! than!one;third!of! these!children!will!not! survive!past! their! first!birthday!
[2].! In! 2003,! WHO! launched! the! 3! by! 5! Initiative! and! mobilised! resources! to! increase! access! to!
effective!antiretroviral! therapy! in!resource;poor!settings!to!reduce!morbidity!and!mortality!caused!
by! HIV.! Substantial! improvements! have! been! made! in! sub;Saharan! Africa! for! adults,! with! the!
estimated! 100! 000! people! receiving! antiretroviral! therapy! in! 2003,! increasing! to! more! than! 1.3!
million! in! 2006! [3].!Despite! this! success,! progress! has! been! uneven! and! coverage! for! children! has!
lagged!behind![4].!
Antiretroviral!therapy!programmes!face!many!obstacles!in!sub;Saharan!Africa.!These!include!a!lack!
of! trained! physicians! and! other! health;care! workers! available! to! provide! antiretroviral! therapy,!
poorly! developed! drug! procurement! and! distribution! systems! [5,6],! and! unaffordable! assays! for!
monitoring! response! to! therapy! (particularly! HIV;1! viral! load)! and! medication! side;effects.! These!
obstacles! can! be! even! more! challenging! in! the! provision! of! care! to! HIV;infected! children.! The!
diagnosis!of!HIV!infection!in!infancy!requires!a!higher!level!of!technology!than!is!currently!available!





to! emerge! from! sub;Saharan! Africa! and! their! evaluation! is! crucial! to! overcoming! obstacles! and!
improving!the!care!of!HIV;infected!children.!We!review!the!effectiveness!of!paediatric!antiretroviral!







We! searched! the! online! databases! PubMed! and!Web! of! Science! for! articles! published! in! English!
before! Oct! 1,! 2007,! with! the! following! terms:! “HIV”! AND! “Africa”! AND! “antiretroviral”! AND!
(“treatment”!or!“therapy”)!AND!(“pediatric”!or!“child”).!Subject!headings!(PubMed!only),!titles,!and!
abstracts!were! searched.! The! search! identified! 258! potential! articles! from!PubMed! and! 133! from!
Web!of!Science.!Titles!and!abstracts!were!reviewed!to!identify!eligible!articles.!Articles!were!eligible!
(1)!if!they!included!HIV;1;infected!children!from!programmes!in!west!Africa!or!HIV;infected!children!
from!programmes! in!east!and!southern!Africa!where!HIV;1! is!predominant;!and! (2)! if! results!were!
reported! on! clinical,! immunological,! or! virological! outcomes,! adherence,! or! adverse! events! from!
studies!of!treatment;naive!children.!Reports!of!clinical!trials,!special!populations!of!children,!such!as!
children! in! intensive! care! units,! children!with! tuberculosis,! children!within! specific! age;groups,! or!
programmes!in!which!outcomes!for!children!were!not!reported!separately!from!those!of!adults!were!





were! also! searched! (details! of! this! search! are! in! the! webappendix).! These! searches! yielded! 48!
abstracts! [32;79],! although! one! was! subsequently! excluded! because! most! children! were! not!
treatment!naïve![77].!
If! several! abstracts! and! published! articles! reported! results! from! the! same! cohort! or! treatment!
programme,!the!most!recent!published!article!or!abstract!(if!only!abstracts!were!available)!was!used.!
If!relevant!information!was!not!available!from!these!sources,!or!separate!reports!were!available!on!
specific! topics,! such! as! adherence! or! adverse! reactions,! articles! or! abstracts! from! previous! years!
were! used.! In! general,! abstracts! provided! less! information! than! published! papers! and! reported!
preliminary! results.! To! determine! whether! the! information! obtained! from! abstracts! altered! our!




























































































































































































































































































































the! 26! studies! that! reported! the! age! at! which! children! started! antiretroviral! therapy,! 19! studies!
(73%)!reported!a!median!or!mean!age!of!5!years!or!older.!Only!two!studies!reported!a!median!age!






antiretroviral! therapy,! following! WHO! or! US! Centers! for! Disease! Control! and! Prevention! (CDC)!
treatment! guidelines! [80,81].!19! studies! reported! a!median! percentage! of! CD4! T! cells! in! children!
starting!antiretroviral!therapy!of!6–15%,!and!ten!(53%)!studies!reported!a!median!of!less!than!10%!
(table! 1).! The! proportion! of! children! with! less! than! 15%! CD4! T! cells,! an! indication! of! severe!
immunosuppression,!ranged!from!56%!to!96%!(table!1).!11!studies!reported!results!of!HIV!viral!load!
testing!before!starting!antiretroviral!therapy![9,18,24,30,31,42,49,51,56,62,65].!The!mean!or!median!













24!of! 30! studies! described! the! antiretroviral! regimens! used! (table! 1).! The!most! common! regimen!
(92%!of! studies)! included! two!nucleoside! reverse;transcriptase! inhibitors! plus! one! non;nucleoside!
reverse;transcriptase!inhibitor,!typically!a!combination!of!zidovudine!or!stavudine,! lamivudine,!and!




stavudine,! lamivudine,! and! nevirapine! [17;19,31,49].! Fixed;dose! combinations! were! used! in! an!
additional! six! studies! that! did! not! report! immunological! or! virological! treatment! outcomes! [27;
29,67,70,74].!Didanosine!and!abacavir!were!used!in!nine!studies!(38%),!but!were!primarily!available!
as! second;line! drugs! or! for! children! receiving! rifampicin.! Protease! inhibitors,! including! lopinavir;
ritonavir,! ritonavir,! or! nelfinavir,! were! used! in! 15! (63%)! studies,! primarily! as! first;line! drugs! for!
children!under!3!years!of!age!or!as!second;line!drugs.!
Reasons!for!the!use!of!specific!regimens!were!not!reported,!with!the!exception!of!adult!fixed;dose!
combinations,! which! were! used! because! alternative! paediatric! formulations! were! not! available.!








[13,15,16,18,19,23,30,31,37,48–50,53,55,60,65,66].! On! average,! children! gained! 1.8–3.6! kg! in! the!
first! year! of! treatment! [19,53,55,60,66].! In! general,! the! mean! or! median! weight;for;age! Z! scores!
were!−2!or!below!at!baseline!and! improved! substantially!by! approximately!1! SD!by!12!months!of!
treatment! [16,18,19,23,30,31,37,49,50].!These! improvements!were!maintained!2–3!years!after! the!
start!of!antiretroviral!therapy!in!studies!of!longer!duration![13,65].!Mean!or!median!height;for;age!Z!
scores!were!also!−2!or!below!at!baseline!and! improved!with! treatment! [13,15,16,23,30,31,37,49];!
however,!the!gains!were!not!significant!in!several!studies![13,15,23].!In!one!study,!the!incidence!of!




28! studies! reported! significant! immunological! reconstitution! in! children! receiving! antiretroviral!
therapy.! CD4! T;cell! percentage! increased! within! the! first! year! of! treatment! and! then! seemed! to!
plateau!after!12–18!months!of! treatment! (figure!1).!The!median!gain! in!percentage!of!CD4!T!cells!
was! 7.0–13.8%! at! 6–8! months! [15,17,19,23,31,43,45,66],! 10–16%! at! 12–15! months!
[16,17,23,31,42,50,52,60],! 10%! at! 24! months! [52],! and! 21%! at! 36! months! [65].! Estimates! of! the!
percentage! of! CD4! T! cells! at! least! 1! year! after! the! start! of! treatment! were! based! on! very! few!
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All! 17! studies! with! the! capacity! to! measure! HIV! viral! load! reported! significant! declines! after!
treatment! initiation! (figure! 2)! [9,13,18,20,23,24,30,31,42,44,47,49,51,52,54,56,57,60,64,65],! with!
median! viral! load! decreasing! by! approximately! 2.0! log10! copies! per! mL! within! 1! year! of! starting!
therapy! [9,31,42,49,57,60,64].! Viral! load! then! remained! stable! for! the! duration! of! treatment,!
although!this!was!based!on!data!from!only!two!studies![9,31].!
Studies! defined! viral! suppression! differently! depending! on! the! lower! limit! of! assay! detection.! For!
studies!with!a! lower! limit!of!detection!of!250!copies!per!mL,!400!copies!per!mL,!or!unknown,! the!
proportion! of! children! achieving! viral! suppression!was! 54–55%! at! 3!months! [31,64],!46–81%! at! 6!
months![18,20,24,31,44,56],!68%!at!9!months![31],!and!49–81%!at!12!months!after!starting!therapy!
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class! of! drugs! was! 23%! and! 44%! [10,42].! Resistance! mutations! to! lamivudine! or! non;nucleoside!
reverse;transcriptase! inhibitors! were! most! common.! In! Côte! d’Ivoire,! 62%! of! children! receiving!
regimens! containing! lamivudine! and! 78%! receiving! efavirenz;containing! regimens! had! reverse;









for! perfect! adherence! in! the! specified! time! period! (3! or! 7! days,! or! 1! month)!
[11,15,23,25,31,33,50,76],!and!80–92%!for!those!taking!at!least!95%!of!doses![23,27,69,72].!A!mean!
adherence!of!95%![67]!and!97%![27]!was!reported!in!two!studies.!!
Adherence! by! pill! count! or! measured! medications! ranged! from! approximately! 80%! of! children!







re;dosing! [11,23,76],! drug! stock! exhaustion[11,69,73,76],! delays! in! getting! new! prescriptions!
because!of!financial!constraints,!long!distances!to!travel,!and!long!waiting!times![11,23,25,69,73,76],!
incorrect!dosing!by!caregiver![23],!confusion!between!multiple!caregivers![23,73],!and!problems!of!
disclosure! [25,73,76],! particularly! fear! of! disclosure! because! of! HIV;related! stigma! [25,73].! In! a!
qualitative! study! in! Uganda,! barriers! also! included! the! child’s! and! caregiver’s! attitude! towards!




























The!Mildmay!Centre25! Kampala,!Uganda! 42! 29%!perfect!
adherence!
..! ..! ..!






















Abstracts! ! ! ! ! ! !
Mukhtar!Yola!et!al69! Kano,!Nigeria! 40! 80%!>95%!adherence! ..! ..! 88%!kept!all!
appointments!







Nalubega!et!al67! Kampala,!Uganda! 78! Mean:!95%! ..! ! ..!
Semwendero!et!al76!! Kampala,!Uganda! 117! 72%!perfect!
adherence!
..! ! ..!








therapy! (grandparents! in! particular)! [71,76],! living! outside! an! urban! area! [71],! only! the! primary!
caregiver! being! aware!of! the! child’s!HIV! status! [27],!fewer! hospital! admissions! before! the! start! of!
antiretroviral! therapy! [27],! no! adult! caretaker! in! the! home! also! on! antiretroviral! therapy! [67],!









of! classifying! adverse! events! (table! 3)! [13,17,18,20,26,31,48,50,54,58,68].! Four! of! 11! studies!
reported! that!more! than! 20%! of! children! had! adverse! events![13,18,31,58].!Most! adverse! events!
were!mild,!and!the!most!common!were!gastrointestinal!problems!and!skin! rashes.!Severe!adverse!





Few! studies! reported! immune! reconstitution! disease! in! children! (including! one! by! Barry! and!
colleagues! [82]! that! was! excluded! from! the! previous! review! because! only! infants! were! enrolled)!
[22,39].! In! 122! children! in! CapeTown,! South! Africa,! three! (2.5%)! developed! suppurative,! regional!
lymphadenitis,! and! BCG! site! ulceration! within! 4! weeks! of! starting! antiretroviral! therapy,! and! all!
required! antimycobacterial! therapy! [39].!In! a! separate! case! series! [22],! investigators! described! 11!
cases! of! tuberculosis;associated! immune! reconstitution! disease,! four! with! new! diagnoses! of!
pulmonary! tuberculosis,! three! with! recurrent! pulmonary! tuberculosis! after! treatment! for!






Changes! in! drug! regimens! were! not! reported! consistently,! and! distinctions! between! drug!
substitutions! and! regimen! switches! were! not! clear.! Consequently,! a! change! in! at! least! one!
antiretroviral! drug! is! reported! here! to! best! summarise! reported! results.! A! change! in! at! least! one!
antiretroviral!drug!was!experienced!by!up!to!59%!of!children![13,15,16,23,24,31,44,51,56,64].!Of!the!
ten! studies! reporting! changes! in! drug! regimen,! five! reported! that! more! than! 15%! of! children!
changed!drugs![13,16,31,51,56].!More!than!one!change!during!the!study!period!was!rare.!The!main!














Published!studies! ! ! ! !







Diack!et!al26! Dakar,!Senegal! 4!of!36!(11%)! 1!of!36!(3%)! Mild:!vomiting,!rash!
Kenyatta!National!Hospital31! Nairobi,!Kenya! >20%*! 7!of!67!(10%)! Mild:!rash,!nausea/vomiting!
Severe:!rash,!anaemia,!abacavir!
hypersensitivity!





















Abstracts! ! ! ! !
Warren!et!al46! Addis!Ababa,!Ethiopia! ! 0! ;;;!
Nannyonga!Musoke!et!al48! Kampala,!Uganda! 4!of!83!(5%)! 2!of!83!(2%)! Peripheral!neuropathy,!rash,!hepatic!toxicity!
The!Mildmay!Centre50! Kampala,!Uganda! 28!of!355!(8%)! ! Nausea/vomiting,!rash,!neuropsychiatric!
disorders!
Nabacwa!et!al68! Kampala,!Uganda! >7%*! ! Rash,!peripheral!neuropathy,!headache,!
diarrhoea!
Kariyo!et!al54! Bujumbura,!Burundi! >7%*! ! Anaemia,!rash,!lipidystrophy!
DeNaeyer!et!al70! Kigali,!Rwanda! ! >5.2%*! Severe:!hepatic!abnormalities!and!skin!
manifestations!










Pretoria,!South!Africa! ! 23!of!259!(9%)! Mild:!skin!rashes,!gastro;intestinal!
manifestations,!neurological!side!effects!







four! of! 14! studies! of! 1–2! years! had! a! mortality! greater! than! 10%! (range! 0–15s4%)! [16,18,28–
30,45,47,48,50,51,59,62,75,78],! and! one! of! three! studies! of! 3! years! reported! a! mortality! greater!







antiretroviral! therapy! [9,13].! Most! deaths! occurred! within! 6! months! of! treatment,! with! several!
studies! reporting! a! mean! or! median! time! to! death! of! 57–182! days! [13,17,31,51,78],! and! others!
reporting!that!55–100%!of!deaths!occurred!within!the!first!6!months!of!treatment![20,23,24,29,55].!
Causes!of!death!were!reported!in!several!studies;!however,!the!methods!of!ascertaining!or!verifying!




severe! malnutrition! [19,23,29],! HIV;positive! primary! caregiver! [23],! and! the! presence! of!
tuberculosis,! gastroenteritis,! pneumonia,! or! Pneumocystis! jirovecii! pneumonia! at! treatment!
initiation! [23,55].! In! Mozambique,! investigators! compared! mortality! among! children! receiving!
antiretroviral! therapy! and!HIV;infected! children! ineligible! for! treatment,! and! found! that!mortality!
was!higher!(hazard!ratio!3.8,!95%!CI!1s9–7s5)!for!the!untreated!group,!despite!better!immunological!
and!virological!conditions!at!baseline![18].!
Loss! to! follow;up!was! low! in!most! studies! (table!1).! Studies!of! less! than!1!year! reported! losses! to!
follow;up! of! 0–11%! [15,17,23,28,55,66]! and! most! reported! that! some! children! transferred! to!










































North! America! and! Europe,! and! indicate! that! better! outcomes! could! be! achieved! among! these!
children.!
!
Adherence! in! HIV;infected! children! in! sub;Saharan! Africa! varied! depending! on! the! measurement!
used,! but! also! were! similar! to! those! reported! from! high;income! countries.! In! a! recent! review! of!
antiretroviral! therapy! adherence! in! children! residing! primarily! in! North! America! and! Europe! [90],!
100%!adherence!was! reported!by!34–100%!of!caregivers,!mean!adherence!by!pill! count!was!90%,!
and!100%!of! scheduled! clinic! visits!were! kept!by!21–88%!of! children.!Although! it! is! hard! to!make!
meaningful! comparisons,! the! ! studies! from! sub;Saharan! Africa! also! reported! results! within! these!
ranges.!Loss!to!follow;up!was!also!low!in!sub;Saharan!Africa,!with!less!than10%!of!children!dropping!







Although! it! is! encouraging! that! treatment! programmes! in! sub;Saharan! Africa! are! reporting!
responses! similar! to! those! from! high;income! countries,! several! issues! emerge! that! are! cause! for!
concern!and!highlight!areas!in!which!improvements!could!be!made!to!enhance!successful!treatment!
responses!(panel).!!
First,! the! information! reported! from!sub;Saharan!Africa!was!not! consistent!across! studies,!making!
synthesis! and! summary!of! the! data! difficult.! To! adequately!monitor! and! compare! the!progress! of!
children!starting!antiretroviral!therapy!in!different!settings,!standardised!monitoring!and!assessment!
systems!should!be!developed.!
Second,! children! are! entering! treatment! programmes! at! older! ages! in! sub;Saharan! Africa.! Most!
children! in! these! studies! were! older! than! 5! years! when! they! started! antiretroviral! therapy.! In! a!
pooled!analysis!of!mortality!among!HIV;infected!treatment;naive!African!children,!an!estimated!35%!





enrolled! in! the! antiretroviral! therapy! programmes:! most! were! identified! as! HIV;infected! and!
clinically!in!need!of!treatment!through!health;care!services,!rather!than!in!infancy!through!PMTCT!or!
voluntary! counselling! and! testing! programmes,! when! children! are! often! asymptomatic! [13,31].!




Third,! children! in! sub;Saharan!Africa!are!entering! treatment!programmes!with!advanced! immuno;!
suppression.!By!definition,!children!eligible!for!treatment!by!CDC!or!WHO!guidelines!have!moderate!
to!severe! immunosuppression! [80,81].!However,!with!a!median!CD4!T;cell!percentage!of! less! than!
10%! in! most! studies,! children! in! sub;Saharan! Africa! are! starting! antiretroviral! therapy! at! more!
advanced!stages!of!disease!(CD4!T;cell!percentage!of!approximately!5–10%!lower)!than!children!in!
high;income! countries! [83–86,88,89],! thereby!putting! them!at! increased! risk! for! treatment! failure!
[85,94]!and!poor! immunological! response! [84,89,94–96].!The! late! identification!of!clinically! ill!HIV;
infected! children! at! health;care! facilities! further! supports! the! need! for! earlier! diagnosis! and!
treatment!of!HIV;infected!children![7,97].!PMTCT!programmes!need!to!be!strengthened!to!identify!
and!monitor! HIV;exposed! children,! and! low;cost! technology! needs! to! be! developed! for! the! early!
diagnosis!of!HIV;infected!infants.!Earlier!diagnosis!will!remain!problematic!if!dependent!on!detection!
of! HIV;1! DNA! or! RNA,! although! the! use! of! dried! blood! spots! will! facilitate! specimen! collection,!
handling,! and! shipping! [98].! Further!development!of! less! expensive!but!highly! sensitive!assays! for!





study! suggest! that! initiation! of! antiretroviral! therapy! before! 12! weeks! of! age! results! in! a! 75%!





from! South! Africa! [23].! In! all! studies! that! assessed! this! issue,! nutritional! status! improved! after!
antiretroviral! therapy;! however,! the! effect! of! malnutrition! on! virological! success! and! immune!
reconstitution! has! not! been! fully! explored.! Treatment! programmes! need! to! address!malnutrition!
and! micronutrient! deficiencies! through! an! integrated! model! of! care! or! by! partnering! with!
organisations!that!have!the!resources!to!provide!nutritional!supplementation![104].!One!example!of!
this! approach! is! the! Drug! Resources! Enhancement! against! AIDS! and! Malnutrition! (DREAM)!
programme! in! Mozambique! [18],!which! provides! free! HIV! diagnosis! and! antiretroviral! therapy! in!





preparations,! and! fixed;dose! combinations! are! not! usually! available! for! children,! and! second;line!
regimens!are!costly.!Up!to!59%!of!children!required!regimens!to!be!changed!because!of!treatment!
failure!or! adverse! reactions.! From! the! limited!number!of! studies! that! did! resistance! testing,!most!
treatment!failures!were!associated!with!the!development!of!mutations!that!conferred!resistance!to!
an! entire! class! of! drugs.! However,!most! studies! only! had! nucleoside! and! non;nucleoside! reverse;




lamivudine,! and! nevirapine! resulted! in! subtherapeutic! nevirapine! concentrations! in! a! substantial!








nutritional!status,!ability! to!access!care! (including!distance,!cost,!and!feasibility!of! travelling!to!the!
clinic),!different!patterns!of!comorbid!conditions,!and!differences!in!stigma!that!could!affect!health;
seeking!behaviour!and!adherence.!Additionally,!rural!clinics!might!face!different!logistical!problems,!
including! shortages! of! physicians! and! other! clinic! staff,! making! it! more! difficult! to! provide!
antiretroviral! therapy! and!monitor! patient! progress! and! adherence.! Several! studies! of! adults! and!
children!have!used!a! community;based!model! to!provide!antiretroviral! therapy!by! integrating!HIV!
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Background:! Successful! antiretroviral! treatment! programs! in! rural! sub;Saharan! Africa! may! face!
different!challenges!than!programs!in!urban!areas.!The!objective!of!this!study!was!to!identify!patient!







28%!of!whom!were! receiving! antiretroviral! therapy! (ART)! at! enrollment.! The!median! age!was! 3.3!
years!for!children!not!receiving!ART!(IQR:!1.8,!6.7)!and!4.5!years!for!children!receiving!ART!(IQR:!2.7,!
8.6).! 91%! travelled!more! than! one! hour! to! the! clinic! and! 26%! travelled!more! than! 5! hours.!Most!
participants!(73%)!reported!difficulties!accessing!the!clinic,! including!insufficient!money!(60%),! lack!
of!transportation!(54%)!and!roads!in!poor!condition!(32%).!The!54!children!who!were!receiving!ART!
at! study! enrollment! had! been! on! ART! a! median! of! 8.6! months! (IQR:! 2.7,! 19.5).! The! median!
percentage!of!CD4+!T!cells!was!12.4!(IQR:!9.2,!18.6)!at!the!start!of!ART,!and!increased!to!28.6!(IQR:!
23.5,! 36.1)! at! the! initial! study! visit.! However,! the! proportion! of! children! who! were! underweight!
decreased!only!slightly,!from!70%!at!initiation!of!ART!to!61%!at!the!initial!study!visit.!
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An! estimated! 2!million! children! under! the! age! of! 15!were! living!with! HIV! infection! at! the! end! of!
2007,! with! almost! 90%! residing! in! sub;Saharan! Africa! [1].! Since! the! World! Health! Organization!






Africa! can! achieve! outcomes! similar! to! those! in! North! America! and! Europe! [6].! However,! as! the!
rollout!of!ART!continues,! concerns!have!been! raised!about!how!equitably!access! to!ART!has!been!
distributed!within!countries![7;9].!HIV!care!services!have!primarily!been!implemented!in!urban!areas!
and! have! lagged! behind! in! rural! areas,! where! there! are! shortages! of! trained! personnel! and! the!
health! care! system! faces! many! challenges! [10].! Barriers! faced! by! residents! in! rural! areas! may!
prevent!them!from!accessing!HIV!care,!including!lower!treatment!literacy![11],!greater!distances!and!
travel!times!to!clinics![3],!and!fewer!financial!resources!for!transportation![12,13].!
To! address! these! issues,! decentralized! models! for! health! care! delivery! have! been! developed! to!
increase! access! to! care! in! several! rural! settings! [14;18].! Initial! reports! from! rural! programs! have!









HIV;infected! children! younger! than! 16! years! and! attending! the! Antiretroviral! Clinic! at! Macha!
Hospital! in! Macha,! Zambia! were! eligible! for! enrollment.! Macha! is! located! in! Southern! Province,!
approximately! 80! km! from! the!nearest! town!of! Choma.! The! catchment! area!of!Macha!Hospital! is!




hospitals! and! rural! health! centers! within! an! 80! km! radius,! serving! a! population! of! over! 150,000!
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through!the!Government!of!Zambia's!antiretroviral!treatment!program,!with!additional!support!from!
the! President's! Emergency! Plan! for! AIDS! Relief! (PEPFAR)! through! the! non;governmental!
organization,!AidsRelief.!A!program!to!prevent!maternal;to;child!HIV!transmission!began!at!Macha!
Hospital!simultaneous!with!the!implementation!of!the!ART!clinic!in!2005.!
HIV;infected! children! are! referred! to! the! clinic! from! voluntary! counseling! and! testing! programs,!
outpatient! clinics! and! hospitals.! Since! February! 2008,! children! born! to! HIV;! infected! women! are!
routinely!tested!for!HIV!infection!at!approximately!6!weeks!of!age,!using!dried!blood!spot!samples!
and!HIV!DNA!PCR!performed!in!Lusaka,!Zambia.!Clinical!care!is!provided!without!charge!by!medical!
doctors! and! clinical! officers,! and! adherence! counseling! by! nurses! and! trained! counselors.! Home!
visits! are! attempted! for! persons! who! fail! to! return! for! scheduled! follow;up! visits.! Children! were!
considered!eligible!for!antiretroviral!therapy!if!they!had!WHO!stage!3!or!4!disease,!or!a!CD4+!T!cell!
percentage!of! <25%! for! children!<!11!months!of! age,! <!20%! for! children!12;35!months!of! age,!or!
<15%!for!children!≥!36!months!of!age.!The!first;line!antiretroviral!treatment!regimen!consists!of!two!

















For!the!present!analysis,! information!was!used!from!the! initial!study!visit! for!HIV;infected!children!
enrolled! into! the! cohort! study! between! September! 2007! and! September! 2008.! Children! were!
classified!as!HIV;infected!if!they!were!older!than!18!months!with!a!positive!serological!test,!younger!
than! 18!months!with! confirmed! infection! by! PCR! either! prior! to! or!within! 3!months! of! the! initial!




Data! were! entered! in! duplicate! using! EpiInfo! (Centers! for! Disease! Control! and! Prevention)! and!
analyses!were!conducted!in!SAS!for!Windows!version!9.1!(SAS!Institute!Inc.,!Cary,!NC).!Proportions!
are! reported! for! categorical! variables!and!differences!were! tested!using!chi;square! tests.!Medians!
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with 26% travelling more than 5 hours (Figure 1). For par-
ticipants who used motorized vehicles, 53% spent more
than 20,000 ZMK (approximately 5 USD at that time) of
their own (54%) or their family's (46%) money for trans-
portation. No significant differences were found in mode,
time or cost of transportation between children who were
and were not receiving ART at study enrollment.
Seventy-three percent of participants reported ever experi-
encing problems accessing the clinic (Figure 2), primarily
due to lack of money (60%), transportation (54%), and
because roads were in poor condition (32%). No caretak-
ers reported problems attending the clinic due to lack of
time, forgetting about appointments or inability to find
childcare. Caretakers tended to report more problems
accessing the clinic during the rainy season (78%) from
mid-November to mid-April than during the dry season
(67%, P = 0.2). Significantly more children not receiving
ART reported problems attending the clinic than children
receiving ART (79% vs. 59%, P = 0.01).
Characteristics of children not receiving ART at the initial 
study visit
138 HIV-infected children were not receiving ART at study
enrollment (Table 2). These children had been followed
in the clinic a median of 3.2 months before study enroll-








Median age in years (IQR)a 3.5 (1.9, 7.4) 3.3 (1.8, 6.7) 4.5 (2.7, 8.6)
Male (%)a 91 (47) 55 (40) 36 (67)
Parents
Status (%)
Both alive 121 (65) 94 (69) 27 (54)
Mother deceased 26 (14) 20 (15) 6 (12)
Father deceased 19 (10) 11 (8) 8 (16)
Both deceased 20 (11) 11 (8) 9 (18)
Primary Caregiver
Relationship to child (%)
Mother/father 139 (74) 104 (76) 35 (70)
Grandparent 28 (15) 17 (12) 11 (22)
Aunt/uncle 14 (7) 11 (8) 3 (6)
Sibling 3 (2) 2 (1) 1 (2)
Other 3 (2) 3 (2) 0 (0)
Median age (IQR)b 35.8 (30.3, 43.6) 35.5 (29.2, 43.6) 38.0 (33.3, 43.5)
Education (%)b
None 8 (5) 5 (4) 3 (7)
Primary 98 (56) 75 (58) 23 (52)
Secondary 64 (37) 46 (35) 18 (41)
Higher 4 (2) 4 (3) 0 (0)
Household SES (%)
!25th percentile 131 (70) 97 (71) 34 (68)
26-50th percentile 48 (26) 33 (24) 15 (30)
51-75th percentile 7 (4) 6 (4) 1 (2)
76-100th percentile 1 (1) 1 (1) 0 (0)
Travel to ART clinic
Median distance in km
IQR)
28 (18-45) 28 (17-45) 30 (18-42)
ART = antiretroviral therapy; IQR = interquartile range; SES = socioeconomic status
ap < 0.05 for difference between HIV-infected children on ART and not yet on ART
bexcluding respondents who are not the child's primary caregiver (n = 13) +
The! majority! of! children! were! cared! for! by! a! parent! (74%),! although! 35%! had! lost! one! or! both!
parents,!and!the!majority!of!parents! (96%)!reported!signs!and!symptoms!of!disease!at!the!time!of!
the! initial! clinic! visit.!Most! children!whose! primary! caregiver!was! not! a! parent!were! cared! for! by!
other!family!members,!primarily!a!grandparent.!The!median!age!of!the!primary!caregiver!was!35.8!
years! (IQR:! 30.3,! 43.6)! and! their! educational! status!was! low,!with! 61%! of! caregivers! achieving! at!
most! a! primary! level! of! education,! and! only! 52%! of! these! caregivers! completed! grade! 7.! The!
socioeconomic! status! of! the! households! also!was! low,!with! 70%! of! children! living! below! the! 25th!
percentile.!Children!receiving!ART!at!the!initial!study!visit!were!older!(median!age:!4.5!vs.!3.3!years)!
and!were!more!likely!to!be!male!(67%!vs.!40%),!but!were!otherwise!similar!to!children!who!were!not!
receiving! ART! at! the! initial! study! visit.! The! use! of! antiretrovirals! to! prevent! mother;to;child!


















told,! and! 1%! reporting! that! only! other! non;family! members! had! been! told.! Significantly! more!
caregivers!of!children!on!ART!had!disclosed!to!both! family!members!and!others! in! the!community!
compared! to! children! not! receiving! treatment! (86%! vs.! 36%,! P! <! 0.0001).! Few! caregivers! (2%)!
reported!being!fearful!of!others!finding!out!about!their!child's!HIV!infection!status,!or!felt!that!they!
(3%)! or! their! children! (6%)! were! stigmatized! because! of! their! child's! status.! Significantly! more!
caregivers!of!children!on!ART!reported!that!they!(9%!vs.!1%,!P!=!0.004)!or!their!child!(16%!vs.!2%,!P!=!





Children! and! their! caregivers! travelled! an! estimated! median! distance! of! 28! km! (IQR:! 18,! 45)! to!
attend! the! clinic.! The! majority! of! participants! used! a! single! mode! of! transportation,! including!
walking! (30%),! cycling! (39%)! or! public! transportation! (31%).! The! majority! (91%)! of! participants!
travelled!more! than!one!hour! to! the! clinic,!with! 26%! travelling!more! than!5! hours! (Figure! 1).! For!
participants!who!used!motorized!vehicles,!53%!spent!more!than!20,000!ZMK!(approximately!5!USD!
at! that! time)! of! their! own! (54%)! or! their! family's! (46%)!money! for! transportation.! No! significant!
differences!were! found! in!mode,! time! or! cost! of! transportation! between! children!who!were! and!
were!not!receiving!ART!at!study!enrollment.!!
Seventy;three! percent! of! participants! reported! ever! experiencing! problems! accessing! the! clinic!
(Figure!2),!primarily!due!to! lack!of!money! (60%),! transportation! (54%),!and!because!roads!were! in!
poor! condition! (32%).! No! caretakers! reported! problems! attending! the! clinic! due! to! lack! of! time,!





during! the! dry! season! (67%,! P! =! 0.2).! Significantly! more! children! not! receiving! ART! reported!
problems!attending!the!clinic!than!children!receiving!ART!(79%!vs.!59%,!P!=!0.01).!
!
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ment (IQR: 0.5, 10.1). The median percentage of CD4+ T
cells was 20.7 (IQR: 16.0, 30.0), but 37% of children were
severely immunosuppressed. In addition, 54% of children
were classified as WHO stage 3 or 4 at the initial study
visit. In this group, 79 (60%) children were eligible at the
initial study visit to start treatment based on the 2006
WHO treatment guidelines [21]. These children had been
followed in the clinic a median of 2.8 months (IQR: 0.4,
9.0), and for 14% of children this visit represented their
first visit in the clinic. Children eligible for treatment were
significantly younger (2.3 vs. 3.6), had lower median
WAZ (-2.4 vs. -2.1), and, as expected, had a lower median
percentage of CD4+ T cells (17.4 vs. 29.6) and higher stage
of disease progression (78% classified as WHO stage 3 or
4 vs. 0%). Based upon detailed review of the medical
records of those children deemed eligible for ART at the
initial study visit and who had been followed at the clinic
a sufficient length of time to have a potential delay in ini-
tiation of ART, the most common reasons for a potential
delay were loss to follow-up (10 children), concurrent
tuberculosis (9 children) and need for adherence coun-
seling (3 children).
Response to therapy among children receiving ART at the 
initial study visit
54 children were receiving ART at study enrollment (Table
3). These children had been followed in the clinic a
median of 13.6 months (IQR: 6.4, 23.2) and had been on
ART a median of 8.6 months (IQR: 2.7, 19.5). The median
percentage of CD4+ T cells was 12.4 (IQR: 9.2, 18.6) at the
start of ART and increased to 28.6 (IQR: 23.5, 36.1) at the
initial study visit. The median increase in percentage of
CD4+ T cells from ART initiation to the initial study visit
was 18.1 (IQR: 6.0, 26.8). The percentage of CD4+ T cells
increased with the duration of ART use (Figure 3). The
proportion of children with a percentage of CD4+ T cells
greater than 25% increased from 64% among those who
had received ART for less than 12 months (n = 22) to 83%
among those who had received ART for at least 12 months
(n = 18). Children were not consistently classified accord-
ing to WHO clinical stage; however, among those with
WHO staging available (28 at ART initiation and 34 at the
initial study visit) there was a decrease in the proportion
of children in stage 3 or 4 from 89% at ART initiation to
65% at the initial study visit. However, the proportion of
children who were underweight decreased only slightly,
from 70% at ART initiation to 60.5% at the initial study
visit for 37 children with available data. WAZ scores
increased a median of 0.24 (IQR: -0.57, 0.84) from initia-
tion of ART to the initial study visit.
ART regimens and adherence
ART regimens at treatment initiation and the initial study
visit consisted of a combination of 2 NRTIs and 1 NNRTI.
Side effects were rarely reported, with only two children
reporting a rash and one child reporting headaches after
treatment initiation. A median of two adults (IQR: 2-3)
were involved in supervising the administration of ART.
The primary person responsible for ART administration
was the child's mother (56%). Sixty-one percent of chil-
dren were living in households where at least one other
person, primarily a parent, also was receiving ART. Among
respondents, 22% of 41 reported problems with adher-
ence. Among those who did, the primary reasons for a
child missing a dose were forgetting (n = 2), the pills being
either too numerous (n = 1) or too large to swallow (n =
1), the child refusing (n = 1), side effects (n = 2), the car-
egiver being away (n = 1), and finishing the supply of
drugs prior to the next clinic appointment (n = 1).
Method of transportation and travel time to the ART clinic among HIV-infected childreFigure 1
Method of transportation and travel time to the ART 
clinic among HIV-infected children. Note: Modes of 
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ment (IQR: 0.5, 10.1). The median percentage of CD4+ T
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percentage of CD4+ T cells (17.4 vs. 29.6) and higher stage
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been! followed! in! the! clinic! a!median! of! 3.2!months! before! study! enrollment! (IQR:! 0.5,! 10.1).! The!
median! percentage! of! CD4+! T! cells!was! 20.7! (IQR:! 16.0,! 30.0),! but! 37%!of! children!were! severely!
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Discussion
Most assessments of the care of HIV-infected children in
sub-Saharan Africa have been from urban sites, often from
established research programs [6]. Our observations high-
light barriers to the care of HIV-infected children unique
to rural settings, specifically long travel times and lack of
transportation, but are encouraging in that age at clinic
enrollment and immunologic outcomes in the first year of
treatment did not differ substantially from published
reports on the care of HIV-infected children in urban sub-
Saharan Africa. These findings suggest that the barriers to
the care of HIV-infected children in rural settings do not
pose insurmountable obstacles to desirable treatment
outcomes.
The median age of HIV-infected children receiving care in
rural southern Zambia was younger than commonly
reported (4.5 years for children receiving ART and 3.3
years for children not receiving ART). Among studies
reporting the effectiveness of pediatric ART in sub-Saha-
ran Africa, 73% of 26 studies reported a median or mean
age of five years or older at initiation of ART [6]. In Lusaka,
Zambia, the median age at which HIV-infected children
began care was 5.4 years (IQR: 1.9, 9.5) [24]. Thus, com-
pared to this urban Zambian pediatric cohort, children
accessing care in this rural setting do not appear to face
additional delays; however, the number of children undi-
agnosed or not accessing care is not known. There is
urgent need to diagnose HIV infection and initiate ART
within the first year of life given the high mortality rate in
early childhood [25] and the demonstrated benefits of ini-
tiating treatment in early infancy [26]. In rural Zambia, as
elsewhere in sub-Saharan Africa, children accessing care
are a subset of HIV-infected children with slower disease
progression. At Macha Hospital, infant diagnosis of HIV
infection using dried blood spots and PCR was introduced
in February 2008, and is likely to reduce the age at which
HIV-infected children enter care.
One of the major barriers to care in rural sub-Saharan
Africa is access to health facilities. In rural southern Zam-
bia, more than 90% of HIV-infected children travelled
more than one hour to the clinic and more than one quar-
ter travelled more than five hours. Lack of transportation,
insufficient financial resources and poor roads were com-
monly cited obstacles to accessing the clinic, particularly
during the rainy season. Such obstacles are unlikely to be
major barriers to care in urban settings and could result in
suboptimal treatment outcomes for HIV-infected children
residing in rural areas. Significantly more children not on
Table 2: Characteristics at study enrollment of HIV-infected children not receiving ART
Total (n = 138) Children not eligible for ARTc 
(n = 53)
Children eligible for ART at study 
enrollment (n = 79)
Median age (yrs) (IQR)a 3.3 (1.8, 6.7) 3.6 (2.5, 6.7) 2.3 (1.3, 6.7)
Male (%) 55 (40) 20 (38) 34 (43)
Length of time (months) since 
enrolling in ART clinic
3.2 (0.5, 10.1) 3.8 (0.2, 11.7) 2.8 (0.4, 9.0)
Median WAZ (IQR) (n = 120)a,b -2.2 (-3.2, -1.3) -2.1 (-2.7, -1.0) -2.4 (-3.5,-1.6)
WAZ <-2 66 (55) 25 (53) 41 (59)
WAZ !-2 54 (45) 22 (47) 28 (41)
Median CD4+ T cell % (IQR) (n = 
122)a
20.7 (16.0, 30.0) 29.6 (23.2, 36.9) 17.4 (12.1, 21.1)
Median CD4+ T cell count (IQR) (n = 
126)a
815 (455, 1372) 980 (578, 1434) 735 (377, 1287)
Severe immunodeficiencya,d 47 (37) 0 (0.0) 47 (64)
Median total lymphocyte count 
(IQR) (n = 73)
4266 (2238, 7025) 3289 (2179, 4847) 4464 (2328, 7236)
Median hemoglobin (IQR) (n = 110)a 10.5 (9.2,11.6) 11.3 (9.8,11.7) 10.1 (8.8, 11.3)
Hemoglobin <8 gm/dL 6 (5) 1 (3) 5 (7)
Hemoglobin !8 gm/dL 104 (95) 36 (97) 68 (93)
WHO stage (n = 101)a
1 17 (16) 11 (34) 5 (7)
2 33 (32) 21 (66) 10 (14)
3 38 (37) 0 (0) 38 (55)
4 16 (15) 0 (0) 16 (23)
ART = antiretroviral therapy; IQR = interquartile range; WAZ = weight-for-age Z score; WHO = World Health Organization
a p < 0.05 for difference between children eligible and ineligible for ART at study enrollment
b for children <10 yrs old
c eligibility for ART determined based on the 2006 WHO treatment guidelines; 6 children could not be classified as WHO stage and laboratory 
results were not available at baseline
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ART reported problems accessing the clinic but the rea-
sons are unknown. It may be that caregivers who have
committed to providing ART for their child perceive fewer
problems, as the journey to and from the clinic has
become routine.
The majority of children (78%) were not receiving ART at
the time of study entry. Although these children were fol-
lowed for only a median of 3.2 months, some were
deemed eligible for ART at study entry. Over a third were
severely immunosuppressed and slightly more than half
were classified as WHO stage 3 or 4 at the initial study
visit. Consequently, many of these children were eligible
for ART at the study visit according to the WHO guide-
lines. However, many met criteria for WHO stage 3
because of poor nutritional status, which in this setting
does not necessarily represent advanced HIV disease and
is not in itself a criterion for treatment initiation. In addi-
tion, many children had not been followed in the clinic
long enough to fulfill the requirements for treatment ini-
tiation, including eligibility and adherence visits. For chil-
dren who had been in the clinic a sufficient time, delayed
initiation of ART could have resulted from biomedical,
social or health care-associated factors. In a study con-
ducted in Pretoria, South Africa, reasons for delayed initi-
ation of ART among 147 eligible, HIV-infected children
included: tuberculosis co-infection (26%); inadequate
clinic staffing (20%); social problems, including lack of
transportation, absence of legal guardian and denial
(17%); and inaccurate clinical or immunological staging
(14%) [27]. In this study, delays in initiation of ART most
frequently resulted from loss to follow-up or concurrent
tuberculosis. Given the advanced clinical and immuno-
logical stages at which children entered the clinic, delays
in ART initiation could be detrimental, leading to higher
pre-ART mortality [28], more rapid disease progression
[26], or poorer response to treatment.
In rural Zambia, three quarters of the HIV-infected chil-
dren seeking care had a parent as the primary caregiver,
although one third had lost at least one parent. Children
who are orphans [29] and children whose primary car-
egiver is not a parent [30] may be at increased risk for non-
adherence to the antiretroviral regimen. Few children,
even among the older age groups, were reported to be
aware of their HIV-infection status, primarily because the
caregivers thought the child too young to be told the diag-
nosis or they were afraid to tell the child. However, this
finding must be interpreted with caution as this informa-
tion was reported by the caregiver rather than the child
and may be an underestimate of the children's true knowl-
edge of their status.
Table 3: Characteristics of children receiving ART (n = 54)
At clinic enrollment At ART initiationa At study enrollment
Median age (yrs) (IQR) 3.6 (1.5, 7.7) 3.8 (2.0, 8.0) 4.5 (2.7, 8.6)
Median WAZ (IQR)b -2.7 (-3.5, -1.5) -2.5 (-3.9, -1.8) -2.4 (-3.2, -1.5)
WAZ <-2 27 (61.4) 28 (70.0) 26 (60.5)
WAZ !-2 17 (38.6) 12 (30.0) 17 (39.5)
Median CD4+ T cell % (IQR) 14.0 (9.2, 19.0) 12.4 (9.2, 18.6) 28.6 (23.5, 36.1)
Median CD4+ T cell count (IQR) 505 (281, 985) 368 (219, 559) 973 (466, 1522)
Severe immunodeficiencyc 16 (50) 24 (63) 2 (5)
Median total lymphocyte count (IQR) 3194 (1948, 5351) 2747 (1634, 5351) 3372 (1862, 5276)
Median hemoglobin (IQR) 10.6 (10.0, 11.7) 10.8 (10.0, 12.0) 11.9 (10.6, 12.3)
Hemoglobin <8 gm/dL 1 (2.0) 0 (0) 4 (8.9)
Hemoglobin !8 gm/dL 49 (98.0) 36 (100.0) 41 (91.1)
WHO stage
1 2 (5.1) 2 (7.1) 6 (17.7)
2 9 (23.1) 1 (3.6) 6 (17.7)
3 22 (56.4) 20 (71.4) 20 (58.8)
4 6 (15.4) 5 (17.9) 2 (5.9)
ART regimen
AZT/3TC/EFV --- 12 (26.1) 11 (42.3)
AZT/3TC/NVP --- 11 (23.9) 7 (26.9)
d4T/3TC/EFV --- 5 (10.8) 2 (7.7)
d4T/3TC/NVP --- 18 (39.1) 6 (23.1)
ART = antiretroviral therapy; IQR = interquartile range; WAZ = weight-for-age Z score; WHO = World Health Organization; AZT = zidovudine; 
3TC = lamivudine; EFV = efavirenz; NVP = nevirapine; d4T = stavudine
a7 children transferred to Macha and had already initiated ART
bfor children <10 yrs old






reporting!headaches!after!treatment! initiation.!A!median!of!two!adults! (IQR:!2;3)!were! involved! in!
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Despite these barriers, the 54 children receiving ART at
study entry achieved good immunological responses, with
the percentage of CD4+ T cells increasing a median of
17.6% after a median of 8.1 months of therapy. This com-
pares favorably with 28 published studies of the immuno-
logical response to ART among HIV-infected children in
sub-Saharan Africa residing largely in urban settings, in
which the median gain in percentage of CD4+ T cells was
7-14% at 6-8 months and 10-16% at 12-15 months of
therapy [6]. In contrast, weight gain among HIV-infected
children receiving ART in rural Zambia did not achieve the
levels reported elsewhere in sub-Saharan Africa, with WAZ
scores increasing a median of 0.24 after receiving ART a
median of 8.6 months. Among 17 published studies that
reported nutritional outcomes, weight-for-age Z scores
improved by 1 SD after twelve months of ART [6]. Simi-
larly, among 749 HIV-infected Ugandan children who
received ART for a mean of 6 months, the mean weight-
for-age Z score increased from -3.2 to -2.1 over the study
period [31]. HIV-infected children receiving ART in rural
sub-Saharan Africa may have poorer weight gain because
of lower dietary intake than children residing in urban
areas.
Conclusion
HIV-infected children in rural southern Zambia have long
travel times to access care and may have poorer weight
gain on ART than children in urban areas. Despite these
barriers, children in rural Zambia had a substantial rise in
CD4+ T cell counts in the first year of ART although longer
follow-up may indicate these gains are not sustained.
Developing strategies to improve access to care and nutri-
tion will be necessary to ensure optimal, long-term treat-
ment outcomes for HIV-infected children residing in rural
sub-Saharan Africa.
List of Abbreviations
3TC: lamivudine; ART: antiretroviral therapy; AZT: zido-
vudine; d4T: stavudine; EFV: efavirenz; IQR: interquartile
range; NVP: nevirapine; SES: socio-economic status; USD:
United States dollar; WAZ: weight-for-age Z-score; WHO:
World Health Organization; ZMK: Zambian Kwacha
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Most!assess ents!of!the!care!of!HIV;infected!children!i !s b;Saharan!Africa!have!been!from!urban!
sites,!often!from!established!research!programs![6].!Our!observations!highlight!barriers!to!the!care!
of! HIV;infected! chil ren! unique! to! rural! settings,! specifically! long! travel! times! nd! lack! of!
transportation,!but!are!encouraging! in! that!age!at!clinic!enrollment!and! immunologic!outcomes! in!
the! first! year! of! reatment! did! not! differ! subs antially! from!published! r ports! on! the! care! of!HIV;
infected!children!in!urban!sub;Saharan!Africa.!These!findings!suggest!that!the!barriers!to!the!care!of!
HIV;infe t d!children!in!rural!settings!do! ot!pose!insurm ntable! bstacles! o!desirable!treatment!
outcomes.!!
The!median!age!of!HIV;infected!children!receiving!care!in!rural!southern!Zambia!was!younger!than!
commonly! reported! (4.5! years! for! children! receiving! ART! and! 3.3! years! for! children! not! receiving!
ART).!Among!studies! reporting! the!effectiveness!of!pediatric!ART! in!sub;Saharan!Africa,!73%!of!26!
studies! reported! a!median! or!m an! age! of! five! years! or! old r! at! initiation! of! ART! [6].! In! Lusaka,!
Zambia,!the!median!age!at!which!HIV;infected!children!began!care!was!5.4!years!(IQR:!1.9,!9.5)![24].!
Thus,!compared!to!this!urban!Zambian!pediatric!cohort,!children!accessing!care!in!this!rural!setting!
do! not! appear! to! face! additional! delays;! however,! the! number! of! children! undiagnosed! or! not!
accessing!care!is!not!known.!There!is!urgent!need!to!diagnose!HIV!infection!and!initiate!ART!within!
the! first! year! of! life! given! the! high! mortality! rate! in! early! childhood! [25]! and! the! demonstrated!








One!of! the!major!barriers! to! care! in! rural! sub;Saharan!Africa! is! access! to!health! facilities.! In! rural!
southern!Zambia,!more!than!90%!of!HIV;infected!children!travelled!more!than!one!hour!to!the!clinic!
and! more! than! one! quarter! travelled! more! than! five! hours.! Lack! of! transportation,! insufficient!
financial! resources! and! poor! roads! were! commonly! cited! obstacles! to! accessing! the! clinic,!
particularly!during!the!rainy!season.!Such!obstacles!are!unlikely!to!be!major!barriers!to!care!in!urban!
settings! and! could! result! in! suboptimal! treatment! outcomes! for! HIV;infected! children! residing! in!




The!majority!of! children! (78%)!were!not! receiving!ART!at! the! time!of! study!entry.!Although! these!
children!were! followed! for! only! a!median! of! 3.2!months,! some!were! deemed! eligible! for! ART! at!




advanced! HIV! disease! and! is! not! in! itself! a! criterion! for! treatment! initiation.! In! addition,! many!
children! had! not! been! followed! in! the! clinic! long! enough! to! fulfil! the! requirements! for! treatment!
initiation,! including! eligibility! and! adherence! visits.! For! children! who! had! been! in! the! clinic! a!
sufficient!time,!delayed!initiation!of!ART!could!have!resulted!from!biomedical,!social!or!health!care;
associated! factors.! In!a! study!conducted! in!Pretoria,!South!Africa,! reasons! for!delayed! initiation!of!
ART!among!147!eligible,!HIV;infected!children!included:!tuberculosis!co;infection!(26%);!inadequate!
clinic!staffing!(20%);!social!problems,!including!lack!of!transportation,!absence!of!legal!guardian!and!
denial! (17%);! and! inaccurate! clinical! or! immunological! staging! (14%)! [27].! In! this! study,! delays! in!
initiation!of!ART!most! frequently!resulted!from!loss!to! follow;up!or!concurrent!tuberculosis.!Given!
the!advanced!clinical!and! immunological! stages!at!which!children!entered!the!clinic,!delays! in!ART!




caregiver,! although! one! third! had! lost! at! least! one! parent.! Children! who! are! orphans! [29]! and!
children!whose!primary!caregiver!is!not!a!parent![30]!may!be!at!increased!risk!for!non;adherence!to!






Despite! these!barriers,! the!54! children! receiving!ART!at! study!entry!achieved!good! immunological!
responses,!with!the!percentage!of!CD4+!T!cells! increasing!a!median!of!17.6%!after!a!median!of!8.1!
















poorer!weight! gain! on! ART! than! children! in! urban! areas.! Despite! these! barriers,! children! in! rural!
Zambia!had!a!substantial!rise!in!CD4+!T!cell!counts!in!the!first!year!of!ART!although!longer!follow;up!
may! indicate! these! gains! are! not! sustained.! Developing! strategies! to! improve! access! to! care! and!
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obtained! from! medical! records.! Participants! included! human! immunodeficiency! virus;infected!
children!<15!years!of!age!presenting!for!care!between!August!2004!and!July!2008.!Characteristics!at!





vs.!12.8%),! less!advanced!disease! (47.5%!vs.!62.3%! in!World!Health!Organization!stage!3/4),! lower!















[1],! concerns! have! been! raised! about! inequities! in! the! distribution! of! ART! [2,3].! Many! human!
immunodeficiency!virus!(HIV);infected!children!live!in!rural!areas!where!access!to!therapy!has!been!
limited.! Treatment! programs! in! rural! health! facilities! may! face! additional! challenges,! including!
inadequate! infrastructure! and! shortages! of! trained! health! personnel! [4;6].! Children! and! their!
caregivers! residing! in! rural! areas!may! face! unique! barriers! to! care,! including! greater! distances! to!
travel,!greater!direct!and!indirect!costs,!and!limited!knowledge!of!HIV/!AIDS!testing!and!treatment!
services! [2,5,7;9].! These! factors! can! affect! decisions! regarding! when! to! access! HIV;treatment!
programs,!the!quality!of!care!once!enrolled,!and!ultimately!treatment!response.!
Many! pediatric! treatment! programs! in! urban! settings! in! sub;Saharan! Africa! have! treatment!
















administered! by! the! Brethren! in! Christ! Church! [17].!Mukinge! Hospital,! located! in! North!Western!
Province,! is! a! district;level! hospital! administered! by! the! Evangelical! Church! in! Zambia.! Both! areas!
have!lower!population!density!than!Lusaka!(63.5,!14.2,!and!4.6!per!km2!in!Lusaka,!Southern!Province!
and!North!Western!Province,!respectively)!and!are!populated!primarily!by!subsistence!farmers![21].!
The! study!was! approved! by! the!University! of! Zambia! Research! Ethics! Committee,! the!Ministry! of!





Standard! of! care! included!measurement! of! CD4+
!
T;cell! counts/percentages! (not! available! the! first!






The! clinics! followed! similar! visit! schedules! [15,20].! Eligible! children!were! started!on! standard!ART!
regimens! (stavudine/zidovudine/abacavir! plus! lamivudine! plus! efavirenz/nevirapine)! [24]! after!
achieving! adequate! adherence! with! cotrimoxazole! and! multivitamins.! Children! were! seen! in! the!
clinic!up!to!4!times!during!the!first!month!of!treatment,!monthly!up!to!6!months,!and!then!every!2!to!
3! months,! depending! on! progress! and! adherence.! At! each! visit,! children! were! seen! by! a! clinical!
officer! or! medical! doctor! and! received! adherence! counseling.! Immunologic! status! was! assessed!
every! 6!months! or! when! clinically! indicated.! Children! ineligible! for! treatment! were! seen! every! 3!
months.!
Attempts!were!made!to!contact!children!who!missed!appointments.!Deaths!were!reported!by!clinic!





and! data! from!Matero! Reference! Clinic!were! abstracted! from!medical! records! (95%! of! files!were!
located).! HIV;infected! children! younger! than! 15! years! with! at! least! one! clinic! visit! between!
implementation!and!July!31,!2008!were!included!in!the!analysis.!Infants!who!were!not!presumptively!
diagnosed!and!treated!and!children!transferring!to!the!clinics!already!receiving!ART!were!excluded.!
Children!were! included! in! the! analysis! until! they! transferred! to! another! clinic,! died,! defaulted,! or!
were! censored! on! July! 31,! 2008.! Children!who!missed! at! least! 2! clinic! visits! scheduled! 3!months!
apart!by!the!end!of!follow;up!were!censored!at!their!last!clinic!visit!(defaulted).!
Eligibility! for! ART! at! the! initial! evaluation! visit! was! defined! retrospectively! based! on! treatment!
guidelines! in! effect! at! that! time.! The! 2003! guidelines! relied! more! heavily! on! clinical! judgment,!




age,! and! weight;for;height! z;scores! below! ;2! were! considered! to! be! indicative! of! underweight,!
stunting,!and!wasting,!respectively.!
Distance! to! the! clinic! was! self;reported! in! Macha! and! Mukinge.! In! Matero! Reference! Clinic,!
participants! reported! township!of! residence;!geographic! information!system!mapping!was!used! to!
estimate!the!distance!from!the!township!center!to!Matero!Reference!Clinic.!Children!were!classified!
as!living!a!short,!medium,!and!long!distance!from!the!clinic!according!to!township!for!Matero!(short:!




of! treatment,! were! calculated.! Factors! associated! with! each! outcome! were! assessed! using! Cox!
proportional! hazards!models,!with! final!models! including! location! (rural! vs.! urban)! and! covariates!
found!to!be!(P!<!0.05)!or!known!to!be!associated!with!the!outcome.!
Treatment! outcomes! were! assessed! immunologically,! with! CD4+! T;cell! percentage,! and! clinically,!
with!WAZ.!For!both!outcomes,!children!were! included! if! they!had!a!pre;ART!measure!and!at! least!
one!post;ART!measure.!For!reporting!outcomes!at!specific!intervals,!measurements!were!aggregated!




















1).! Urban! and! rural! children! contributed! a!median! of! 11.9!months! (Interquartile! range! (IQR):! 2.8,!










Significant! differences! were! observed! in! the! characteristics! of! urban! and! rural! children! at! initial!
presentation! (Table,! Supplemental! Digital! Content! 1,! http://links.lww.com/INF/A516).! Urban!
children! presented! at! an! older! age,! were! less! likely! to! be! underweight,! and! were!more! likely! to!
























Rural!clinic! 0.40!(0.32,!0.50)! 0.38!(0.29,!0.48)! ! 0.96!(0.64,!1.44)! 0.59!(0.37,!0.95)!
Age!(yrs)! ! ! ! ! !
<!2! 0.92!(0.73,!1.15)! ! ! 2.33!(1.47,!3.69)! 2.62!(1.57,!4.38)!
2;4.9! 0.95!(0.76,!1.18)! ! ! 0.84!(0.49,!1.44)! 0.94!(0.53,!1.69)!
≥!5! 1! ! ! 1! 1!
Male!sex! 1.05!(0.88,!1.25)! ! ! 1.09!(0.73,!1.63)! !
History!of!tuberculosis! 1.18!(0.97,!1.42)! ! ! 1.63!(0.87,!3.06)! !
Weight=for=age!z=score! ! ! ! ! !
<!;3! 1.12!(0.88,!1.42)! ! ! 3.23!(1.79,!5.82)! 3.25!(1.77,!5.98)!
;3!to!;2.1! 1.15!(0.87,!1.51)! ! ! 2.03!(1.14,!3.62)! 2.22!(1.21,!4.07)!
≥!;2! 1! ! ! 1! 1!
High!WHO!stagea! 0.89!(0.73,!1.09)! ! ! 1.31!(0.80,!2.13)! !
Low!CD4!%b! 1.88!(1.52,!2.34)! 1.89!(1.52,!2.35)! ! 2.12!(1.23,!3.66)! 2.03!(1.17,!3.53)!
Hemoglobin!<!8!g/dL! 1.19!(0.93,!1.51)! ! ! 0.93!(0.65,!1.32)! !
Distance!to!the!clinic! ! ! ! ! !
Near! 1! ! ! 1! !
Mid!distance! 1.02!(0.83,!1.26)! ! ! 0.96!(0.58,!1.58)! !








Distance! traveled! was! significantly! associated! with! defaulting,! with! more! children! defaulting! at!
greater! distances! (short:! 6.8%! vs.! medium:! 12.2%! vs.! long:! 14.8%;! P=! 0.05,! P! for! trend! =! 0.02),!
particularly!in!the!rural!areas!(9.3%!vs.!17.1%!vs.!20.0%).!
The! time! to! ART! initiation!was! significantly! shorter! for! urban! (median:! 0.9!months;! IQR:! 0.5,! 1.5)!
compared! with! rural! children! (median:! 3.6! months;! IQR:! 1.0,! 9.2;! P<0.0001)! (Fig.,! Supplemental!
Digital! Content! 2,! http://links.lww.com/INF/A517).! Factors! associated!with! ART! initiation! included!






another! clinic,! and! 21%! defaulted,! with! no! significant! differences! by! location.! The! proportion! of!











By! July! 31,! 2008,! 607! children!had! initiated!ART,! contributing! a!median!of! 13.7!months! (IQR:! 3.8,!
29.3)!of!follow;up!on!ART!in!the!urban!clinic!and!7.6!months!(IQR:!2.9,!16.3)!in!the!rural!clinics!(P<!
0.0001).!Similar!differences!in!the!characteristics!of!urban!and!rural!children!were!observed!at!ART!









but!experienced! the! same!pattern!of! immune! reconstitution,! resulting! in! consistently! lower!mean!












! Crude! ! Adjusted!
Urban! Rural! p=value! ! Urban! Rural! p=value!
CD4+!T–cell!percentagea! ! ! ! ! ! ! !
CD4!%!at!ART!initiation!(SE)! 12.51!(0.49)! 15.50!(1.17)! 0.02! ! 14.77!(1.47)! 17.38!(1.80)! 0.08!
Increase!per!month!in!first!6!
months!(SE)!
1.94!(0.06)! 1.83!(0.23)! 0.64! ! 2.06!(0.08)! 1.86!(0.21)! 0.39!
Increase!per!month!after!6!
months!(SE)!
0.13!(0.02)! ;0.06!(0.18)! 0.29! ! 0.14!(0.03)! 0.008!(0.16)! 0.41!
Weight=for=age!z=scoreb! ! ! ! ! ! ! !
WAZ!at!ART!initiation!(SE)! ;2.26!(0.08)! ;2.76!(0.11)! <0.0001! ! ;2.30!(0.21)! ;2.69!(0.24)! 0.02!





























5.31,! 9.06);! it!was! significantly!higher! among! rural! (13.53!deaths!per!100!PY;!95%!CI:! 8.82,! 20.75)!
than! urban! children! (5.30! deaths! per! 100! PY;! 95%! CI:! 3.77,! 7.45)! (P!=! 0.0007).! The! probability! of!
survival!at!6,!12,!and!24!months!was!94%!(95%!CI:!91,!96),!93%!(95%!CI:!89,!95)!and!90%!(95%!CI:!87,!
93)! among!urban! children,! respectively,! and! 88%! (95%!CI:! 81,! 92),! 85%! (95%!CI:! 78,! 90)! and! 84%!
(95%!CI:!75,!89)!among!rural!children!(log;rank!test:!P!=!0.03)!(Fig.,!Supplemental!Digital!Content!4,!
http://links.lww.com/INF/A519).!
Mortality! rates!were!significantly!higher! in! the! first!90!days!of! treatment! for!both!rural!and!urban!


















children!presented!with!advanced!disease!and! immune!suppression,! consistent!with! findings! from!
other!pediatric!studies!in!sub;Saharan!Africa![10,26].!The!more!advanced!disease!at!presentation!in!








Assessing! time! to!ART! initiation!among!eligible! children!provides! an!estimate!of! the! time! to! fulfill!
requirements!to!initiate!ART.!The!longer!time!to!initiation!in!the!rural!clinics!could!not!be!explained!
by! the! characteristics! of! the! children!but! could! be! explained!by! differing! clinic! procedures.! In! the!
rural!clinics,!distance!was!a!recognized!barrier!and,!when!possible,!efforts!were!made!to!synchronize!
visits! between! children! and! their! caregivers,! resulting! in! longer! intervals! between! visits! (data! not!
shown).!The!time!to!ART!initiation!among!ineligible!children!may!provide!a!measure!of!how!quickly!
children! progress! once! evaluated,! although! this! interval! is! composed! of! both! the! time! to! ART!
eligibility!and! initiation.!No!differences!were! found!between!urban!and! rural! children.!However,! if!
the!longer!time!from!eligibility!to!initiation!still!applies!to!ineligible!rural!children,!this!finding!might!
suggest! more! rapid! disease! progression,! potentially! due! to! a! younger,! more! malnourished!
population.!Once! these! factors!were! accounted! for,! a! longer! time! to! ART! initiation!was! observed!
among!rural!children,!lending!support!to!this!hypothesis.!




However,! the! level!of! immunologic!and!clinical! response!was! influenced!by!their!differing!baseline!
characteristics.! For! immunologic! response,! children! in! the! urban! clinic! initiated! ART!with! a! lower!
CD4+! T;cell! percentage! and! this! difference! persisted! throughout! treatment,! resulting! in! a! lower!
percentage!of! children!achieving! complete! immune! reconstitution.! This!was!partially! explained!by!
the!older!urban!population,!as!older! children!with!higher! levels!of! immunodeficiency!have!poorer!
immunologic!responses!to!ART![20].!Mortality!was!consistently!higher!in!the!rural!clinics,!in!part!due!
to! younger!age!and!higher! levels!of!malnutrition,! and!was!higher! than! that! reported!by! the!KIDS;
ART;LINC!collaborative!study!in!sub;Saharan!Africa![26].!However,!loss!to!follow;up!was!higher!in!the!
urban! clinic! and!was! associated!with! the! same! risk! factors! as!mortality! (data! not! shown).! Studies!
among! adults! receiving! ART! found! that! almost! half! of! those! lost! to! follow;up! had! died! [29];!
therefore,! it! is!possible! that! the! increased!mortality! in! the!rural!areas!was!due!to!more!successful!
contact!tracing!and!ascertainment!of!outcome.!
!




and! accounts! for! any! observed! differences! in! treatment! outcome.! Third,! this! research! was!
conducted! in! 3! clinics! and! the! profile! of! children! and! their! treatment! outcomes! may! not! be!
representative! of! experiences! in! other! urban! and! rural! clinics! in! Zambia! or! sub;Saharan! Africa.!
Results! from!the!urban!government!clinic!were!similar! to! those!reported! from!the!18!government!
facilities! administered!by!CIDRZ! (Centre! for! Infectious!Disease!Research! in! Zambia)! in! Lusaka! [20],!
and! may! therefore! be! representative! of! the! ART! experience! in! Lusaka! and! other! urban! areas! of!
Zambia.! In! contrast,! the! 2! rural! clinics! were! from! faith;based! health! facilities,! which! may! have!
different! support! and! healthcare! personnel! than! government! clinics! and! may! therefore! not! be!
representative!of!all!rural!clinics!in!Zambia.!
Despite!these! limitations,!these!findings!demonstrate!the!feasibility!of! implementing!pediatric!ART!
programs! in! rural! sub;! Saharan! Africa! and! support! the! continued! expansion! of! ART! programs! to!
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Background:! Many! HIV;infected! children! in! sub;Saharan! Africa! reside! in! rural! areas,! yet! most!




2007!and!September!2010!at! the! rural!HIV!clinic! in!Macha,!Zambia.!HIV;infected!children!younger!
than!16!years!of!age!at!study!enrollment!who!received!antiretroviral!therapy!(ART)!during!the!study!
were! eligible.! Treatment! outcomes! during! the! first! two! years! of! ART,! including! mortality,!
immunologic! status,! and! virologic! suppression,! were! assessed! and! risk! factors! for! mortality! and!
virologic!suppression!were!evaluated.!
!
Results:!A! total! of! 69! children!entered! the! study! receiving!ART!and!198! initiated!ART!after! study!
enrollment.! The! cumulative! probabilities! of! death! among! children! starting! ART! after! study!
enrollment!were!9.0%!and!14.4%!at!6!and!24!months!after!ART!initiation.!Younger!age,!higher!viral!
load,! lower! CD4+! T;cell! percentage! and! lower! weight;for;age! z;scores! at! ART! initiation! were!
associated!with!higher!risk!of!mortality.!The!mean!CD4+!T;cell!percentage!increased!from!16.3%!at!
treatment! initiation! to! 29.3%! and! 35.0%! at! 6! and! 24! months.! The! proportion! of! children! with!




Conclusions:! HIV;infected! children! receiving! treatment! in! a! rural! clinic! experienced! sustained!









With! increasing!evidence! that!pediatric! treatment!programs! in! resource;poor! settings! can!achieve!
treatment! outcomes! comparable! to! those! of! developed! countries! [2,3],! most! countries! in! sub;
Saharan! Africa! have! implemented! policies! to! increase! access! to! antiretroviral! therapy! (ART).!
However,! considerable! inequities! in! access! to! treatment! remain! [4],! as! most! HIV! services! are!
concentrated!in!urban!areas!distant!from!where!many!HIV;infected!children!reside.!
Rural! clinics! and! residents! face! unique! barriers! to! care! and! treatment.! Shortages! of! health! care!
personnel,!equipment!and!drugs!may!more!heavily!affect!rural!clinics,!and!several!studies!identified!
limited!modes!of!transportation!and!food!security!as!factors!affecting!the!ability!of!rural!residents!to!
access! care!and! treatment! [5,6,7,8].! These! factors!may! impact! treatment! responses!of! children.!A!
recent!study!comparing!HIV;infected!children!receiving!ART!in!urban!and!rural!Zambia!found!higher!
levels! of! undernutrition! and! mortality! throughout! treatment! in! the! rural! clinics! [9].! To! minimize!
barriers! to! care,! different! models! of! service! delivery! have! been! implemented! in! rural! areas! to!
increase! accessibility! of! ART,! including! the! use! of! nurses! [10,11,12,13,14,15]! and! general!
practitioners![16]!in!the!provision!of!ART!at!primary!care!clinics,!and!home;based!care!provided!by!
trained!field!officers![17]!and!volunteers![18].!Consequently,!evaluation!of!treatment!programs!and!
treatment!outcomes! in! rural! settings! is!needed.! Several! reports!are!available! from!rural!programs!
[10,12,13,14,15,16,17,18,19],!but!few!focus!on!children![5,11].!















has! been! described! in! detail! elsewhere! [5].! Briefly,! the! catchment! area! of! Macha! Hospital! is!
populated!primarily!by!traditional!villagers!living!in!small,!scattered!homesteads.!Macha!Hospital!is!a!
208;bed!district;level!referral!hospital!administered!by!the!Zambian!Brethren! in!Christ!Church!that!
functions!within! the!healthcare! system!of! the!Ministry! of!Health.! Since!2005,!Macha!Hospital! has!
been!one!of!the!primary!ART!providers!in!the!district!and!has!cared!for!over!6000!HIV!infected!adults!
and!children!through!the!Government!of!Zambia’s!antiretroviral!treatment!program,!with!additional!






medical! doctors! and! clinical! officers,! and! adherence! counseling! by! nurses! and! trained! counselors.!
Eligibility! for! ART! is! determined! based! on! WHO! treatment! guidelines! [20,21].! The! first;line!
antiretroviral! treatment! regimen! consists! of! two! nucleoside! reverse! transcriptase! inhibitors!
(lamivudine! plus! zidovudine,! stavudine! or! abacavir)! and! a! non;nucleoside! reverse! transcriptase!





at! Macha! Hospital! were! eligible! for! enrollment! into! a! prospective,! observational! cohort! study!
beginning! in! September! 2007.! Children! were! evaluated! at! study! visits! approximately! every! three!
months,!at!which! time!a!questionnaire!was!administered! to! the!guardian,! the!child!was!examined!
and! a! blood! specimen! was! obtained.! The! questionnaire! included! information! on! demographic!
information,! household! characteristics,! medical! history,! HIV;related! stigma! and! adherence! for!
children! receiving! treatment.! Adherence! was! measured! at! each! visit! by! pill! count! for! children!
receiving!pills!and!by!weight!for!children!receiving!syrups.!Blood!specimens!were!collected!in!EDTA!
tubes.!As!part!of!routine!clinical!care,!CD4+!T!cell!counts!and!percentages!were!measured!using!the!




performed!on!batched!samples;! therefore,! results!were!not!available! for! clinical! care.! Information!
prior! to! study! enrollment! was! abstracted! from!medical! records.! Home! visits! were! attempted! for!











Data! were! entered! in! duplicate! using! EpiInfo! (Centers! for! Disease! Control! and! Prevention)! and!
analyses!were!conducted! in!SAS! for!Windows!version!9.1! (SAS! Institute! Inc.,!Cary,!NC)!and!STATA,!
version! 9! (StataCorp! LP,! College! Station,! Texas).! Characteristics! at! study! enrollment! and! ART!
initiation! were! compared! between! groups! of! children.! The!Wilcoxon! rank! sum! test! was! used! to!
compare!continuous!variables!and!the!chi;square!test!was!used!to!compare!categorical!variables.!A!
measure! of! socio;economic! status! (SES)! was! calculated! based! on! the! Demographic! and! Health!




(<25th=0–6;! 26–50th=7–12;! 51–75th=13–18;! >75th=19–24).! Weight;for;age! z;scores! were!
calculated! based! on! the! WHO! growth! standards! [23]! and! children! with! z;scores! below! ;2! were!
defined!as!underweight.!Severe!immunodeficiency!was!defined!by!age!according!to!the!2006!WHO!
treatment! guidelines! [20],! and! severe! anemia!was! defined! as! haemoglobin! concentration! <8! g/dL!





CD4+!T;cell! percentage,!WAZ,! anemia!and!viral! load.! Factors!associated!with!mortality! (p<0.10)! in!
the!univariable!models!were!eligible!for!inclusion!in!the!multivariable!model.!!
Immunologic! and! virologic! treatment! outcomes! as! well! as! adherence! were! assessed.! For! all!
outcomes,! children!were! included! if! they! had! at! least! one! post;ART!measure! available.! To! report!
outcomes!at! specific! time!points,!measurements!were!aggregated! to!within!45!days.! Immunologic!








after! ART! initiation!were! assessed! among! children! in! group! B.! As! children! could! contribute!more!
than! one! measure! of! viral! load,! repeated! measures! logistic! regression! models! were! fit! with!
generalized!estimating!equations.!Predictors!of!interest!included!age,!sex,!orphan!status,!education!
of! the!primary!caregiver,!socioeconomic!status,! travel! time,!ART!regimen,!underweight!and!severe!
immunodeficiency! at! ART! initiation.! Adherence! and! the! presence! of! others! in! the! household!









Between! September! 2007! and! September! 2010,! 267! children! received! ART,! including! 69! children!
who! entered! the! study! already! receiving!ART! (Group!A)! and! 198! children!who! initiated!ART! after!
study! enrollment! (Group! B).! Children! in! Group! A! entered! the! study! a! median! of! 8.0! months!















Children!were!primarily! cared! for! by! a! parent! (78.4%),! although!27.9%! reported! that! at! least! one!





! Total!(n=267)! Group!A!(n=69)! Group!B!(n=198)! p=value!
Study+enrolment+
Median!age!in!years!(IQR)! 2.67!(1.41,!6.38)! 3.80!(2.26,!8.54)! 2.21!(1,27,!5.26)! 0.001!
<2!yrs! 104!(39.0)! 14!(20.3)! 90!(45.5)! !
2;5!yrs! 86!(32.2)! 29!(37.7)! 57!(28.8)! !
≥5!yrs! 77!(28.8)! 26!(37.7)! 51!(25.8)! 0.001!
Male!sex!(%)! 131!(49.1)! 41!(59.4)! 90!(45.5)! 0.05!
Mother!received!PMTCT!(%)! 15!(5.3)! 1!(1.5)! 13!(6.6)! 0.19!
Vital!status!of!parents!(%)! ! ! ! !
Both!alive! 189!(72.1)! 41!(62.1)! 148!(75.5)! !
One!parent!died! 52!(19.9)! 15!(22.7)! 37!(18.9)! !
Both!died! 21!(8.0)! 10!(15.2)! 11!(5.6)! 0.03!
Travel!times!(hours)!(%)! ! ! ! !
<1! 24!(9.1)! 6!(9.1)! 18!(9.1)! !
1;2! 80!(30.4)! 21!(31.8)! 59!(30.0)! !
3;4! 88!(33.5)! 19!(28.8)! 69!(35.0)! !
≥5! 71!(27.0)! 20!(30.3)! 51!(25.9)! 0.80!
ART+Initiation+
Median!age!in!years!(IQR)! 2.73!(1.57,!6.73)! 2.90!(1.71,!7.75)! 2.69!(1.50,!5.92)! 0.37!
<1!yrs! 39!(14.6)! 10!(14.5)! 29!(14.7)! !
1;1.9!yrs! 59!(22.1)! 12!(17.4)! 47!(23.7)! !
2;4.9!yrs! 87!(32.6)! 23!(33.3)! 64!(32.3)! !
≥5yrs! 82!(30.7)! 24!(34.8)! 58!(29.3)! 0.69!
Median!WAZ!(IQR)a! ;2.28!(;3.37,!;1.39)! ;2.48!(;3.64,!;1.72)! ;2.16!(;3.22,!;1.34)! 0.10!
Underweight!(%)! 120!(56.6)! 34!(66.7)! 86!(53.4)! 0.10!
Missing!(%)! 55!(20.6)! 18!(26.1)! 37!(18.7)! !
Median!CD4%!(IQR)! 15.9!(10.5,!20.1)! 13.1!(9.4,!16.2)! 16.8!(10.9,!20.6)! 0.03!
Severe!immunodeficiency!(%)b! 140!(63.1)! 28!(73.7)! 112!(60.9)! 0.14!























































(n!=!5),!meningitis! (n!=!2),! cerebral!malaria! (n!=!1),! encephalopathy! (n!=!1),! and!possible!Kaposi’s!
sarcoma! (n!=!1).! Location!of!death!was!available! for!21!children.!Ten!children!died! in! the!hospital!
(47.6%),!two!children!died!on!the!way!to!the!hospital!(9.5%),!one!child!died!in!the!rural!health!center!







improved! within! three! to! six! months! of! starting! ART! (Table! 3).! Mean! CD4+! T;cell! percentage!
increased!from!16.3%!at!treatment!initiation!to!29.3%,!33.9%,!33.0%!and!35.0%!at!6,!12,!18!and!24!
months! on! ART.! Consequently,! the! proportion! of! children! with! a! CD4+! T;cell! percentage! >25%!
increased!from!10.9%!at!treatment!initiation!to!66.7%,!81.5%,!84.5%!and!87.5%!at!6,!12,!18,!and!24!
months!on!ART.!Results!of!the!longitudinal!models!indicated!that!CD4+!T;cell!percentage!increased!
by! 1.80! (standard! error! [SE]:! 0.088;! p;value! ≤0.0001)! percentage! points! per! month! in! the! first! 6!









No!difference! in! the!pattern!of! improvement!was! found!by!age,! sex!or!underweight!status!at!ART!
initiation.!Monthly!increases!in!CD4+!T;cell!percentages!in!children!with!severe!immunodeficiency!at!
ART! initiation! were! significantly! greater! than! in! children! without! severe! immunodeficiency,! both!




Median! viral! load! decreased! rapidly! after! the! start! of! ART,! from! 5.4! log! copies/mL! at! treatment!
initiation! to! <2.6! log! copies/mL! throughout! treatment! (Table! 3).! The! proportion! of! children! with!
undetectable!viral! load! increased!to!90.0%,!88.5%,!88.3%,!86.8%!and!77.8%!at!3,!6,!12,!18!and!24!
months! on! ART.! One! hundred! and! four! children! received! ART! for! at! least! 6!months,! 90! (87%)! of!




The! 4! children! with! persistent! detectable! viral! load! had! no! evidence! of! clinical! or! immunologic!
failure,!and!no!children!in!group!B!were!switched!to!a!second!line!regimen!due!to!treatment!failure!







3!months! 6months! 12!months! 18!months! 24!months!
Immunologic+outcome! N=183! N=149! N=135! N=119! N=97! N=72!
Mean!CD4%!(STD)! 16.3!(7.6)! 26.6!(11.0)! 29.3!(10.4)! 33.9!(9.6)! 33.0!(9.0)! 35.0!(8.5)!
Mean!change!in!CD4%!from!ART!
initiation!(STD)!
_! 9.4!(8.9)! 12.4!(8.5)! 17.4!(8.8)! 17.3!(9.9)! 19.0!(9.2)!
%!with!CD4%!>25%! 10.9! 54.4! 66.7! 81.5! 84.5! 87.5!
%!missing,!of!those!in!carea! 7.8! 27.7! 25.0! 23.7! 20.5! 20.0!
























%!with!undetectable!VL! _! 90.0! 88.5! 88.3! 86.8! 77.8!
%!missing,!of!those!in!carea! 46.5!! 45.1! 35.1! 29.4! 30.3! 34.1!
Adherence+ ! N=150! N=133! N=115! N=87! N=71!
Median!(IQR)! ! 98.5!(89,100)! 98!(93,!100)! 99!(96,!100)! 100!(96,!100)! 99!(95,!100)!
%!≤95%! ! 35.3! 32.3! 23.5! 24.1! 25.4!








Adherence!data!were!available! for!at! least!one!study!visit! for!216!children!(Group!A:!55;!Group!B:!
161).! Estimated!adherence,!defined!as! the!minimum!adherence!of! all! drugs! taken,!over! the! study!
period! was! high,! with! a!median! of! 98–100%! at! all! time! points! up! to! 24!months! after! treatment!
initiation!(Table!3).!The!proportion!of!children!who!were!non;adherent!(adherence!percentage!less!
than! 95%)! decreased! over! time,! from! 35.3%! at! 3! months! to! 25.4%! at! 24!months.!We! examined!
patterns!of!adherence!over!time!to!determine!if!the!same!children!were!consistently!non;adherent.!














































regimens! including! fixed! dose! combinations! were,! however,! less! likely! to! be! non;adherent! (e.g.!






Longer! travel! time,! younger! age,! non;orphan! status! and! use! of! nevirapine! at! ART! initiation!were!
significantly!associated!with!a!lower!risk!of!viral!suppression!(Table!4;!Figure!2).!These!characteristics!
were! correlated,! as! children! with! shorter! travel! times! were! more! likely! to! be! older! and! to! be!
orphans.!Children!receiving!nevirapine!were!also!more!likely!to!be!younger.!After!adjustment,!longer!












This! study!of! treatment!outcomes!among!HIV;infected! children! in! Zambia!demonstrated! that!ART!
could! effectively! be! delivered! in! this! rural! setting! and! that! these! children! responded! well! to!
treatment.!Two!groups!of!children!were!assessed,!those!who!entered!the!study!receiving!ART!and!
those!who!initiated!ART!during!the!study!period.!Children!in!the!latter!group!were!younger!and!had!





The! proportion! of! children! who! died! (14.4%)! within! 24! months! of! starting! ART! was! higher! than!
reported! from!other!studies!of!children! in!sub;Saharan!Africa.!The!KIDS;ART;LINC!study! in!17!sites!
across!sub;Saharan!Africa!reported!cumulative!probabilities!of!mortality!of!4.8%,!6.0%!and!6.0%!at!6,!







follow;up! represented! unreported! deaths! [29].! In! fact,! when! the! IeDEA;SA! study! accounted! for!








24!months!after! initiating!ART.!Contrary! to! the! results!of! an!earlier! cross;sectional! analysis! in! this!
cohort! [5],! early! gains! in! CD4+! T;cell! percentages!were!maintained! throughout! follow;! up.! Similar!
improvements! in! immune! status! were! observed! in! other! African! studies! [2].! The! level! of! viral!
suppression! in! this! cohort,! however,! was! higher! than! reported! in! many! other! studies! of! African!
children! [2,27].! Few! studies! are! available! for! comparison! from! rural! areas,! but! one! study! in! rural!
South!Africa!reported!that!71%!of!children!remaining!on!treatment!after!12!months!achieved!viral!
suppression![30].!
Correlates! of! viral! suppression!were! explored,! including! established! factors! such! as! drug! regimen!
and!adherence,!and!factors!related!to!treatment!in!a!rural!setting,!such!as!travel!time!to!the!clinic.!
Clinical!trials! in!adults![31,32]!and!observational!studies! in!children![33,34,35]!showed!higher!rates!
of! virologic! failure! with! nevirapine;based! regimens! compared! to! efavirenz;based! regimens,!
consistent! with! our! findings.! Adherence! in! this! cohort! was! high! throughout! treatment! and! was!











The! main! novel! factor! associated! with! viral! suppression! was! travel! time.! As! this! was! a! rural!
population,!participants! travelled! from!surrounding!villages! to! the!clinic!and!over!a!quarter!of! the!
study! population! reported! travelling! five! or! more! hours.! Transportation! and! distance! have! been!




is! the! first! report! of! an! association! between! travel! time! and! virologic! outcome,! with! children!
travelling!five!or!more!hours!significantly!less!likely!to!achieve!viral!suppression.!This!relationship!is!
hypothesized! to! be! due! to! the! impact! of! travel! time! on! the! frequency! of! visits! to! the! clinic! and!
pharmacy.! In! this! study,! associations! between! travel! time! and!missed! or! delayed! visits! as!well! as!
adherence!were!not! found;!however,! information!on!pharmacy!or!clinic!appointments! in!between!
study! visits! was! not! available.! This! finding! should! be! confirmed! in! other! populations! as! it! has!
important! implications! for! the! treatment! of! HIV;infected! children! as! treatment! programs! are!
increasingly!implemented!and!scaled!up!in!rural!areas.!
!
The! main! limitations! of! the! study! include! the! small! sample! size,! particularly! at! longer! follow;up!
times,! and! missing! data! on! adherence! and! treatment! outcomes,! which! may! have! led! to! an!
overestimation!of!the!success!of!ART.!However,!this!is!one!of!the!few!pediatric!studies!conducted!in!
rural! sub;Saharan! Africa,! and! the! high! proportion! of! children! with! available! immunologic! and!
virologic!measures!suggests!minimal!bias!for!these!outcomes.!In!addition,!children!cared!for!at!the!
Macha!ART!clinic!benefit!from!being!enrolled!in!a!research!study!and!attending!a!faith;!based!health!
facility,!which!may!have!higher! levels!of! support!and!staffing! than!government!clinics! in! the!same!
region.! While! the! study! relied on! laboratory! tests! (with! the! exception! of! viral! load)! and! clinical!
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Methods:! Between! 2007! and! 2009,! 193!HIV;infected! children!were! enrolled! in! a! cohort! study! in!
Macha,! Zambia.! Children! were! evaluated! every! 3! months,! at! which! time! a! questionnaire! was!
administered,!height!and!weight!were!measured,!and!blood!specimens!were!collected.!Weight;!and!
height;for;age!z;scores!were!constructed!from!WHO!growth!standards.!All!children!receiving!ART!at!
enrollment! or! initiating! ART! during! the! study!were! included! in! this! analysis.! Linear!mixed! effects!
models!were!used!to!model!trajectories!of!weight!and!height;for;age!z;scores.!
!
Results:! A! high! proportion! of! study! children! were! underweight! (59%)! and! stunted! (72%)! at!
treatment!initiation.!Improvements!in!both!weight;!and!height;for;age!z;scores!were!observed,!with!
weight;for;age!z;scores! increasing!during!the! first!6!months!of! treatment!and!then!stabilizing,!and!
height;for;age! z;scores! increasing! consistently! over! time.! Trajectories! of! weight;for;age! z;scores!
differed! by! underweight! status! at! treatment! initiation,! with! children! who! were! underweight!
experiencing!greater!increases!in!z;scores!in!the!first!6!months!of!treatment.!Trajectories!of!height;




high! proportion! of! children! remained! underweight! and! stunted! after! two! years! of! treatment.!








Children! in! sub;Saharan! Africa! have! high! levels! of! undernutrition,! exhibiting! lower! weight;! and!
height;for;age!than!children!in!high!resource!settings.!Both!of!these!conditions!are!exacerbated!by!
HIV! infection! [1;4],!and!can!be!used! to!determine!disease!status!and!monitor! treatment! response!
[5].! As! implementation! of! antiretroviral! treatment! (ART)! programs! in! sub;Saharan! Africa! has!
increased! [6],! many! HIV;infected! children! are! benefitting! from! treatment! and! are! experiencing!
reductions! in! morbidity! and! mortality.! Several! studies! have! shown! that! many! of! the! deficits! in!
growth! due! to! HIV! infection! are! reversed! with! ART,! with! children! exhibiting! consistent!
improvements! in! weight;for;age! [7;19].! Some! studies,! but! not! all! [12,13,17],! have! also! reported!
improvements! in! height;for;age! [7;10,14,16,18,19].! Gains! in!weight! have! been! found! to! correlate!
with!treatment!response![19].!
Many!of!these!studies!have!been!conducted!in!urban!areas,!where!food!security!tends!to!be!higher!
and! levels!of!undernutrition! lower!than! in!surrounding!rural!areas![20].! In!addition,!many!of!these!
studies!were!conducted!in!the!first!years!of!program!implementation!when!the!majority!of!children!
initiating!ART!were!older! [21].!Both!age![11]!and! level!of!undernutrition!at!treatment! initiation![7]!
have!the!potential!to!impact!growth!trajectories!and!the!effect!of!ART.!Consequently,!this!study!was!








setting! and! population! have! been! described! in! detail! elsewhere! [22].! Briefly,!Macha!Hospital! is! a!
district;level! referral! hospital! administered!by! the! Zambian!Brethren! in! Christ! Church.! Since! 2005,!
Macha! Hospital! has! provided! care! to! over! 6000! HIV;infected! adults! and! children! through! the!
Government! of! Zambia’s! antiretroviral! treatment! program,! with! additional! support! from! the!
President’s! Emergency! Plan! for! AIDS! Relief! (PEPFAR)! through! the! non;governmental! organization,!
AidsRelief.!
Children!with!a!positive!HIV!serologic! test!are!referred!to!the!clinic! from!voluntary!counseling!and!
testing! programs,! outpatient! clinics! and! rural! health! centers.! Early! infant! diagnosis! has! been!
available! since! February! 2008.! Clinical! care! is! provided! without! charge! by! medical! doctors! and!
clinical! officers,! and! adherence! counseling! by! nurses! and! trained! counselors.! ART! is! initiated!
according!to!WHO!guidelines![23,24].!The!first;line!antiretroviral!treatment!regimen!consists!of!two!
nucleoside! reverse! transcriptase! inhibitors! (lamivudine! (3TC)! plus! zidovudine! (AZT)! or! stavudine!





Beginning! in!September!2007,!HIV;infected!children!younger! than!16!years! seeking!HIV! care!were!
eligible!for!enrollment!into!a!cohort!study.!Written!informed!consent!was!obtained!from!parents!or!
guardians! and! assent! was! obtained! from! children! 8;16! years! of! age.! Children! were! evaluated! at!
study!visits!approximately!every!three!months,!at!which!time!a!questionnaire!was!administered,!the!












Data! were! entered! in! duplicate! using! EpiInfo! (Centers! for! Disease! Control! and! Prevention)! and!
analyses!were!conducted!in!STATA,!version!9!(StataCorp!LP,!College!Station,!Texas).!Weight;for;age!




WAZ! and! HAZ! after! ART! initiation! were! assessed! among! children! with! at! least! one! post;ART!
measure.! Children!were! followed!until! they!died,!were! lost! to! follow;up,! or!were! administratively!
censored! on! September! 30,! 2009.! Children! who! had! not! returned! for! at! least! 6! months! were!
assumed! lost! to! follow;up.! For! reporting! outcomes! at! specific! time! points! after! ART! initiation,!
measurements!were!aggregated!to!within!45!days.!Treatment!outcomes!were!evaluated!using!linear!
mixed! effects! models! with! random! intercept,! exchangeable! correlation! structure! and! robust!
standard! error! estimation.! As! changes! in! WAZ! were! not! linear,! a! spline! term! was! added! at! 7.5!
months,! the! upper! window! around! the! 6;! month! measure.! Covariates! of! interest! included! sex,!
orphan! status,! education! of! the! primary! caregiver,! age,! underweight,! stunting! and! severe!









receiving! ART! and! 126! initiating! ART! after! study! enrollment.! Children! receiving! ART! at! study!
enrollment! entered!a!median!of! 8.3!months! (IQR:! 2.3,! 17.7)! after! initiating!ART,!while! treatment;



















Study+enrollment+ ! ! ! !
Median!age!in!years!(IQR)! 3.01!(1.62,!6.89)! 4.25!(2.46,!8.61)! 2.53!(1.27,!6.34)! 0.0005!
<1!yr! 24!(12.4)! 2!(3.0)! 22!(17.5)! !
1;1.9!yrs! 38!(19.7)! 8!(11.9)! 30!(23.8)! !
2;4.9!yrs! 66!(34.2)! 29!(43.3)! 37!(29.4)! !
5+!yrs! 65!(33.7)! 28!(41.8)! 37!(29.4)! 0.002!
Male!sex! 99!(51.3)! 43!(64.2)! 56!(44.4)! 0.009!
Mother!received!PMTCT!(%)! 5!(2.6)! 0!(0.0)! 5!(4.0)! 0.24!
Vital!status!of!parents!(%)! ! ! ! !
Both!alive! 135!(71.1)! 39!(60.9)! 96!(76.2)! !
One!parent!died! 37!(19.5)! 15!(23.4)! 22!(17.5)! !
Both!died! 18!(9.5)! 10!(15.6)! 8!(6.4)! 0.05!
Primary!caregiver!(%)! ! ! ! !
Mother/father! 148!(77.5)! 48!(73.9)! 100!(79.4)! !
Grandparent! 26!(13.6)! 11!(16.9)! 15!(11.9)! !
Aunt/uncle! 12!(6.3)! 5!(7.7)! 7!(5.6)! !
Other! 5!(2.6)! 1!(1.5)! 4!(3.2)! 0.55!
Education!of!primary!caregiver!(%)!
None! 11!(6.3)! 3!(5.3)! 8!(6.8)! !
Primary! 100!(57.1)! 31!(54.4)! 69!(58.5)! !
Secondary! 62!(35.4)! 23!(40.4)! 39!(33.1)! !
Higher! 2!(1.1)! 0!(0.0)! 2!(1.7)! 0.62!
ART+initiation+ ! ! ! !
Median!age!in!years!(IQR)! 2.93!(1.66,!6.84)! 3.07!(1.71,!7.91)! 2.87!(1.60,!6.73)! 0.33!
<1!yr! 23!(11.9)! 6!(9.0)! 17!(13.5)! !
1;1.9!yrs! 41!(21.2)! 15!(22.4)! 26!(20.6)! !
!2;4.9!yrs! 64!(33.2)! 21!(31.3)! 43!(34.1)! !
5+!yrs! 65!(33.7)! 25!(37.3)! 40!(31.8)! 0.72!
Median!WAZ!(IQR)a! ;2.30!(;3.46,!;1.37)! ;2.55!(;3.92,!;1.80)! ;2.10!(;3.22,!;1.26)! 0.02!
Underweight! 89!(58.9)! 34!(70.8)! 55!(53.4)! 0.04!
Median!HAZ!(IQR)! ;3.49!(;4.47,!;2.41)! ;4.86!(;6.26,!;3.15)! ;3.40!(;4.32,!;2.33)! 0.17!
Stunted! 53!(79.1)! 7!(87.5)! 46!(78.0)! 0.53!
Median!CD4%!(IQR)! 16.3!(11.5,!20.1)! 13.6!(9.7,!16.6)! 17.4!(12.9,!20.5)! 0.01!
Severe!immunodeficiency!
(%)b!











of! primary! care;! givers! had! no! high! school! education! and! 9.5%! of! children!were! double! orphans.!
Very!few!mothers!(2.6%)!had!received!drugs!to!prevent!mother;to;child!transmission.!
The!median! age! at! ART! initiation!was! 2.9! years! (IQR:! 1.7,! 6.8).! The!median!WAZ! and!HAZ! at! ART!







a! regimen! including! ABC! (2.0%)! and! one! child! received! a! regimen! including! emtricitabine! and!
tenofovir!(0.5%).!



















1.4! and! ;1.7! at! 6,! 12,! 18! and! 24! months! on! ART,! respectively! (Figure! 1A).! Consequently,! the!
proportion!of!underweight!children!decreased!from!59.7%!at!treatment! initiation!to!28.8%,!35.3%,!
26.5%!and!45.0%!at!6,!12,!18,!and!24!months!on!ART,!respectively.!Results!of!the!crude!longitudinal!

















Crude+model+ ! ! ! ! !
Time!(per!month)!on!ART! ! ! ! 0.053!(0.012)! <0.0001!
0;6!months! 0.12!(0.02)! <0.0001! ! ! !
>6!months! ;0.003!(0.012)! 0.81! ! ! !
Adjusted+model+ ! ! ! ! !
Time!(per!month)!on!ART! ! ! ! 0.10!(0.01)! <0.0001!
0;6!months!! 0.12!(0.02)! <0.0001! ! ! !
>6!months! 0.003!(0.01)! 0.72! ! ! !
Female! 0.48!(0.21)! 0.02! ! 0.60!(0.29)! 0.04!
Severe!immunodeficiencyb,c! ;0.35!(0.21)! 0.09! ! ;0.55!(0.29)! 0.06!
Age!(years)c! ! ! ! ! !
2;4.9! ;0.55!(0.26)! 0.04! ! 0.49!(0.41)! 0.23!
≥5! ;0.52!(0.27)! 0.05! ! 1.16!(0.36)! 0.001!
Double!orphanc! ;0.70!(0.29)! 0.02! ! ! !
Underweightc! ! ! ! ;1.68!(0.31)! <0.0001!
Stratified+by+WAZ+at+ART+initiationd:!
WAZ!≥;2!(ref)! ! ! ! ! !
0;6!months!(per!month)! 0.04!(0.02)! 0.08! ! ! !
>6!months!(per!month)! 0.04!(0.01)! 0.005! ! ! !




>6!months!(per!month)! ;0.01!(0.01)! 0.21!/!0.003! ! ! !
Stratified+by+age+(years)+at+ART+initiationd:!
0;1.9!(ref):!time!(per!month)! ! ! ! 0.15!(0.025)! <0.0001!
2;4.9:!time!(per!month)! ! ! ! 0.11!(0.020)! <0.0001!/!0.18!









Male! sex,! double! orphan! status! and! older! age! at! ART! initiation!were! significantly! associated!with!
lower!WAZ.!Severe! immunodeficiency!at!ART! initiation!was!marginally!associated!with! lower!WAZ.!





















both! weight! and! height;for;age! improved! after! initiation! of! ART.! Age! and! undernutrition! at! ART!





minimal! improvements! thereafter,! whereas! HAZ! consistently! improved! over! time.! Similar!
trajectories! for!WAZ!and!HAZ!were!reported! in!one!study! in!South!Africa! [10],!while!other!studies!
found! linear! improvements! in!WAZ!during! the! first! 24!months! of! treatment! [11,26].! ! Reasons! for!
these!differences!are!unknown!but!may!be!due! to! the!higher! levels!of!undernutrition!observed! in!
this! rural! population! [26].!Over! half! of! the! study! population!was underweight! and! three;quarters!
stunted! at! ART! initiation.! Differences! in! trajectories! were! found! between! children! who! were!
underweight!and!those!with!normal!weight,!with!greater!weight!improvements!in!the!first!6!months!
for!children!underweight!at!ART! initiation.!A!more!consistent! increase!was!found!for!children!with!
normal!weight.! Consequently,! it! is! possible! that! this! group!of! rural! children! experienced!different!
trajectories!than!the!urban!populations!in!previous!studies.!
Due!to!the!relatively!young!age!of!the!study!population,!the!impact!of!age!at!ART!initiation!on!both!
WAZ! and! HAZ! could! be! evaluated.! Older! age! was! associated! with! both! WAZ! and! HAZ! at! ART!
initiation;! however,! only! age! impacted! the! trajectories! for! HAZ,! with! children! older! than! 5! years!









children!with!measures! available! at!ART! initiation! (Figure! 1).! The! role! of! food! supplementation! in!
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some! children!die!prior! to!ART! initiation.! This! study!was!undertaken! to!determine!mortality! rates!
and!clinical!predictors!of!mortality!during!the!period!prior!to!ART!initiation.!
!
Methods:! A! prospective! cohort! study! of! HIV;infected! treatment;naïve! children! was! conducted!
between!September!2007!and!September!2010!at!the!HIV!clinic!at!Macha!Hospital!in!rural!Southern!
Province,!Zambia.!HIV;infected!children!younger!than!16!years!of!age!who!were!treatment;naïve!at!
study! enrollment!were! eligible! for! analysis.!Mortality! rates! prior! to!ART! initiation!were! calculated!
and!risk!factors!for!mortality!were!evaluated.!
!
Results:! 351! children!were! included! in! the! study,! of! whom! 210! (59.8%)!were! eligible! for! ART! at!
study!enrollment.!Among!children! ineligible! for!ART!at!enrollment,!6!children!died! (mortality! rate:!
0.33;!95%!CI:!0.15,!0.74).!Among!children!eligible!at!enrollment,!21!children!died!before!initiation!of!
ART!and!their!mortality!rate!(2.73!per!100!person;years;!95%!CI:!1.78,!4.18)!was!significantly!higher!
than! among! children! ineligible! for! ART! (incidence! rate! ratio:! 8.20;! 95%! CI:! 3.20,! 24.83).! In! both!














Since! 2003,! antiretroviral! treatment! (ART)! programs! in! sub;Saharan! Africa! have! rapidly! scaled;up!
and! currently! provide! treatment! to! an! estimated! 356,000!HIV;infected! children! [1].! Reports! from!







supporter’)! [4,5,6,7].!During! this! time,! children!also!are!diagnosed!and! treated! for!any! concurrent!
opportunistic! infections.! In! addition,! children! not! eligible! for! ART! at! enrollment! are! monitored,!
typically!every!three!months,!and!may!experience!rapid!disease!progression.!Few!programs!report!
outcomes!during!this!period!prior!to!ART!initiation,!but!several!studies!among!adults![5,7,8,9,10,11]!
and! children! [3,6,12,13]! indicate! that! significant! mortality! occurs! among! both! ART! eligible! and!








The! study! was! approved! by! the! Government! of! Zambia! Ministry! of! Health,! the! Research! Ethics!
Committee! of! the! University! of! Zambia! and! the! Institutional! Review! Board! of! the! Johns! Hopkins!






district;level! referral! hospital! administered!by! the! Zambian!Brethren! in! Christ! Church.! Since! 2005,!
Macha! Hospital! has! provided! care! to! over! 7000! HIV;infected! adults! and! children! through! the!
Government! of! Zambia’s! antiretroviral! treatment! program,! with! additional! support! from! the!
President’s! Emergency! Plan! for! AIDS! Relief! (PEPFAR)! through! the! non;governmental! organization,!
AidsRelief.!
Children!with!a!positive!HIV!serologic! test!are!referred!to!the!clinic! from!voluntary!counseling!and!
testing! programs,! outpatient! clinics! and! rural! health! centers.! Early! infant! diagnosis! based! on!
detection!of!HIV!DNA!has!been!available!since!February!2008.!
Clinical! care! is! provided! without! charge! by! medical! doctors! and! clinical! officers,! and! adherence!
counseling!by!nurses! and! trained! counselors.! Routine! follow!up!occurs! approximately! every! three!








Beginning! in!September!2007,!HIV;infected!children!younger! than!16!years! seeking!HIV! care!were!
eligible! for! enrollment! into! a! cohort! study.! Children!were! evaluated! at! study! visits! approximately!
every!three!months,!at!which!time!a!questionnaire!was!administered,!the!child!was!examined!and!a!
blood! specimen! was! obtained.! The! study! questionnaire! was! designed! to! collect! information! on!
demographics,! the! vital! status! and! education! of! the! parents! and! primary! caregiver,! the! child’s!
medical,! medication,! and! vaccination! history,! disclosure! of! HIV! status! and! transportation! to! the!
clinic.! During! each! physical! examination,! height! and! weight! were! measured.! As! part! of! routine!
clinical!care,!CD4+!T!cell!counts!and!percentages!were!measured!using!the!Guava!Easy!CD4!system!
(Guava! Technologies,! Inc.,! Hayward,CA).! Hemoglobin! was! measured! using! an! ABX! Micros! ES! 60!
Hematology! Analyzer! (Horiba!Medical,! France).! For! children! who!missed! study! visits,! home! visits!
were! attempted! to! ascertain! their! status.! For! children!who! died,! cause! of! death!was! ascertained!





and!September!2010!were! included.!Children!were! followed!until! the! first!of!either!ART! initiation,!
death,! loss! to! follow;up! or! September! 1,! 2010.! Children! whose! last! visit! occurred!more! than! six!
months!prior!to!September!1,!2010!were!considered!lost!to!follow;up.!!
Eligibility! for! ART! at! study! enrollment! was! defined! retrospectively! based! on! the!WHO! criteria! in!
effect! at! the! time! of! study! enrollment.! At! the! beginning! of! the! study,! the! 2006!WHO! treatment!
guidelines! were! in! effect! [16],! which! recommended! ART! for! all! children! with!WHO! stage! 3! or! 4!
irrespective!of!immunologic!status.!For!children!with!WHO!stage!1!or!2,!ART!was!recommended!on!






was! defined!based!on! immunologic! or! clinical! criteria! alone.! Immunologic! and! clinical! parameters!





the! 2006! WHO! treatment! guidelines! (≤11! months:! <25%;! 12–35! months:! <20%;! 36–59! months:!
<15%;!≥5!years:!<15%)![16].!Severe!anemia!was!defined!as!hemoglobin!<8!g/dL![19].!A!measure!of!
socioeconomic!status! (SES)!was!calculated!based!on!the!Demographic!and!Health!Survey!SES!scale!




50th! =! 7–12;! 51–75th! =! 13–18;! >75th! =! 19–24).! Kaplan;Meier! survival! methods! were! used! to!
estimate! the! cumulative! probability! of! ART! initiation! and! death.! Survival! curves! were! compared!
between!groups!using!the!logrank!test.!Mortality!rates!were!calculated!per!100!person;years!at!risk!
and!were! compared!using!Poisson! regression.! Risk! factors! for!mortality!were!evaluated!using!Cox!
proportional! hazards! regression.! Characteristics! associated! with! mortality! in! univariable! analysis!
(p<0.1)!were!considered!for!inclusion!in!the!multivariable!model.!All!analyses!were!conducted!in!SAS!







362! were! enrolled.! Three! hundred! and! fifty;one! (97%)! children! had! sufficient! information! to!




single! or! double! orphans! (Table! 1).! Over! half! (54.0%)! of! children! were! moderately! (24.1%)! or!














































































































(2.6%)! transferred! to! another! clinic,! 27! (7.7%)! died,! and! 108! (30.8%)! were! still! in! care! but! not!
receiving!ART.!Children!eligible!for!ART!at!enrollment!were!significantly!more!likely!to!have!started!
ART! (p<0.0001)! and!died! (p! =! 0.05)! (Figure! 1).! Among! children! eligible! at! enrollment,! the!median!
time!from!study!enrollment!to!ART!initiation!was!2.07!months!(IQR:!0.92,!6.59)!(Figure!2).!!
!
At! 12! and! 24! months,! the! cumulative! probability! of! ART! initiation! was! 84.1%! and! 88.0%,!
respectively.!Chart!reviews!were!conducted!for!69!children!who!had!either!taken!more!than!three!
months! to! initiate! ART! or! had! been! enrolled! in! the! study! for! more! than! three! months! without!
starting!ART! to!determine! reasons! for! potential! delays! in!ART! initiation! (Table! 2).! The!majority! of!
children!(81.2%)!were!found!to!have!an!identifiable!reason!for!delay.!The!most!common!reason!was!






































Other! reasons! included! provider! delay! (28.6%),! primarily! due! to! misinterpretation! of! laboratory!
results,! HIV! staging! or! eligibility! criteria! by! clinicians;! medical! delay! (19.6%),! primarily! due! to!
treatment! for! tuberculosis;! and! a! combination! of! family,! provider! and! medical! delays! (16.1%).!
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The! overall! pre;ART! mortality! rate! was! 1.05! (95%! CI:! 0.72,! 1.53)! per! 100! person;years.! Among!
children! ineligible! for!ART,! the!mortality! rate!was! 0.33! (95%!CI:! 0.15,! 0.74)! per! 100!person;years.!























score! (HR! for! <! ;3! vs.! ≥! ;2:! 7.63;! 95%! CI:! 1.80,! 32.39)! and! anemia! (HR:! 3.50;! 95%! CI:! 1.25,! 9.77)!
remained! independently! associated! with! a! higher! risk! of! mortality! (Table! 4).! Younger! age! was!
marginally!independently!associated!with!mortality!(hazard!rate![HR]!for!<2!years!vs.!≥5!years:!3.58;!
95%!CI:!0.98,!13.09).!CD4+!T;cell!percentage!at!study!enrollment!and!sex!were!not!associated!with!
mortality.! The! cumulative!probability!of!mortality! six!months!after! study!enrollment!was!8.0%! for!
children!with!WAZ!≥!;2,!24.3%!for!children!with!WAZ!;3!to!;2,!and!35.0%!for!children!with!WAZ!<!;3!
(logrank!test!=0.04;!Figure!4A).!The!cumulative!probability!of!mortality!six!months!after!enrollment!
was! 13.8%! for! children!without! anemia! and! 34.6%! for! children!with! anemia! (logrank! test=! 0.001;!

















Male!sex! 10!(37.0)! 87!(46.0)! 0.38! 61!(45.2)! 0.44!
Median!age!(IQR)! 1.4!(0.7,!2.6)! 2.0!(1.1,!4.7)! 0.07! 4.3!(2.1,!7.0)! <0.0001!
<2!yrs! 18!(66.7)! 94!(46.8)! ! 31!(23.0)! !
!2;4!yrs! 5!(18.5)! 58!(28.9)! ! 49!(36.3)! !
≥5!yrs! 4!(14.8)! 49!(24.4)! 0.20! 55!(40.7)! <0.0001!
Median!WAZ!(IQR)c! ;3.7!(;4.4,!;2.1)! ;2.3!(;3.6,!;1.4)! 0.03! ;1.8!(;2.6,!;0.9)! 0.0002!
!!≥;2! 4!(21.1)! 71!(42.0)! ! 59!(54.6)! !
<!;2!to!;3! 4!(21.1)! 37!(21.9)! ! 31!(28.7)! !
!<!;3! 11!(57.9)! 61!(36.1)! 0.12! 18!(16.7)! 0.0003!
Median!CD4%!(IQR)! 20.7!(14.9,!26.8)! 17.0!(10.5,!21.1)! 0.03! 25.8!(22.1,!33.3)! 0.001!
Severe!immunodeficiencyd! 10!(41.7)! 119!(67.2)! 0.01! 0!(0.0)! <0.0001!
Median!hemoglobin!(IQR)! 8.9!(7.7,!9.3)! 9.5!(8.6,!10.5)! 0.002! 10.6!(9.3,!11.3)! <0.0001!
<8!g/dL! 8!(33.3)! 21!(11.4)! 0.001! 7!(5.9)! <0.0001!
WHO!stage! ! ! ! ! !
1! 1!(5.3)! 11!(7.1)! ! 38!(41.3)! !
!2! 3!(15.8)! 21!(13.7)! ! 54!(58.7)! !
3!or!4! 15!(78.9)! 121!(79.1)! 0.51! 0!(0.0)! <0.0001!
Parent’s!vital!status! ! ! ! ! !
Both!alive! 19!(73.1)! 151!(79.9)! ! 94!(71.2)! !
One!parent!died! 7!(26.9)! 28!(14.8)! ! 29!(22.0)! !
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Male!sex! 0.53!(0.20,!1.37)! ;;;! 2.47!(0.45,!13.49)!
Age!(years)! ! ! !
<2! 3.31!(0.96,!11.42)! 3.58!(0.98,!13.09)! 3.90!(0.35,!43.23)!
!2;4! 0.63!(0.11,!3.78)! 1.03!(0.16,!6.60)! 3.29!(0.34,!31.74)!
≥5! 1! 1! 1!
Weight;for;age!z;scorea! 0.74!(0.54,!1.01)! ! 0.48!(0.26,!0.91)!
≥!;2! 1! 1! ;;;!
<!;2!to!;3! 2.76!(0.62,!12.34)! 4.47!(0.88,!22.74)! ;;;!
<!;3! 4.62!(1.23,!17.28)! 7.63!(1.80,!32.39)! ;;;!
CD4%!(per!10)! 1.17!(0.71,!1.95)! ;;;! 0.53!(0.16,!1.75)!
Severe!immunodeficiencyb! 0.92!(0.36,!2.36)! ;;;! ;;;!









the! first! few!months! after! enrollment! among! children! eligible! for! ART.! Risk! factors! for! mortality!
included! younger! age,! undernutrition! and! anemia,! and! were! similar! among! children! eligible! and!
ineligible!for!ART!at!study!enrollment.!
Most! treatment!programs!report!on!mortality!and!treatment!outcomes!after! initiation!of!ART!and!
few!have! focused!on! the!period!prior! to!ART! initiation.!However,! this!period! should!be!evaluated!
along!with! the! interval! after! ART! initiation! as! it! provides! additional! insight! into! the! population! of!
children! reached! by! the! program! and! the! effectiveness! of! the! treatment! program! in! reducing!
mortality.!A!study!of!HIV;infected!children!from!Cambodia!evaluated!mortality!prior!to!and!after!ART!
initiation! and! found! that! the! majority! of! deaths! occurred! before! starting! ART! [6].! Similar! to! this!
study,! the!majority! of! deaths! occurred!within! the! first! three!months! after! enrollment! and! among!








and! that! 12.3%! of! ART;naïve! children! compared! to! 9.5%! of! children! on! ART! in!Mozambique! died!
during!follow;up![12].!Similar!trends!of!high!pre;ART!mortality! in!the!first!few!months!of!follow;up!
and!similar!risk! factors!were!also! found! in!studies!of!HIV;infected!adults! [5,7,8,9,10].! In!this!study,!

















for! maintaining! high! adherence! in! their! children.! This! process! can! take! longer! in! rural! areas! as!
transportation!and!travel!distance!pose!challenges,!and!necessitate! longer! intervals!between!visits!
and!synchronization!of!visits!with!other!family!members![3].!Additional!delays!in!ART!initiation!can!
lengthen! this! period,! and! can! be! due! to! treatment! for! concurrent! tuberculosis! or! other! illnesses,!
insufficient!human!resources!(primarily!in!the!early!years!of!a!treatment!program),!incorrect!clinical!
or! immunological! staging! by! physicians,! and! social! problems! in! the! family,! such! as! lack! of!










percentage,! lower! WAZ,! and! lower! hemoglobin.! These! characteristics! were! well;established! risk!




this! study,! risk! factors! for!mortality! among! children! eligible! for!ART! included! younger! age,! severe!
undernutrition!and!severe!anemia.!Interestingly,!CD4+!T;cell!percentage!was!not!predictive!of!early!
mortality,!although!the!median!CD4+!T;cell!percentage!was!relatively!high!in!this!group!of!children.!
These! risk! factors! are! similar! to! risk! factors! for! early! mortality! among! children! receiving! ART!
[3,25,26,27].! As! a! result! of! the! late! stage! of! disease! at! study! enrollment,! most! deaths! occurred!
within! the! first! few! months! of! follow;up! before! children! could! prepare! for! and! start! ART.!
Consequently,!continued!efforts!are!needed!to!promote!testing!of!infants!and!children!so!that!HIV;




There!were! several! limitations! to! this! study.! First,! the! follow;up! time!was! relatively! short! and! the!
number!of!observed!deaths!was! low,!particularly! among! children! ineligible! for!ART,!which! limited!
our!ability!to!evaluate!risk!factors!for!mortality!in!this!group.!Second,!study!enrollment!was!used!as!a!
proxy!for!clinic!enrollment,!as!children!had!only!been!seen!in!the!clinic!for!a!short!duration!prior!to!
study! enrollment.! The! reported!mortality! rates!may,! therefore,! underestimate! the! true!mortality!
rate! in!this!population,!as!deaths!may!have!occurred!soon!after!clinic!enrolment,!which!would!not!
have!been!captured.!However,!the!loss!to!follow;up!was!low!and!it!is!unlikely!that!many!deaths!were!
not! reported.! The! mortality! rate! is! likely! to! be! accurate! for! the! group! of! children! surviving! long!
enough! to! enroll! in! the! study.! Lastly,! eligibility! at! study! enrollment! was! defined! retrospectively!
based!on!immunologic!and!clinical!criteria.!Some!misclassification!of!eligibility!status!is!likely!to!have!
occurred,!as!children!with!undernutrition!in!this!setting!who!are!initially!classified!as!WHO!stage!3!or!
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initiated! a! NVP;based! regimen,! 7! of! whom! also! were! treated! for! tuberculosis.! Children! receiving!
both!regimens!were!comparable!in!age,!but!children!receiving!EFV!started!ART!with!a!lower!CD4+!T;
cell! percentage! and! weight;for;age! z;score.! Children! receiving! EFV! experienced! increases! in! both!
CD4+! T;cell! percentage! and! weight;for;age! z;score! during! follow;up,! such! that! levels! were!
comparable!to!children!receiving!NVP!after!two!years!of!ART.!Cumulative!survival!after!12!months!of!
ART! did! not! differ! between! groups! (NVP:87%;! EFV:80%;! p=0.25).! Eleven! children! experienced!
virologic! failure! during! follow;up.! The! adjusted! hazard! ratio! of! virologic! failure! comparing! EFV! to!














The! dual! burden! of! human! immunodeficiency! virus! (HIV)! infection! and! tuberculosis! represents! a!
significant! threat! to!the!health!of!children! in!sub;Saharan!Africa.!An!estimated!3.4!million!children!
worldwide!are!infected!with!HIV![1],!the!majority!of!whom!live!in!sub;Saharan!Africa.!In!areas!of!high!
HIV!prevalence,! as!many!as!half! of! incident!pediatric! tuberculosis! cases!occur! in! children! infected!











The!optimal! antiretroviral! regimen! for! children! receiving! anti;tuberculous! treatment!has!not!been!
established.! Rifampicin! is! a! potent! inducer! of! the! cytochrome! P450! system! and! hepatic!
glucuronidation,!resulting!in!significant!reductions!in!serum!levels!of!several!antiretroviral!drugs![8].!
The!alternative,! rifabutin,!has! fewer!drug! interactions!but! is!often!not!available! in!most! resource;
limited! settings,! has! not! undergone! formal! pharmacokinetic! and! safety! studies! in! children,! and! is!
associated!with!corneal!deposits!and!other!ocular!toxicity!in!children![9].!The!preferred!antiretroviral!
regimen!for!co;administration!with!rifampicin!in!adults!and!older!children!is!two!nucleoside!reverse!




The! product! labeling! for! EFV! includes! dosages! only! for! children! older! than! 3! years! of! age! and!
weighing!greater!than!10!kg,!as!EFV!dosing!for!younger!or!smaller!children!had!not!been!established.!




In! the! P1021! trial,! which! assessed! the! efficacy! of! a! once;daily! regimen! containing! didanosine,!
emtricitabine! and! EFV,! serum!EFV! levels! in! children! younger! than! 3! years! of! age!were!within! the!






Given! the! limited! antiretroviral! treatment! options! in! resource;constrained! settings! for! children!
receiving!rifampicin,!and!the!need!to!initiate!ART!as!soon!as!possible!to!avoid!excess!morbidity!and!
mortality,! an!EFV!dosing! schedule!extrapolated! from!available!data!was!developed! for! the! clinical!
care!of!young!children!with!tuberculosis.!We!assessed!the!effectiveness!of!EFV;based!regimens!by!
comparing!treatment!outcomes!between!young!co;infected!children!receiving!both!anti;tuberculous!
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The!study!was!conducted!at! the!pediatric!HIV!clinic!at!Macha!Hospital! in! rural! Southern!Province,!
Zambia.!The!study!setting!and!population!were!described!in!detail!elsewhere![23,24].!Briefly,!Macha!
Hospital! is!a!district;level! referral!hospital! that!has!provided!care! to!over!7500!HIV;infected!adults!
and!children!since!2005.!HIV!care!services,!including!antiretroviral!treatment,!are!provided!through!
the!Government! of! Zambia’s! antiretroviral! treatment! program,!with! support! from! the! President's!
Emergency! Plan! for! AIDS! Relief! (PEPFAR)! through! the! non;governmental! organization,! AIDSRelief.!
Care!and!treatment!are!provided!free!of!charge!by!medical!doctors!and!clinical!officers.!Mothers!and!
infants! are! provided! drugs! to! prevent! mother! to! child! transmission! (PMTCT)! according! to! WHO!
guidelines! [25].! Children! diagnosed! with! HIV! infection! are! determined! to! be! eligible! for! ART!
according!to!the!WHO!treatment!guidelines![6,14,15].!Standard!ART!regimens!consist!of!stavudine!or!
zidovudine!plus!lamivudine,!and!a!non;nucleoside!reverse!transcriptase!inhibitor!(NVP!or!EFV).!!
Young! children! suspected! of! having! tuberculosis! undergo! a! physical! examination! and! chest!
radiograph.!The!clinical!diagnosis!of!tuberculosis! is!based!on!the!results!of!these!examinations!and!
the! judgment!of! the!health! care!provider.! Children!with! tuberculosis! are! treated!with! isoniazid! (6!
months),!rifampicin!(6!months),!and!pyrazinamide!(2!months).!Children!treated!with!rifampicin!and!
eligible!for!ART!are!treated!with!two!NRTI!and!EFV.!!An!EFV!dosing!schedule!based!on!available!data!
[16,17,18,19,20,21,26]! was! provided! to! clinics! supported! by! AIDSRelief! throughout! Zambia!














approximately! every! three! months,! at! which! time! a! questionnaire! was! administered! to! obtain!
information! on! demographics,! household! characteristics! and! medical! history.! The! child! was!
examined!to!measure!height!and!weight,!and!a!blood!specimen!was!obtained!to!measure!CD4+!T;cell!
counts!and!percentages! (Guava!Easy!CD4!system;!Guava!Technologics,! Inc.,!Hayward,!CA)!and!ALT!
(Reflotron! Plus! Chemistry! Analyzer! and! Cobas! C111;! Roche!Molecular! Systems)! as! part! of! clinical!
care.!Plasma!levels!of!HIV!RNA!were!quantified!by!reverse!transcriptase!polymerase!chain!reaction!












nucleoside! analogues! plus! either! EFV! or! NVP! prior! to! January! 1,! 2011! (Figure! 1).! The! group! of!




NVP! who! were! subsequently! diagnosed! with! tuberculosis! (n=4)! were! excluded.! Children! were!











































Data! were! entered! in! duplicate! using! EpiInfo! (Centers! for! Disease! Control! and! Prevention)! and!
analyses!were!conducted!using!SAS!for!Windows!version!9.1!(SAS!Institute!Inc.,!Cary,!NC)!and!STATA,!
version! 9! (StataCorp! LP,! College! Station,! TX).! Characteristics! of! children! receiving!NVP! and! EFV! at!
ART! initiation! were! compared! using! chi;square! tests! for! binary! variables! and!Wilcoxon! rank! sum!
tests!for!continuous!variables.!Severe!immunosuppression!was!defined!by!age!according!to!the!2006!
WHO! treatment! guidelines! [14].! Weight;for;age! (WAZ)! z;scores! were! calculated! based! on! WHO!
growth!standards![27],!and!children!with!WAZ!below!;2!were!considered!underweight.!Children!with!
hemoglobin!<8!g/dL!were!considered!severely!anemic![28].!Use!of!drugs!by!the!mother!or!child!to!
prevent! mother! to! child! transmission! (PMTCT)! was! ascertained! by! interview! and! confirmed! by!
review! of! medical! records.! If! measurements! were! not! available! from! the! visit! at! which! ART! was!
initiated,!results!within!3!months!prior!to!the!date!of!initiation!were!used.!!!
Clinical!and!immunologic!outcomes!were!evaluated!among!children!with!at!least!one!measurement!
after! ART! initiation! using! longitudinal! data! analysis.! Linear! mixed! effects! models! with! random!
intercept,! exchangeable! correlation! structure! and! robust! standard! error! estimation! were! used.!
Interaction! terms! between! EFV! and! time!were! included! to! determine!whether! trajectories! of! the!
outcomes!differed!between!children!receiving!EFV!or!NVP.!For!CD4+!T;cell!percentage,!a!spline!term!
was!added!at!6!months!as!trajectories!were!not!linear!over!time.!!!






were! receiving! anti;tuberculous! therapy! at! ART! initiation! subsequently! switched! to! EFV.! Cox!




initiation! and! compared! between! children! receiving! NPV! and! EFV! using! chi;square! tests.! As! for!
mortality,! virologic! failure!was! evaluated!using!Kaplan!Meier! survival! curves! and!Cox!proportional!
hazards!models!with!EFV!treated!as!a!time;varying!covariate.!Virologic!failure!was!defined!according!
to!WHO! guidelines! [6]! as! at! least! two! viral! load!measurements! >5000! copies/mL! among! children!
who!received!at!least!six!months!of!ART,!and!was!defined!on!the!date!of!the!second!measurement.!
An! alternate! definition! of! virologic! failure! was! also! assessed! using! a! cut;off! of! ≥400! copies/mL.!
Children!entered! the! analysis! on! their! first! viral! load!measure! at! or! beyond!6!months!of!ART!and!
were! included! until! they! experienced! virologic! failure,! were! lost! to! follow;up! or! were!
administratively!censored!on!May!1,!2011.!
For! all! analyses,! characteristics! known! to! be! associated! with! the! outcome! from! the! published!
literature!or!found!to!be!associated!with!the!outcome!(p<0.10)!in!the!crude!models!were!considered!
for!inclusion!in!the!multivariable!models.!
Caregivers! were! instructed! to! bring! all! unused! medications! at! each! visit! and! adherence! was!
measured!by!pill! count!or!measurement!of! liquids! for! each!drug!prescribed.!Adherence!measures!
were! capped! at! 100%.! For! children! taking!more! than! one! drug,! the! adherence! percentage! of! the!
drug!to!which!the!patient!was!least!adherent!was!used.!Children!were!defined!as!adherent!using!two!
thresholds,! depending! upon! whether! they! took!more! than! 90%! or! 95%! of! drugs! prescribed.! The!












ART! during! the! intensive! phase! of! anti;tuberculous! therapy! (within! the! first! two!months),! and! 17!
(38%)! during! the! continuation! phase! (within! 2;6! months;! median! 2.4! months).! Among! children!
receiving! NVP,! five! children! were! previously! treated! for! tuberculosis! but! started! ART! after!









percentage,!weight! and!WAZ.! They!were!marginally!more! likely! to!have!a! lower!hemoglobin! level!
(Table!1).!
!At! the! end! of! follow;up,! 8! (12.1%)! children! receiving! NVP! and! 10! (20.8%)! receiving! EFV! died!
(p=0.21),!and!5! (7.6%)!children!receiving!NVP!and!one!(2.1%)!receiving!EFV!transferred!to!another!
clinic! (p=0.19).! No! child! was! lost! to! follow;up.! The! median! duration! of! follow;up! on! ART! was!





experienced! significantly! greater! increases! in! WAZ! during! follow;up! (NVP:! mean! change! +0.1,!
standard! deviation! [SD]! 1.0;! EFV:! +1.8,! SD! 1.6,! at! 12!months;! p<0.0001)! (Figure! 2).! Results! of! the!
longitudinal!data!analysis!showed!significantly!different!trajectories!of!WAZ!between!the!two!groups!
of! children,! with! children! receiving! EFV! experiencing! a! significantly! greater! increase! in! WAZ! per!













Age!in!months:!median!(IQR)! 69/45! 20.2!(11.0,!27.1)! 17.4!(13.6,!22.6)! 0.36!




69/45! 6!(8.7)! 6!(13.3)! 0.21!
WHO!stage!3!or!4:!n!(%)! 32/36! 25!(78.1)! 36!(100.0)! 0.01!
CD4%:!median!(IQR)! 64/41! 18.5!(15.7,!25.2)! 14.2!(9.8,!20.7)! 0.007!
Severe!immunosuppressiona:!n!(%)! ! 41!(64.1)! 29!(70.7)! 0.48!
Hemoglobin!(g/dL):!median!(IQR)! 66/44! 9.4!(8.6,!10.3)! 9.0!(7.9,!9.8)! 0.08!
Weight!(kg):!median!(IQR)!! 69/45! 8.8!(7.2,!10.0)! 7.2!(6.2,!8.6)! 0.005!
Weight;for;age!z;score:!median!(IQR)! 69/45! ;1.7!(;2.8,!;0.5)! ;2.7!(;3.6,!;1.8)! 0.001!
Underweightb:!n!(%)! ! 32!(46.4)! 31!(68.9)! 0.02!
BCG!vaccination!scar!present:!n!(%)! 69/45! 65!(94.2)! 41!(91.1)! 0.53!
Regimen:!n!(%)! 69/45! ! ! !
Stavudine/lamivudine! ! 59!(85.5)! 33!(73.3)! !
Zidovudine/lamivudine! ! 9!(13.0)! 10!(22.2)! !





























Time since ART initiation (months) 
NVP EFV 
NVP N: 58 53 44 34 35 30 26 22 19 
Mean: -1.4 -1.2 -0.8 -0.6 -1.1 -0.7 -0.9 -0.6 -0.7 
EFV N: 39 38 34 32 28 22 18 17 8 
































Time since ART initiation (months) 
NVP EFV 
NVP N: 55 39 40 29 29 27 22 20 16 
Mean: 20.7 32.3 34.4 37.5 39.1 37.6 37.5 37.6 37.6 
EFV N: 37 34 28 25 24 19 15 14 5 
Mean: 16.3 25.0 26.0 27.3 31.4 29.1 33.0 35.8 35.3 !
!
Figure!3.!Mean!CD4+!T!cell!percentage!(95%!confidence!interval)!after!ART!initiation!by!regimen!
Children! receiving! EFV! also! initiated! ART! with! a! significantly! lower! CD4+! T;cell! percentage! than!
children! receiving! NVP,! but! experienced! comparable! increases! in! CD4+! T;cell! percentage! during!
follow;up!(NVP:!+16.9%,!SD!8.4;!EFV:!+15.0%,!SD!9.6!at!12!months;!p=0.47)!(Figure!3).!Results!of!the!
longitudinal! data! analyses! showed! significantly! different! trajectories! of! CD4+! T;cell! percentages!
between! the! two! groups! of! children.! Among! children! receiving! NVP,! CD4+! T;cell! percentage!
increased!rapidly!in!the!first!6!months!of!ART!and!then!stabilized!for!the!duration!of!follow;up!(Table!
2).! In!contrast,!among!children!receiving!EFV,!CD4+!T;cell!percentage! increased!more!slowly! in! the!




Within! the! first! 3!months!of!ART,! the!majority!of! children! receiving!NVP! (80.7%)! and!EFV! (87.5%;!
p=0.50)!achieved!virologic!suppression.!The!majority!of!children!maintained!virologic!suppression!at!
12! (NVP:! 78.8%;! EFV:! 91.7%;! p=0.19)! and! 24! months! (NVP:! 68.4%;! EFV:! 77.8%;! p=0.61)! of! ART.!
Virologic!failure!was!assessed!among!the!72!children!(40!receiving!NVP!and!32!receiving!EFV)!with!at!
least!two!viral!load!measures!at!or!beyond!6!months!of!ART.!Four!children!receiving!EFV!(12.5%)!and!
7! children! receiving! NVP! (17.5%;! p=0.56)! experienced! virologic! failure! (Figure! 4;! log;rank! test:!




PMTCT,!and!number!of!viral! load!measures,! the! risk!of!virologic! failure!was! lower!among!children!
receiving! EFV! (adjusted! HR:! 0.25;! 95%! CI:! 0.05,! 1.24;! Table! 3),! although! this! result! was! not!
statistically! significant.!When! virologic! failure! was! defined! by! two! viral! load!measures! above! the!
lower! limit! of! detection! (400! copies/mL)! after! 6!months! of! ART,! the! percentage! of! children!with!




















26 26 26 19 16 15 8 EFV 
31 31 31 27 23 20 14 NVP 
Number at risk 
6 9 12 15 18 21 24 

























Eighteen! deaths! were! recorded! among! study! children! (NVP:! 12.1%;! EFV:! 20.8%;! p=0.21).! Among!
children! who! died,! the!median! time! to! death! after! ART! initiation! was! 1.6!months! (IQR:! 1.1,! 4.3)!
among!children!receiving!NVP!and!3.4!months!(IQR:!0.9,!7.3)!among!children!receiving!EFV!(p=0.41).!
Cumulative!survival!was!high!at!6!months!(NVP:!89%,!95%!CI:!79,!95;!EFV:!87%,!95%!CI:!74,!94)!and!
12!months! (NVP:! 87%,! 95%!CI=76,! 93;! EFV:! 80%,!CI=65,! 89)! after! initiating!ART!and!did!not!differ!
significantly! between! groups! (Figure! 5;! log;rank! test:! p=0.25).! The!mortality! rate! per! 100! person;
years!was!8.71!(95%!CI:!4.36,!17.41)!among!children!receiving!NVP!and!15.81!(95%!CI:!8.51,!29.38)!
among! children! receiving! EFV.! The! risk! of! mortality! was! non;significantly! higher! among! children!
receiving! EFV! (HR:! 1.72;! 95%! CI:! 0.68,! 4.36).! After! adjusting! for! CD4+! T;cell! percentage,!WAZ! and!




















45 43 41 34 30 EFV 
69 59 49 43 38 NVP 
Number at risk 
0 3 6 9 12 


















The! percentage! of! children! who! took! more! than! 90%! of! their! dispensed! medication! at! all! visits,!
verified! by! pill! count! and! syrup! measurement,! was! 56%! for! children! receiving! NVP! and! 46%! for!
children! receiving! EFV! (p=0.35).! No! significant! differences! were! observed! in! adherence! between!






(p=0.04).! Convulsions! were! reported! 2! weeks! to! 9!months! after! ART! initiation.! No! children!were!
prescribed!antiepileptic!drugs.!The!dose!of!EFV!was!reduced!in!one!child!whose!caregiver!reported!
intermittent!seizures!at!one!clinic!visit!3!months!after!ART!initiation.!The!child!was!reported!to!have!
had! no!more! convulsions,!was! switched! to!NVP! after! completing! anti;tuberculous! treatment,! and!
died! in!the!home!five!months! later!with!symptoms!of!gastroenteritis!and!pneumonia.! In!the!other!
five! children,! including! one! child!with! convulsions! reported! before! and! after! EFV! initiation,! three!
children! whose! convulsions! were! suspected! to! be! related! to! febrile! episodes! (2! receiving! EFV,! 1!
receiving!NVP),!and!one!child!with!suspected!HIV!encephalopathy,!treatment!was!continued!without!
modification!and!the!seizures!did!not!recur!during!the!period!of!observation.!No!other!differences!in!
clinical! symptoms!were! found!between! children! receiving! EFV! and!NVP.! Twenty;two! children! had!
transiently!elevated!alanine!aminotransferase!levels!(ALT!≥!62.5!U/L![6])!during!follow;up:!29.4%!of!
children! receiving! NVP! and! 19.4%! of! children! receiving! EFV! (p=0.29).! The!median! time! from! ART!
initiation! to! the! first! episode! of! elevated! ALT! was! 30! weeks! (IQR:! 26,! 49;! range! 2;129)! among!
children!receiving!NVP!and!49!weeks!(IQR:!28,!76;!range:!23;76)!among!the!children!receiving!EFV.!!







tuberculosis! and! received! an! EFV;based!ART! regimen! showed! significant! improvements! in! clinical,!
immunological! and! virologic! outcomes,! comparable! to! young! children! receiving! a! NVP;based!
regimen.!
To!our!knowledge,!no!studies!of!the!virologic!efficacy!of!EFV;based!regimens!have!been!conducted!
among! children! younger! than! 3! years! of! age! to! support! recommendations! for! its! use! in! this!
population.!However,! use!of! EFV;based! regimens! for! young! children! co;infected!with! tuberculosis!
would!be!a!useful!alternative!treatment!strategy!given!the!limited!treatment!options!available.!WHO!
currently! recommends! that! HIV;infected! infants! and! children! younger! than! 3! years! of! age! and!
treated! for! tuberculosis! receive! either! two! NRTI! plus! NVP! or! three! NRTI! [6].! However,! there! are!
significant! drawbacks! to! both! options.!When! co;administered!with! rifampicin,! studies! have! found!
NVP! levels! to! be! significantly! reduced! in! both! adults! [29,30,31]! and! children! [32,33],! thereby!
increasing! the! likelihood!of!drug! resistance!and!virologic! failure.! Increasing! the!dose!of!NVP!when!
co;administered! with! rifampicin! may! achieve! target! drug! levels! [31,34],! but! may! also! lead! to!
unacceptable!toxicity!and!discontinuation!rates![14,34].!There!is!also!increasing!evidence!that!NVP!is!
inferior! to! EFV! and! other! regimens! in! terms! of! virologic! efficacy! among! adults! and! children,!with!
[35,36]!and!without![11,12,13,37]!tuberculosis.!Regimens!comprising!3!NRTI!are!also!problematic,!as!
they!have!been!associated!with!high!rates!of!virologic!failure! in!both!children![10]!and!adults![38],!
particularly! when! baseline! viral! loads! exceed! 100,000! copies! RNA/mL! [39,40].! In! co;infected!
children,! who! are! likely! to! have! high! baseline! viral! loads,! the! risk! of! such! failure! is! likely! to! be!
unacceptably!high.!!
An!alternative!treatment!option!not!endorsed!by!the!WHO!for!young!children!with!tuberculosis!is!a!
regimen!consisting!of!2!NRTI!plus! ritonavir;boosted! lopinavir! (LPV/r).!As!with!NVP,! lopinavir! levels!
are! significantly! reduced! by! rifampicin! [8].! Doubling! the! dose! of! LPV/r! to! overcome! this!





that! increasing! the! dose! of! ritonavir! to! achieve! a! LPV/r! ratio! of! 1:1! resulted! in! acceptable!
pharmacokinetics! for!most!children!with! little!reported!toxicity![43].!However,!ritonavir!as!a!single!
agent! is! not! yet! widely! available! in! many! resourced;limited! settings! and! is! associated! with! poor!
tolerability![44].!! !
Consequently,!there!is!need!for!alternative!treatment!strategies!for!young!children!with!tuberculosis!
and! data! to! support! their! use.! The! dosing! schedule! for! EFV! in! Zambia! was! developed! based! on!
available! pharmacokinetic! data! [16,17,18,19,20,21,26]! and! was! independent! of! the! observational!
cohort!study.!Children!with! tuberculosis! receiving!EFV;based!regimens! in! this!study!achieved!good!
clinical!and!immunologic!outcomes!that!were!comparable!to!children!receiving!NVP;based!regimens,!
most! of! whom! were! not! co;infected! with! tuberculosis.! Similar! to! studies! in! adults! [35,36],! our!
findings! suggest! that! children! receiving! EFV;based! regimens!were!more! likely! to! achieve! virologic!
suppression! compared! to! children! receiving! NVP;based! regimens.! Children! with! tuberculosis!
receiving! EFV;based! regimens! had! higher! mortality! compared! to! children! receiving! NVP;based!
regimens,!although!the!difference!was!not!statistically!significant!within!the!limited!power!conferred!
by! the! few! number! of! deaths.! This! difference! was! presumably! due! to! the! poorer! clinical! and!
immunologic!state!of!the!children!with!tuberculosis,!and!was!not!observed!after!adjusting!for!these!
factors.! In!other! studies,! co;infection!with! tuberculosis!was!associated!with! increased!mortality! in!
children!receiving!ART![45].!!
!
All! children! tolerated!EFV!and,! in! contrast! to!other! studies! [20,46,47,48,49],!no!child!discontinued!
use!during!the!period!of!observation.!Due!to!the!young!age!of!the!study!population,!symptoms!were!
assessed! by! caregiver! report! and! many! symptoms! possibly! related! to! EFV! use,! including! loss! of!
concentration,! sleep! disorders,! or! psychotic! reactions,! were! difficult! to! evaluate.! Caretakers! and!
guardians!were! asked! about! symptoms! and! complaints! in! routine! clinical! care! but! not! specifically!
about!possible!adverse!events!related!to!ART!or!EFV,!which!may!have!resulted!in!underreporting!of!
side!effects.!However,!if!adverse!events!did!occur!and!were!missed!by!the!guardian!and!healthcare!
worker,! they!were! likely!mild!and!transient.!ALT!was! the!only! laboratory!measure!assessed!during!
follow;up;! however,! the! relevance! of! elevated! ALT! measurements! is! unclear! as! they! occurred!
without!symptoms!and!only!sporadically!in!most!children.!!
The! reports! by! parents! or! caretakers! of! a! seizure! in! five! of! the! children! receiving! EFV! and! one!
receiving!NVP! are! concerning!but! a! causal! association! is! difficult! to! establish! in! this! observational!
study.!In!preclinical!studies!of!EFV,!convulsions!were!seen!in!monkeys!with!high!EFV!levels![50].!Only!






makes! relatively! large! dosages! necessary! to! achieve! adequate! trough! levels,! means! that! some!





the! treating! clinicians.! These! decisions!were! independent! of! the! observational! cohort! study! from!
which!data!for!this!report!were!abstracted,!and!there!was!no!provision!for!pharmacokinetic!studies!
or!comprehensive!safety!monitoring.!With!the!implementation!of!the!EFV!dosing!schedule!at!the!HIV!
clinic,! children! with! tuberculosis! were! prescribed! an! EFV;based! ART! regimen.! Consequently,! the!
characteristics! of! the! children! receiving! EFV;and! NVP;based! ART! regimens! were! different,! as! the!
majority!of!children!receiving!NVP;based!regimens!were!not!co;infected!with!tuberculosis.!Attempts!
were!made!to!account!for!these!differences!in!the!analysis!but!measures!of!all!potentially!relevant!
characteristics! were! not! available.! The! diagnosis! of! tuberculosis! in! children! is! difficult! and!
radiographic!or!microbiologic!tests!were!not!performed!on!all!children!in!the!study.!We!attempted!
to!address!this!issue!by!excluding!children!diagnosed!with!tuberculosis!after!ART!initiation!but!could!
not! account! for! children! with! undiagnosed! tuberculosis! during! the! study! period.! Additional!
limitations! include!the!small! sample!size,!which! limited!the!power!to!detect!statistically!significant!
differences! between! the! two! groups! (particularly! for! virologic! outcomes),! the! relatively! short!
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Background:! Travel! time! and!distance! are! barriers! to! care! for!HIV;infected! children! in! rural! sub;




Methods:! Outcomes! were! measured! within! an! ongoing! cohort! study! of! HIV;infected! children!
seeking!care!at!Macha!Hospital,!Choma!District,!Southern!Province,!Zambia!since!September!2007.!
Children! in! the!outreach!group! received!ART! from! the!Macha!HIV!clinic!and! transferred! to!one!of!
















Conclusions:! Despite! similar! clinical! and! immunologic! outcomes,! children! in! the! outreach! group!
were! less! likely! to!maintain! virologic! suppression,! potentially! due! to! lower! adherence.! Continued!










lifesaving! treatment.! The!number!of! children! receiving!antiretroviral! therapy! (ART)! in! sub;Saharan!
Africa!increased!from!85,000!in!2006!to!387,500!in!2010![2].!However,!progress!must!continue!so!all!
eligible! HIV;infected! children! have! access! to! treatment.! Only! 21%! of! children! in! need! currently!
receive!ART![2].!
In!much! of! sub;Saharan! Africa,! provision! of! free! ART! services! has! created! huge! demands! on! the!
health!system!that!are!not!sustainable!given!current! levels!of! infrastructure!and!human!resources.!
This! has! necessitated! a! shift! away! from! a!medical!model! of! care,! primarily! used! in! resource;rich!
countries! and! relying! on! highly! trained! medical! personnel! in! specialized! healthcare! facilities! to!
provide! individualized!HIV!care!and!treatment,!to!a!public!health!model!that!delivers!treatment!to!
more! individuals! [3].!The!public!health!model!relies!on!decentralization!of!HIV!services!to! increase!
access,! particularly! in! rural! areas,! task;shifting! of! activities! to! overcome! the! dearth! of! healthcare!





with! care! and! treatment! administered! by! general! practitioners,! clinical! officers! or! nurses! [6;20].!
Several! of! these! programs! are! assisted! by! mobile! teams! from! hospital! programs! to! support! ART!
provision! in! primary! health! centers! that! do! not! have! the! full! complement! of! facilities! and!human!
resources! to! provide! comprehensive! HIV! services.! Others! have! implemented! home;based! [21;23]!
and! community;based! [24]! programs,! with! care! and!medication! delivered! closer! to! the! home! by!
trained!volunteers!or!field!officers.!By!delivering!care!and!treatment!closer!to!home,!these!programs!
have! succeeded! in! removing! the!main! structural!barriers,! including! transportation!and!distance! to!
the!clinic,!to!initiating!and!sustaining!care![25].!Evaluations!of!these!programs,!many!of!which!have!
been! conducted! among! adults,! have! found! improved! retention! and! lower! loss! to! follow;up!
compared!with!centralized,!hospital;based!care![6;9,!17,!20].!!
While! decentralization! has! succeeded! in! increasing! access! to! care! for! large! numbers! of! patients,!
particularly!in!rural!areas,!one!concern!is!that!transitioning!from!specialized!healthcare!facilities!and!
trained! healthcare! personnel! may! compromise! the! quality! of! care.! The! published! evaluations! of!
treatment!outcomes!in!decentralized!programs!have!largely!been!favorable!and!several,!but!not!all!
[6,!16],!programs!found!similar!or!better!survival!and!clinical!and!virologic!outcomes!compared!with!
hospital;based! care! [7;9,! 17,! 20;22].!However,! additional! evaluations! are! needed!of! decentralized!
programs,! particularly! for! children,! to! ensure! they! receive! optimal! care! and! the! full! benefits! of!
treatment.! In! rural! southern! Zambia,! a! mobile! ART! program! for! children! was! evaluated! and!








primary! care! clinics! in! the! Lusaka!Urban!District! [26]! and! scaling! up! throughout! the! country.! The!
program!provides!ART!and!basic! laboratory!tests,! including!CD4+!T;cell!counts,! free!of!charge.!The!
number!of!ART!sites!increased!from!four!in!2004!to!454!in!2010![27],!!
While!61%!of!the!Zambian!population!resides!in!rural!areas![28],!ART!services!are!primarily!offered!
in! urban! areas! and! in! district! level! hospitals! where! the! infrastructure! and! human! and! technical!
resources! are! greatest.! To! reach! those! affected! by! HIV! in! rural! areas! and! increase! access! to! HIV!
services,! the! Zambian!Ministry! of!Health! introduced! the! national!Mobile!ART! Services! program! in!
2007![29].!Under!this!program,!mobile!ART!teams!of!medical!professionals!were!created!at!district!
hospitals.! Rural! health! centers! (RHC)! in! the! catchment! area! were! selected! as! designated! ART!
outreach!sites!to!be!visited!every!two!weeks!by!the!mobile!ART!teams.!Rural!health!centers!provide!
reproductive,!maternal!and!child!health!care,!treatment!for!tuberculosis,!HIV!testing,!and!other!basic!
services,!but! generally!do!not!have! the! training!or! capacity! to!provide!ART.! The!mobile!ART! team!
assists! staff! at! the! ART! outreach! site! in! providing! ART! services,! builds! capacity,! and! coordinates!






study! setting! and! population! have! been! described! in! detail! elsewhere! [30,! 31].! In! brief,! Macha!
Hospital! serves! as! a! referral! hospital! for! at! least! 13! rural! health! centers,! providing! services! for!
patients!within!an!80!km!radius.!The!catchment!area!of!Macha!Hospital! is!populated!by!traditional!
villagers! living! in! small,! scattered! homesteads,! characteristic! of!much! of! rural! sub;Saharan! Africa,!
with!an!estimated!population!size!of!over!150,000!persons.!The!HIV!clinic!has!provided!care!to!over!
8500! HIV;infected! adults! and! children! since! 2005.! HIV! care! services,! including! antiretroviral!
treatment,! are! provided! through! the! Government! of! Zambia’s! antiretroviral! treatment! program,!
with! support! from! the! President’s! Emergency! Plan! for! AIDS! Relief.! The! clinic! provides! care! and!
treatment!free!of!charge!by!physicians,!clinical!officers!and!nurses.!!
Children!diagnosed!with!HIV!infection!are!determined!to!be!eligible!for!ART!according!to!guidelines!
established! by! the!Ministry! of! Health! [32].! Children! eligible! for! ART!must! undergo! counseling! to!
ensure!that!the!family!is!prepared!for!them!to!initiate!ART.!Upon!initiation,!children!are!seen!every!
two!weeks!for!the!first!month!and!every!month!for!the!following!two!months.!Thereafter,!the!child!













or! licentiate,! nurse,! pharmacy! dispenser,! laboratory! assistant,! counselor! and! data! entry! clerk.!
Medications,!medical! consumables! and! transportation! are!provided!by! the!hospital.!As! laboratory!
testing! cannot!be!performed!at! the!outreach! clinics,! blood! samples! are! collected!and! transported!
from!the!outreach!clinic!to!the!Macha!Hospital!laboratory,!and!results!are!returned!during!the!next!
outreach!visit.!Clinically!stable!patients!with!good!adherence!are!provided!with!a!3;month!supply!of!
medication.! Children! are! eligible! for! referral! to! the! outreach! clinic! for! care! and! treatment! if! they!
have! been! stable! on! ART! for! at! least! three! months,! demonstrated! good! adherence,! have! no!
opportunistic!infections,!and!their!caregiver!requested!to!receive!care!closer!to!home.!Children!not!
yet! eligible! for! ART! and! in! stable! condition! can! also! be! referred! to! the! outreach! clinic! with! the!








questionnaire! was! administered! to! the! caregiver! to! collect! information! on! socio;demographics,!
household!characteristics,!and!medical!and!treatment!history.!The!child!was!examined!to!measure!




upper! limit! of! detection! 750,000! copies/mL)! as! part! of! the! study.!Adherence!was! assessed!by! pill!









before! and! after! transfer! to! the! outreach! clinic! and! assessed! the! perceived! quality! of! care! at! the!






they! live! in! the! vicinity! of! the! clinic! and! would! not! have! been! transferred! to! an! outreach! clinic.!
Children! receiving!ART!who!were! transferred! to! an!outreach! clinic!before! September!1,! 2011!and!
who!had!a!study!visit!after!transfer!were!eligible!for!inclusion!in!the!analysis!in!the!outreach!group.!
Children!receiving!ART!who!reported!the!Macha!HIV!clinic!as!their!rural!health!center,!initiated!ART!











>75th=19;24).! !Weight;for;age! z;scores! (WAZ)! among! children! younger! than! 10! years! of! age!were!




Immunologic,! clinical! and! virologic! treatment! outcomes! were! assessed,! including! CD4+! T;cell!
percentage,!WAZ!and!virologic!failure.!For!CD4+!T;cell!percentage!and!WAZ,!children!were!included!
if!they!had!at! least!one!measure!available!after!ART!initiation.!To!report!outcomes!at!specific!time!




clinic! (hospital! vs.! outreach),!which!was! treated!as! a! time;varying! covariate.! Interactions!between!




below! the! limit! of! detection! (400! copies/mL),! was! calculated! for! each! visit! after! ART! initiation.!








Full! adherence! was! defined! as! taking! more! than! 95%! of! drugs! prescribed.! The! proportions! of!
children!who!were!adherent!at!each!visit!and!at!all! visits!were!compared!between!children! in! the!
hospital!and!outreach!clinics!using!chi;square!tests.!!




















































































































The! proportion! of! children! requiring! public! transport,! as! opposed! to! walking! or! using! a! bicycle,!
decreased! from! 39%! to! 4%! (p<0.0001).! Consequently,! caretakers! reported! lower! transportation!
costs! and! had! fewer! difficulties! in! finding! transportation! after! transferring! to! the! outreach! clinic!












At+entry+ n!(%)! n!(%)! !
Male! 19!(46.3)! 37!(54.4)! 0.41!
Median!age!in!years!(IQR)! 4.9!(2.2,!9.4)! 2.9!(1.6,!7.5)! 0.07!
<1! 3!(7.3)! 7!(10.3)! !
1;1.9! 7!(17.1)! 16!(23.5)! !
2;4.9! 11!(26.8)! 19!(27.9)! !
5+! 20!(48.8)! 26!(38.2)! 0.70!
Status!of!parents!
Both!alive! 22!(53.7)! 51!(75.0)! !
One!parent!alive! 15!(36.6)! 10!(14.7)! !
Both!parents!died! 4!(9.8)! 7!(10.3)! 0.30!
Other!household!member!receiving!ART! 21!(52.5)! 43!(64.2)! 0.23!
SES!quartile!
1st!(lowest)! 28!(68.3)! 41!(60.3)! !
2nd! 10!(24.4)! 26!(38.2)! !
3rd! 2!(4.9)! 1!(1.5)! !
4th!(highest)! 1!(2.4)! 0!(0.0)! 0.21!
Highest!level!of!education!of!primary!caregiversa!
None! 0!(0.0)! 2!(3.1)! !
Primary! 19!(55.9)! 43!(67.2)! !
Secondary! 14!(41.2)! 19!(29.7)! !
College!/!technical!training! 1!(2.9)! 0!(0.0)! 0.20!
At+ART+initiation!
Median!age!in!years!(IQR)! 5.9!(2.4,!10.4)! 2.9!(1.7,!7.3)! 0.03!
<!1! 3!(7.3)! 6!(8.8)! !
1;1.9! 4!(9.8)! 17!(25.0)! !
2;4.9! 11!(26.8)! 20!(29.4)! !
5+! 23!(56.1)! 25!(36.8)! 0.15!
Median!WAZ!(IQR)! ;1.7!(;2.5,!;0.7)! ;2.3!(;3.6,!;1.3)! 0.07!
Underweight! 12!(41.4)! 34!(58.6)! 0.13!
Median!CD4%!(IQR)! 14.4!(11.0,!19.5)! 14.2!(10.5,!18.9)! 0.91!
Severe!immunosuppression! 23!(62.2)! 36!(65.5)! 0.75!
ARV!regimen!
AZT/3TC/EFV! 10!(25.0)! 15!(22.4)! !
AZT/3TC/NVP! 3!(7.5)! 15!(22.4)! !
D4T/3TC/EFV! 16!(40.0)! 24!(35.8)! !
D4T/3TC/NVP! 16!(40.0)! 24!(35.8)! !
















Children! in! the!outreach!and!hospital!groups!were! followed! for!a!median!of!32.3! (IQR:!22.3,!38.8)!
and!33.5!(IQR:!23.1,!42.6)!months!in!the!study!while!receiving!ART!(p=0.50).!Among!children!in!the!
outreach!group,!the!median!time!between!study!enrolment!and!transfer!to!the!outreach!clinic!was!





Hospital)N) 67) 58) 48) 36) 26) 16) 10)
Mean)WAZ) :1.8) :1.0) :1.2) :1.0) :1.3) :1.2) :1.0)
Outreach)N) 1) 7) 24) 29) 27) 18) 12)































0.11! (SE:! 0.02)! per! month! among! children! receiving! care! at! the! hospital! and! 0.08! (SE:! 0.08)! per!
month!among!children!receiving!care!at!the!outreach!clinics!(p=0.70)!(Table!2).!After!six!months!of!
ART,! WAZ! did! not! significantly! change! (mean! increase! per! month:! hospital! clinic! group:! ;0.003;!
outreach!clinic:!;0.003;!p=0.97).!!
!
Mean! CD4+! T;cell! percentage! increased! from! 16.3%! at! ART! initiation! to! 35.2%! after! three! years!
among! children! receiving! care! at! the! hospital! clinic! and! from! 10.1%! to! 32.6%! among! children!
receiving! care! at! the! outreach! clinic! (Figure! 3).! Longitudinal! models! showed! that! both! groups!
experienced!similar!trajectories!in!CD4+!T;cell!percentage!over!time,!with!CD4+!increasing!in!the!first!
six! months! and! then! remaining! relatively! stable.! In! the! first! six! months,! mean! CD4+! T;cell!
percentage,! adjusted! for! age! and! WAZ! at! ART! initiation,! increased! 1.97%! (SE:! 0.13)! per! month!
among! children! receiving! care! at! the! hospital,! and! 1.42%! (SE:! 0.43)! per! month! among! children!




























Hospital"N" 79" 68" 56" 39" 31" 23" 17"
Mean"CD4"%" 16.3" 28.8" 33.2" 33.8" 34.6" 35.3" 35.2"
Outreach"N" 2" 8" 26" 37" 33" 23" 13"












After!24!and!36!months!of! treatment,! the!proportion!of!children!with!undetectable!viral! load!was!
90%!and!82%!among!those!receiving!care!at!the!hospital!and!77%!(p=0.18)!and!77%!(p=0.77)!among!
those!receiving!care!at! the!outreach!clinics.!Fifty;five!children! in!the!outreach!group!and!29! in!the!
hospital!group!had!at!least!two!viral! load!measurements!after!a!minimum!of!six!months!on!ART!to!
assess!virologic!failure.!Ten!children! in!the!outreach!group!(18.2%)!and!one!child!(3.5%;!p=0.06)! in!















CD4++T?cell+percentage+(CD4%)+ ! ! ! ! ! a!
CD4+!T;cell!percentage!at!ART!
initiation!(SE)!








0.07!(0.03)! 0.009!(0.05)! 0.16! 0.07!(0.03)! 0.05!(0.05)! 0.66!
Weight?for?age+z?score+(WAZ)+ ! ! ! ! ! b!
WAZ!at!ART!initiation!(SE)! ;1.97!(0.18)! ;1.60!(0.54)! 0.50! ;1.70!(0.51)! ;1.27!(0.74)! 0.44!
Increase!in!WAZ!per!month!in!
first!6!months!of!ART!(SE)!












a adjusted for age and WAZ at ART initiation 




Month!on!ART! Hospital!Clinic! Outreach!Clinicsa! p=value!
! N! %!undetectable!VL! N! %!undetectable!VL! !
3! 44! 90.9! 3! 100.0! 0.59!
6! 61! 90.2! 6! 100.0! 0.42!
9! 34! 94.1! 8! 50.0! 0.001!
12! 52! 94.2! 24! 87.5! 0.31!
15! 12! 100.0! 12! 91.7! 0.31!
18! 28! 100.0! 29! 82.8! 0.02!
21! 10! 100.0! 15! 93.3! 0.40!
24! 30! 90.0! 26! 76.9! 0.18!
27! 1! 100.0! 2! 50.0! 0.39!
30! 12! 91.7! 16! 81.3! 0.44!
33! 2! 100.0! 1! 0.0! 0.08!




The! proportion! of! children!with! full! adherence! (>95%)! at! each! study! visit! tended! to! be! lower! for!
those!receiving!care!at!the!outreach!clinics!compared!to!the!hospital!clinic,!although!no!significant!
differences! were! observed! (Additional! file! 1).! When! considering! all! visits! after! ART! initiation!
(combining! visits! at! the!hospital! and!outreach! clinics! for! children! in! the!outreach! group),! children!
receiving!care!at!the!outreach!clinic!had!significantly!poorer!adherence.!The!median!percentage!of!
visits!with! full! adherence!was! significantly! lower! in! the! outreach! compared! to! the! hospital! group!
(69.2%!vs.!79.3%;!p=0.01)!and!the!proportion!of!children!with!full!adherence!at!all!study!visits!was!
lower!in!the!outreach!group!compared!to!the!hospital!(24.6%!vs.!32.5%;!p=0.35).!When!adherence!
among! children! in! the! outreach! group! was! further! investigated,! no! significant! difference! in!
adherence!was! found!before!and!after! transfer! to! the!outreach!clinics.! The!median!percentage!of!





! Hospital!Clinic! Outreach!Clinics! p=value!
N! >95%! N! >95%!
%!Adherence;!Month!on!ARTa! ! ! ! ! !
3! 68! 69.1! 6! 50.0! 0.34!
6! 71! 63.4! 6! 83.3! 0.33!
9! 60! 75.0! 17! 64.7! 0.40!
12! 55! 81.8! 24! 70.8! 0.27!
15! 46! 78.3! 25! 64.0! 0.19!
18! 40! 75.0! 28! 75.0! 1.00!
21! 34! 85.3! 33! 69.7! 0.13!
24! 32! 81.3! 28! 75.0! 0.56!
27! 31! 71.0! 26! 73.1! 0.86!
30! 25! 80.0! 16! 62.5! 0.22!
33! 22! 86.4! 24! 66.7! 0.12!
36! 18! 66.7! 16! 75.0! 0.28!
Median!%!of!visits!with!good!adherence! 40! 79.3! 65! 69.2! 0.01!
%!children!with!good!adherence!at!all!
visits!






group! and! 95%! of! children! in! the! hospital! group! were! active! in! the! program.! Among! children!
followed! at! the! hospital! clinic,! none!died! or!were! lost! to! follow;up! and! two! children! (4.9%)!were!
transferred! to! other! clinics.! Among! children! followed! at! the! outreach! clinics,! one! died! from!










Decentralization! from!higher! to! lower! level! health! facilities! and! task;shifting! from!higher! to! lower!
level!care!providers!are!essential!if!access!to!HIV!care!is!to!increase!in!resource;limited!countries!in!
the! face! of! rising! patient! numbers! and! declining! donor! funding! [7].! Many! challenges! remain,!
however,! to! sustaining!decentralized!ART!programs!and! site;specific! strategies!will! be! required! to!
achieve!optimal!provision!of!care![36].! In!this!evaluation!of!mobile!and!hospital;based!HIV!care!for!
children!in!rural!southern!Zambia,!transfer!to!the!outreach!clinic!resulted!in!a!significant!decrease!in!




and! elsewhere! [25,! 30],!with! levels! of! attrition! increasing!with! travel! distance! [37].! One!multisite!
analysis!in!western,!eastern!and!southern!Africa!found!that!the!risk!of!attrition!doubled!if!travel!time!
to!clinic!exceeded!2!hours![25].!Even!for!children!receiving!care!at!the!hospital!clinic,!distance!to!the!
clinic!was!previously!shown!to!be!associated!with!an! increased!risk!of!virologic! failure! [31].!As!HIV!







centers! compared! to! secondary! or! tertiary! health! centers! [17].! However,! other! studies! reported!
higher!mortality! among!HIV;infected! adults! and! children! cared! for! at! health! centers! compared! to!
hospital!clinics![6],!and!higher!percentages!of!adults!with!detectable!viral!load!among!those!followed!
in! primary! health! clinics! [16],! consistent! with! our! findings! in! children.! As! adherence! is! closely!
associated!with!viral!suppression![26],!this!may!have!been!due!to!the!lower!adherence!observed!in!
this!group.!!
In! discussions!with! the! outreach! team,! important! differences! emerged! between! the! hospital! and!
outreach!sites!in!the!cadre!of!clinical!staff!and!infrastructure.!The!HIV!clinic!at!the!hospital!employs!
on! average! three! trained! psychosocial! counselors! to! provide! adherence! and! other! counseling! to!
adults! and! children.! Only! one! counselor! was! part! of! the! outreach! team.! Because! of! the! limited!





As! the! goal! is! to! achieve! the! same! quality! of! ART! services! at! the! outreach! clinics! [29],! additional!
measures!are!needed!to!ensure!that!children!receive!the!same!standard!of!care.!Increased!efforts!on!
the! part! of! government! and! donors! may! be! needed! to! expand! support! for! formal! basic! health!
worker!training,!recruitment!and!retention![39]!so!that!staff!at!rural!health!clinics!can!provide!high!
quality!HIV!care!and! treatment.!The!more! recent! involvement!of! community!volunteers,! including!









the! caregiver.! Only! children! who! responded! well! to! treatment! were! eligible! for! transfer! and!
therefore!the!outreach!group!represented!a!select!group!of!children.!As!a!valid!comparison!group,!
children! of! caretakers! who! named! Macha! Hospital! as! their! rural! health! center! were! selected.!
Differences!in!characteristics!were!adjusted!for!in!the!analysis!but!unmeasured!differences!between!
the!groups!may!have!remained.!Second,!the!sample!size!was!small,!particularly!at!longer!follow;up!
times! and! for! virologic! outcomes.! Children! with! viral! load! measurements! were! slightly!







This! is! one! of! the! few! studies! of! HIV;infected! children! conducted! in! rural! sub;Saharan! Africa!
comparing! treatment! outcomes! between! different! service! delivery! approaches.! HIV! care! and!
treatment! can! be! delivered! to! HIV;infected! children! at! rural! health! centers! through! mobile! ART!
teams,! removing! potential! barriers! to! uptake! and! retention.! With! the! limited! infrastructure! and!
healthcare! personnel,! however,! there! is! the! potential! for! the! quality! of! services,! particularly!
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The! scale;up! of! pediatric! antiretroviral! therapy! (ART)! in! sub;Saharan! Africa! over! the! past! decade!
involved! unprecedented! political! and! donor! commitment.! These! pediatric! ART! programs! have!
demonstrated!they!can!provide!ART!to!human! immunodeficiency!virus! (HIV);infected!children!and!
that! these! children!achieve! treatment!outcomes!comparable! to! children! in!high;resource! settings.!











services,!use!of!electronic!health! records!and! the!potential!need! for! rationing!antiretroviral!drugs.!









Over! the! past! decade! great! strides! have! been! made! in! providing! care! and! treatment! to! human!
immunodeficiency! virus! (HIV);infected! children! in! resource;limited! settings,! particularly! in! sub;
Saharan! Africa,! home! to! 90%! of! the! estimated! 2.5!million! HIV;infected! children! [1].! Globally,! the!
estimated!number!of!children!receiving!antiretroviral!therapy!(ART)! increased!from!75,000!in!2005!
to!over!356,000! in!2009! [2].! This! success!was!possible!as!a! result!of! the!establishment!of! funding!
mechanisms! to! provide! ART! and! the! infrastructure! to! effectively! deliver! these! drugs,! including!
support!from!the!World!Bank!Multi;country!AIDS!Programme!(MAP),!the!Global!Fund!to!Fight!AIDS,!
Tuberculosis!and!Malaria! (GFATM),!and!President!Bush’s!Emergency!Plan!for!AIDS!Relief! (PEPFAR).!
Other! factors! important! for! the! rapid! scale;up! of! ART! programs! included! provision! of! generic!
antiretroviral! drugs! at! reduced! cost! and! collaborations! between! multiple! stakeholders! and!
organizations! enabling! government! officials! and! health! care! providers! to! overcome! some! of! the!
obstacles!to!providing!complex!treatment!to!children!in!resource;limited!settings.!
While!these!represent!great!successes,!the!estimated!ART!coverage!for!eligible!HIV;infected!children!
globally! is! only! 28%! and! lags! behind! the! estimated! 37%! coverage! for! adults! [2].! Pediatric! ART!
coverage!in!sub;Saharan!Africa!is!lower,!at!26%,!although!substantial!regional!variation!exists,!with!
an!estimated!coverage!of!only!12%!in!Western!and!Central!Africa!compared!to!32%!in!Eastern!and!
Southern! Africa! [2].! While! many! challenges! to! providing! ART! to! HIV;infected! individuals! in! such!
settings!exist,!provision!of!ART! to! children!presents!unique!obstacles.!Many!challenges!have!been!














When! ART! programs! were! implemented! in! sub;Saharan! Africa,! not! all! national! guidelines!
encouraged! the!widespread! scale;up! of! ART! for! children! as! some! believed! pediatric! ART!was! too!
complicated! and! difficult! for! clinicians! to! manage! [4].! Administration! of! ART! to! children! is!
complicated! by! the! need! for! pediatric! drug! formulations,! changing! dosages! with! age! and! body!
weight,!more!technologically!advanced!diagnostic! tools! for! infants! (i.e.!nucleic!acid!detection),! the!
use! of! CD4+! T;cell! percentages! to! initiate! and!monitor! ART! responses,! and! healthcare! personnel!
trained!in!use!of!pediatric!ART.!At!the!time!ART!programs!were!established,!most!of!these!issues!had!
not! been! resolved! and! pediatric! drug! formulations! were! not! available.! Despite! these! difficulties,!
many! regions! chose! to! include! children! in! ART! programs,! overcoming! dosage! obstacles! by! using!
split;tablet!adult!formulations!for!children![4,!5].!!
Resources! for!pediatric!ART!have! increased! since!ART!programs!were! first! implemented.!Pediatric!
drug!formulations,!even!in!fixed;dose!combinations,!are!now!available,!many!programs!can!measure!
CD4+!T;cell!percentages!to!inform!ART!initiation!and!monitoring!decisions,!and!many!programs!have!
access! to! HIV! DNA! testing! for! early! infant! diagnosis.! With! these! improvements,! the! estimated!
number!of!children!receiving!ART!in!sub;Saharan!Africa!increased!from!85,000!in!2006![6]!to!296,000!
in! 2009! [2].! Programs! continue! to! scale;up! and! expand,! and! with! new! evidence! supporting! the!
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and! treatment! services,!affecting! the! stage!at!which!children!access! treatment!and! their!ability! to!
adhere!to!treatment!regimens![11].!In!addition,!untreated!children!in!sub;Saharan!Africa!have!higher!
levels!of! comorbid!conditions,! including!malaria,! tuberculosis,!helminths!and!undernutrition,!more!
rapid! disease! progression! and! higher! HIV! viral! load.! All! of! these! factors! contribute! to! the! poorer!
survival! of! untreated! HIV;infected! children! in! sub;Saharan! Africa! compared! to! children! in! high!
resource!settings,!and!could!affect!treatment!responses![11].!
!
Despite! these!differences,! studies!of! the!effectiveness!of!ART!among!HIV;infected!children! in! sub;
Saharan! Africa! indicate! that! treatment! outcomes! similar! to! those! observed! in! Europe! and!North;
America!can!be!achieved!in!the!first!few!years!after!the!initiation!of!ART![11;14].!Viral!suppression!
was!achieved!by!most!children! in! sub;Saharan!Africa!within! the! first!6!months!after!ART! initiation!
and! was! maintained! throughout! follow;up! for! up! to! 2;3! years! [12].! A! recent! meta;analysis! of!
treatment!outcomes!among!14!studies! in!Africa,!Asia!and!the!Caribbean! found!that! the!estimated!
proportion!of! children!with!virologic! suppression!12!months!after! initiating!ART!was!70%! (95%!CI:!
67;73)![14].!CD4+!T;cell!percentages!increased!by!an!estimated!13.7!percentage!points!
(95%! CI:! 11.8,! 15.7)! 12!months! after! starting! ART! in! this! study! [14],! and! have! been! found! to! be!
relatively!stable!thereafter![12].!Weight;for;age!z;scores!also!increased!after!initiation!of!ART,!such!
that!the!proportion!of!children!who!were!underweight!was!reduced!by!30;80%;!however,!similar!
increases! in! height;for;age! z;scores!were! not! observed! [13].!Mortality!was! generally! low! and!was!






care!and! treatment! in! sub;Saharan!Africa! compared! to! children! in!high! resource! settings! [12,!13].!
The!majority!of!children!in!sub;Saharan!Africa!were!older,!with!most!studies!reporting!a!median!age!
greater!than!5!years,!and!initiated!treatment!at!a!late!stage!of!disease,!with!most!children!exhibiting!
World!Health!Organization! (WHO)! stage! 3! or! 4! disease! and! a! CD4+! T;cell! percentage!of! less! than!
15%.!In!addition,! levels!of!undernutrition!were!high,!with!most!studies!reporting!a!median!weight;
for;age!z;score!less!than!;2![12,!13].!!
!These! studies! indicate! that! most! children! enrolled! in! ART! programs! in! sub;Saharan! Africa! are! a!
subset!of!children!who!survived!the!first!few!years!of!life!and!had!signs!of!disease!progression!before!
accessing! HIV! care.! However,! children! who! accessed! treatment! services! and! initiated! ART!
experienced!reductions! in!morbidity!and!mortality!comparable! to! those!observed! in!high;resource!
settings.!These!ART!program!experiences! in! countries! throughout! sub;Saharan!Africa!demonstrate!
that!ART!can!be!effectively!administered!to!children!in!these!settings.!However,!approximately!one!
third! of! children! receiving! ART! developed! virologic! failure! one! year! after! starting! therapy! [14],!
highlighting!the!need!for! low!cost,!effective!second! line!antiretroviral!drug!regimens.!Finally,!more!





Challenges! and! Solutions! to! the! Provision! of! Antiretroviral! Therapy! to!
Children!in!Sub=Saharan!Africa!!
!
Providing! ART! and! scaling! up! ART! programs! is! challenging! in! resource! limited! settings,! and!many!
obstacles! are! faced! that! can! hinder! program! implementation! and! impact! treatment! outcomes.!
Challenges! that! particularly! affect! children! include! shortages! of! properly! trained! health! care!
providers,! lack! of! laboratory! capacity! for! infant! diagnosis! and! treatment! monitoring,! adherence,!
disclosure! of!HIV! infection! status! and! attrition.!With! experience! gained! in! implementing! pediatric!









One!of! the!primary! factors! limiting!the!scale;up!of!ART!programs! is! the!shortage!of! trained!health!
workers.!The!WHO!estimates! that!over!4!million!health!workers!are!needed! to!address! the!global!
shortage,! with! much! of! the! need! in! sub;Saharan! Africa! [16].! While! this! region! is! home! to!
approximately! 67%! of! the! global! burden! of! HIV;infected! persons,! only! 3%! of! the! world’s! health!
workers!and! less!than!1%!of!world!health!expenditure!are! in!sub;Saharan!Africa! [16].!Shortages! in!
this! region! are! compounded! by! uneven! distribution! of! the! workforce,! with! the! majority! of! the!
population! living! in! rural! areas! while! most! health! workers! are! located! in! urban! areas! [17].! The!
shortage! is! particularly! acute! for! pediatric! HIV! care! and! treatment! as! healthcare!workers! require!
specific!knowledge!of!the!diagnosis!and!management!of!HIV!infection!in!children.!Many!do!not!feel!
comfortable!or!adequately!trained!to!manage!HIV!exposed!or!infected!infants!and!children.!
To! address! the! shortage! of! health! workers! while! maintaining! quality! health! care,! the! WHO!
recommended! implementing! task! shifting,! whereby! specific! tasks! are! assigned! to! health! workers!
with! less! training! and! lower! level! qualifications! [16].! Allowing! non;physicians! to! provide! care! and!
treatment!services!to!HIV;infected!children!has!enabled!ART!services!to!be!decentralized,!such!that!
they! can! be! provided! at! health! centres! in! addition! to! hospitals,! and! takes! advantage! of! existing!
healthcare!infrastructure!and!resources.!
Many!programs!have! implemented!task!shifting!to! facilitate!the!scale;up!of!ART!services.!A!recent!
review! of! task! shifting! identified! 24! programs! that! implemented! some! form! of! task! shifting! in!
Malawi,! Zambia,! Rwanda,! South! Africa,! Nigeria,! Democratic! Republic! of! Congo,! Uganda,! Kenya,!
Lesotho,! and!Mozambique! [18].!Many! programs! engaged! new! cadres! of!workers,! including! lay! or!
peer!health!workers! trained! to!perform!non;medical! tasks,! such!as!patient!counselling,!adherence!
monitoring!and!contact!tracing.!Non;physician!medical!officers,!including!clinical!officers!in!Zambia,!
técnicos!de!medicina!in!Mozambique,!and!medical!assistants!in!Malawi,!received!additional!medical!








indicates,!however,! that!this!has!not!happened!and!that!quality!can,! in! fact,! improve!as!errors!are!
minimized! and! patients! are! more! thoroughly! evaluated! in! a! less! burdened! system! [18,! 19].! In!
addition,! good! clinical! outcomes! were! observed! in! these! programs! [18,! 19].! However,! several!
reports! emphasized! the! burden! of! training,! supervising! and! mentoring! lower! level! health! care!
workers,!and!highlighted!the! importance!of! investing! in!these!activities!to!ensure!high!quality!care!
[18,!19].!
!
While! task! shifting! has! allowed! for! the! scale;up! of! pediatric! ART! programs,! it! is! not! a! long;term!
solution! in! the! face! of! a! shortage! of! health! workers! at! all! levels.! Investments! must! be! made! to!
strengthen!health! systems!and! train!health!workers,! including!physicians,!nurses,!pharmacists!and!




skills,! and! are! informed! of! new! developments! in! pediatric! diagnosis,! drug! formulations,! and!
management.!Several!methods!of!providing!ongoing!training!are!available.!E;learning!can!provide!a!
relatively! inexpensive!and!effective!way!of! learning!on;site! [20].!Training! can!be!provided! through!
distance! learning! courses,! OpenCourseWare,! or! telemedicine,! where! consultative! advice! and!
training!are!provided!through!online!conferences!with!experts!around!the!world,!as!demonstrated!in!
the! HIV! online! provider! education! program! (HOPE)! [21].! Another! method! is! to! provide! off;site!
training!to!selected!health!workers!who!are!instructed!to!return!and!provide!on;site!training!to!their!
peers,! as! demonstrated! in! the! PALSA;PLUS!project! in! South! Africa! for! primary! health! care! nurses!
[22].!In!this!way,!service!interruptions!from!off;site!training!of!staff!are!minimized.!
Addressing! shortages! in! human! resources! will! be! critical! for! pediatric! ART! programs! to! expand,!
particularly!into!rural!areas.!This!will!require!innovation!and!ongoing!investment,!commitment!and!





the! timely! diagnosis! of! HIV! infection,! disease! staging,! diagnosis! of! opportunistic! infections! and!
monitoring! treatment! responses.! With! the! rapid! scale;up! of! HIV! treatment! programs,! many!
countries! in! sub;Saharan! Africa! are! poorly! equipped! to! deal! with! the! increasing! demand! for!
laboratory!services!and!are!limited!by!both!physical!and!human!resources![23,!24].!Donor!funds!have!
become!available!to!upgrade!laboratory!facilities!at!many!regional!and!district!hospitals!and!to!train!
staff! in! the! performance! of! laboratory! tests! and! equipment! maintenance.! This! has! been!
accomplished!in!some!areas!through!partnerships!with!institutions!in!high;resource!countries,!such!
as! the! partnership! between! the! Institutes! of! Human! Virology! in! Nigeria! and! the! University! of!




The! laboratory! capacity! for!diagnosing!HIV! infection!and!monitoring! treatment! responses! remains!
particularly!problematic!for!children.!Early!infant!diagnosis!is!complicated!by!the!fact!that!it!cannot!
be!done!with! the! antibody;based! assays! used! to! diagnose! older! children! and! adults,! but! requires!
polymerase! chain! reaction! (PCR);based! technology! currently! available! in! centralized! laboratories.!
Early!identification!of!HIV;infected!children!is!critical!for!their!timely!entry!into!comprehensive!care,!
as!early! treatment! initiation! reduced! infant!mortality!by!76%!and!HIV!disease!progression!by!75%!
[7].! Consequently,! the! WHO! now! recommends! ART! for! all! children! under! the! age! of! 2! years!
regardless!of!clinical!or!immunologic!status![3].!
As! most! facilities! do! not! have! the! capacity! for! early! infant! diagnosis,! samples! must! be! sent! to!
centralized! laboratories.! The! use! of! dried! blood! spots! (DBS)! has! made! this! process! simpler,! as!
samples! can!be!obtained!directly! from!a!heel! or! finger! prick! and! stored! and! transported! at! room!
temperature,! reducing! costs! and! resources! [26].! However,! the! turnaround! time! for! specimens!
transported!to!central!laboratories!can!be!lengthy.!Transportation!of!specimens!can!be!problematic,!




As! the! importance! of! early! infant! diagnosis! has! been! recognized,! much! work! has! been! done! to!
develop! simpler! assays! requiring! less! sophisticated! technologies! that! could! be! performed! in!
peripheral! facilities.!The!ultrasensitive!HIV;1!p24!antigen!enzyme;linked! immunosorbent!assay,! for!
example,!has!high!sensitivity!and!specificity,!can!be!used!with!DBS,!and!does!not!require!specialized!
equipment!or! training! [27,!28].!Point;of;care!assays!are!also!being!developed!that!are! inexpensive!
and!can!be!performed!in!most!facilities!by!trained!healthcare!workers.!Several!new!approaches!are!
based! on! nanotechnology! and! microfluidics,! and! include! biobarcode! amplification;based! assays,!




Monitoring! treatment! responses,! both! with! immunologic! and! virologic!measures,! is! important! to!
detect! treatment! failure,!which!occurs!more! frequently! in! children! than!adults! receiving!ART! [31].!
The! capacity! to! measure! immunologic! responses! with! CD4+! T! cell! percentage! has! become!more!
accessible,!such!that!many!smaller!facilities!outside!regional!and!district!hospitals!have!the!capacity!
to!perform!these!assays.!However,!monitoring!virologic!responses!requires!more!sophisticated!and!
expensive! technology! and! is! still! restricted! to! centralized! laboratories.! Consequently,! monitoring!
treatment!failure!is!either!done!by!clinical!and!immunologic!criteria!alone!or!blood!samples!are!sent!
to! centralized! laboratories! for! HIV! viral! load! testing.! Neither! of! these! options! is! ideal.! Good!
immunologic!responses!without!complete!viral!suppression!are!common!among!children,!leading!to!
poor!sensitivity!and!specificity!of!the!immunologic!and!clinical!criteria!and!delays!in!the!detection!of!
virologic! treatment! failure! [32].! As! for! PCR;based! diagnostic! assays,! the! turnaround! time! for!
specimens! transported! to! central! laboratories! can! be! lengthy,! resulting! in! delayed! detection! of!
treatment!failure.!




load.! While! these! assays! reduce! cost,! the! ExaVir! RT! and! Ultrasensitive! p24! assays! are! time!





personnel! and! assays! has! not! prevented! the! scale;up! of! ART! programs,! they! are! critical! to! their!









High! levels! of! adherence! to! antiretroviral! drugs! are! necessary! to! prevent! emergence! of! drug!
resistance! [35].! Adherence! among! adults! receiving! ART! is! challenging! due! to! social,! logistical! and!
personal! factors!but!adherence!among!children! is! further!complicated!by!their!partial!or!complete!
dependence! on! caregivers,! and! is! therefore! determined! by! the! motivation! and! ability! of! the!
caregiver!to!administer!the!medication,!the!willingness!of!the!child!to!take!the!medication!and!the!
social!dynamics!within!the!family.!Adherence! is!also!difficult! to!measure,!particularly! in!children! in!
resource! limited! settings,! as! direct! measures! of! adherence! using! plasma! drug! levels! and! more!
objective,! indirect! measurements,! such! as! electronic! devices! (e.g.! Medication! Event! Monitoring!
System!(MEMS)![36]),!cannot!be!used!due!to!expense!and!the!lack!of!laboratory!capacity.!
In! addition,! pediatric! fixed! dose! combinations! have! only! recently! become! widely! available;!
therefore,!children!take!many!drugs!in!different!formats!(pills!and!syrups),!making!it!more!difficult!to!
provide! a! combined!measure!of! adherence.! Researchers!must! often!use!more! subjective,! indirect!




high!and!compared!well!with!studies!of!adherence! in!high! income!countries! [12,!35].!Estimates!of!
adherence,!defined!in!various!studies!as!taking!>85%,!>95%!or!100%!of!doses,!ranged!from!49%!to!
100%,! with! only! four! studies! reporting! rates! less! than! 75%! [35].! The! difficulties! in! measuring!
pediatric!adherence,!however,!have!led!to!heterogeneity!in!measures!and!definitions!of!adherence!
used! in! different! studies,! making! comparisons! difficult.! In! general,! studies! using! more! objective!
measures! of! adherence,! such! as! MEMS,! pill! counts! and! visit! compliance,! found! lower! levels! of!
adherence! than! studies! using!more! subjective!measures,! such! as! self,! caregiver! or! health!worker!
reports! [37;39].!Reported! reasons! for!missing!doses! included! the!child! forgetting,! refusing! to! take!
the!drugs!or!vomiting!without!re;dosing,!conflicts!between!the!child!and!caregiver,!insufficient!clinic!
drug! stocks,! delays! in! getting! new! prescriptions! due! to! the! cost! of! transportation,! long! travel!
distances! and!waiting! times,! incorrect!dosing!by! caregivers,! having!multiple! caregivers! involved! in!
administering!or! supervising!drug!administration,!and! issues!of!disclosure,!particularly!due! to!HIV;
related! stigma! [12,! 35].! Several! social! and! environmental! factors! correlated! with! non;adherence,!
including!living!in!a!rural!setting,!low!levels!of!parental!education,!household!poverty,!non;disclosure!
to!the!child!or!other!family!or!community!members,!fewer!hospital!admissions!prior!to!ART,!stigma!
at! school,! limited! caregiver! adherence! strategies,! disorganized! families,! and! no! adult! caregiver!
receiving!ART![12,!35].!The!child’s!and!caregiver’s!positive!attitude!toward!antiretroviral!therapy!and!




implemented! innovative! strategies! to! improve! pediatric! adherence! beyond! the! recommended!
caregiver! education! through! adherence! counselling.! These! strategies! attempt! to! address! the!
complex!psychological,!social,!and!family!issues!affecting!pediatric!adherence.!Several!programmes,!
including! the! Macha! HIV! clinic! in! Zambia! [41],! TASO! in! Uganda! [42],! and! Khayelitsha! clinic! and!
Ndlovu! Medical! Centre! in! South! Africa! [43,! 44],! implemented! an! approach! based! on! directly!
observed!therapy!(DOT)!developed!to!increase!adherence!with!tuberculosis!treatment.!Patients!and!









Other! strategies! that! have! been! implemented! include:! 1)! child;friendly! clinic! environments! with!
dedicated! clinic! days! for! children,! rooms! for! children! furnished! with! toys,! games,! videos! and!
colourful!decorations,!and!a!playground!near!the!clinic!so!that!children!have!a!place!to!congregate!
and! participate! in! group! activities! led! by! young! peer! educators! and! counsellors! [45];! 2)! family;
centred! approaches! so! that! children! and! their! caregivers! can! be! cared! for! at! the! clinic! and!
counselled! on! the! same!days! [45,! 46];! 3)! group! counselling! targeted! to! caregivers,! teenagers! and!
children!so!that!each!group!can!share!their!experiences!and!receive!support!from!peers![45,!47];!4)!
child!and!teenager!fun!days!where!child;friendly!social!activities!are!organized!through!the!clinic!as!a!
way! of! strengthening! links! between! providers! and! patients,! providing! caregivers! and! children! a!
forum! for!establishing! social!networks! [45];!5)! system!of! reminders,! such!as!pill!boxes!and!alarms!







own! adherence,! as! diaries! improved! adherence! in! adults! [48].! However,! no! beneficial! effect! of!
medication! diaries! was! found! on! self;reported! adherence! or! clinical,! immunologic! or! virologic!
outcomes.!Examples!of! interventions! that!have!been!evaluated! in!adults! include! the!WelTel! study!
among!adults!in!Kenya!investigating!the!use!of!mobile!phones!to!improve!communication!between!







Further! research! on! optimal! measures! and! definitions! of! pediatric! adherence! are! needed,! and!
standardization!would!enable!comparison!across!studies!and!settings.!Reporting!and!evaluation!of!
adherence!strategies!to! improve!pediatric!adherence! in!treatment!programs!would!also!be!helpful!




Disclosure! is!an! issue!unique!to!children!as! they!are!not!always!made!aware!of! their!HIV! infection!
status!at!the!time!of!testing.! Information!regarding!their!health!and!disease!status! is!controlled!by!
the! caregiver,! and! the! caregiver! must! decide! when! and! how! to! tell! the! child! that! they! are! HIV!
infected.!There!are!varying!levels!of!disclosure,!ranging!from!no!disclosure!where!the!child!is!not!told!
anything!regarding!their!infection,!to!partial!disclosure!where!the!child!is!informed!that!they!are!sick!




be! beneficial! for! the! child! as! they! have! higher! self;esteem! and! fewer! emotional! problems! [53].!
Disclosure!also!enables!the!child!to!receive!support!from!friends!and!family!and!allows!the!child!to!





Research! on! disclosure! in! sub;Saharan! Africa! is! increasing! and! indicates! that! disclosure! is! not!
common,!even!among!older!children![53,!58;60].!While!caregivers!generally!report!that!the!optimal!
age! for! disclosure! is! 11! or! 12! years! [60],! only! 17;38%!of! adolescents! in! Cote! d’Ivoire! and! Zambia!
were! aware!of! their!HIV! infection! status! [53,! 58,! 59],! and!many! caregivers! felt! that! their! children!
were! too! young! to! be! told! [58].! Significantly! more! children! receiving! ART! in! these! studies! were!
aware!of!their!status,!as!initiating!and!adhering!to!treatment!often!motivate!disclosure.!
Disclosure! is! often! done! by! the! caregiver! [52,! 61,! 62];! however,! healthcare! providers! play! an!
important! role! in! disclosure! by! providing! support! and! information! regarding! HIV! infection! and!
treatment,!and!by!maintaining!open!communication!with!the!caregiver!and!child.!Formal!guidelines!
and!recommendations!are!needed!on!disclosure!to!children!in!sub;Saharan!Africa!as!well!as!training!
for! healthcare! providers! and! counsellors.! For! children,! disclosure! is! a! long;term! process! and!
information!must! be! provided! at! the! appropriate! age! and! stage! of! development! [51].! Healthcare!
providers! and! counsellors! must! be! aware! of! the! contextual,! social,! family! and! individual! issues!





Attrition! in!pediatric!ART!programs! is!a!growing!concern!as!programs!scale;up.! In!addition!to!ART,!
children!attending!HIV!clinics!receive!many!health!benefits,! including!preventative!and!therapeutic!
treatment! for! infections!and!nutritional! supplements.!Consequently,! for! children!not! yet! receiving!
















children! lost! to! follow;up! likely!died!or! transferred!to!another!clinic.!One!study!conducted! in!rural!
and!urban!Zambia!examined!factors!associated!with!loss!to!follow;up!and!found!significantly!higher!
rates!of!attrition!among!children!who!were! ineligible! for!ART!at!presentation![67].!Distance!to!the!
clinic! was! associated! with! attrition! for! both! eligible! and! ineligible! children,! with! higher! rates! of!
attrition! for! children! living! farther!away! from!the!clinic.! In! the!same!study!population,!distance! to!
the! clinic! was! negatively! associated! with! viral! suppression! [68].! Both! direct! and! indirect! costs! of!




children! must! often! rely! on! a! caregiver! to! take! them! to! the! clinic! and! pharmacy.! Consequently,!
strategies! to! improve!retention!must!consider! the!needs!and!motivation!of!both! the!child!and!the!
caregiver.!Several!models!of!care!have!been!implemented!to!improve!patient!retention.!The!first!is!
the! family;centred!approach,!which! treats! the!child!within! the!context!of! the!family!so! that! family!
members!can!support!each!other!in!adhering!to!treatment!regimens!and!visit!schedules![46,!74].!The!
second!is!the!decentralized!model!of!healthcare!delivery,!where!HIV!and!ART!services!are!relocated!
from! district! hospitals! and! delivered! at! peripheral! clinics! to! increase! patient! access! by! bringing!
services!closer!to!their!homes,!particularly!in!rural!areas.!This!can!be!done!by!providing!ART!services,!
including! evaluation,! treatment! initiation! and! treatment! monitoring,! at! the! clinic! level,! with!
supervision!from!a!team!of!physicians!or!medical!officers,!as!in!the!Lusikisiki![75],!Hlabisa![76],!and!
Mseleni! [77]! district!programs! in! South!Africa,! nurse;based!programs! in!Rwanda! [78,! 79],! and! the!
Scott! area! program! in! Lesotho! [80].! Alternatively,! evaluation! and! treatment! initiation! can! be!
performed!at!the!hospital!level,!with!subsequent!treatment!monitoring!at!the!clinic!level!for!children!
who!adequately!respond!to!treatment,!as!in!the!Macha,!Zambia!program![unpublished!data].!A!third!
approach! is! to! provide! homebased! care! and! ART! to! HIV;infected! individuals! with! support! from!
clinics,! as!with! field!officers! in!Uganda! through!TASO! [81,! 82]! and! volunteers! in! a! remote! area!of!
Tanzania! [83],! both!with! favourable! results.! In! these!models,! retention! is! encouraged!by! enabling!
patients!to!access!services!closer!to!home.!














As! programs! overcome! the! initial! challenges! of! providing! pediatric! ART! and! attempt! to! optimize!
their!services,!new!challenges!will!arise.!In!addition,!the!needs!of!the!population!may!change!as!new!
guidelines,! technologies! and! treatments! are! introduced.! Three! challenges! that! many! pediatric!





Provision!of!ART! to!children! in! sub;Saharan!Africa!needs! to!be! tailored! to! local! circumstances!and!
attention!given! to! the!distinct! role!of!each! level!of! the!healthcare! system.! Integration!of!pediatric!
HIV! care! within! primary! health! care! has! been! limited,! with! vertical! programs! independently!





example!of!how!this!can!be!accomplished! to! improve!HIV!care!and!strengthen! the!primary!health!
care!system![87].!ART!services!were!located!in!existing!health!facilities!in!23!districts,!primary!health!
care!workers!were!retrained,!laboratory!services!and!referral!mechanisms!were!improved,!HIV!and!
antenatal! services!were! integrated,! and!district! level!management!was! strengthened.! Three! years!





integrated! into! the! primary! health;care! system,! reducing! the! burden! on! hospital! clinics! and!
improving!access!for!patients!living!in!rural!areas.!As!a!simple!example,!recording!data!related!to!
HIV!infection!(including!exposure!and!testing)!on!the!child’s!under;5!card,!as!recently!introduced!in!
some! countries! (e.g.! Zimbabwe! and! Zambia)! [88],! is! a! step! toward! partial! integration! of! HIV! and!
routine! child! health! care.! Further! integration! in! Zambia! was! attempted! through! a! National!
Management!of!Pediatric!HIV!Clinical!Mentorship!program!to!decentralize!pediatric!HIV!services!and!
increase! the! coverage! of! HIV! infected! children! receiving! treatment! from! 8%! nationally.! After! two!
years!it!was!concluded!that!on;site,!pediatric!clinical!mentorship!models!need!to!be!comprehensive!
and! focus! not! only! on! the! provider’s! knowledge! but! also! on! clinic! delivery! systems.! Without!




been! associated! with! disease! progression! and! death! in! untreated! children! and! with! increased!
mortality! in!children!receiving!treatment![12].!Pediatric!ART!programs!often!do!not!have!access!to!
consistent! food!supplements.! Integrating!nutritional!assessment!with!HIV!care! is!essential!and!can!
be!done!by!performing!routine!anthropometric!assessments,!including!use!of!weight;for;age!charts.!
Proper!referral!for!nutritional!counselling!can!assist!in!identifying!causes!other!than!lack!of!food!and!
result! in! increased! energy! intake! [90].! Sufficient! attention! should! be! given! to! training! healthcare!





To! provide! high! quality! and! continuity! of! care! to! HIV;infected! children,! and! efficiently! manage!
pediatric! ART! programs,! clinicians! and! administrators! need! to! be! equipped! with! appropriate!
information![91].!ART!programs!provide!care!to!hundreds!of!children!over!thousands!of!clinic!visits,!
and! methods! of! summarizing! and! aggregating! that! information! in! a! meaningful! way! is! needed.!
Electronic!medical!records!(EMR),!linking!clinical,!pharmacy!and!laboratory!data,!fulfil!that!need!and!
can!be!useful!for!all!data!users:!clinicians,!administrators,!donors!and!researchers.!Clinicians!need!to!
access! a! child’s! complete!medical! history! in! a! structured! and! easily! accessible! format! to! provide!







system! in! Kenya! [91;93],! OpenMRS! in! South! Africa,! Kenya,! Rwanda,! Lesotho,! Zimbabwe,!
Mozambique,!Uganda,!and!Tanzania![94;96],!the!Patient!Management!Information!System!(PMIS)!in!




While! some!medical! record! systems! still! use! paper;based! forms,!which! are! then! entered! into! the!
EMR!system,!others,!such!as!SmartCare!and!PMIS,!are!working!towards!fully!electronic!systems!with!
clinicians!entering!data!directly!into!computers.!There!also!is!interest!in!integrating!HIV!clinic!records!










facilities!will! be! challenging.! In! resource;constrained! settings,! computers!will! need! to! be! updated!
and!maintained,!and!will!require!a!constant!supply!of!electricity.!Web;based!systems!will!require!a!
reliable! internet!connection,!and,!as!with!all! record!systems,! the!value!of! the!EMR!will!depend!on!
the!quality!of!the!data!entered.!An!evaluation!of!EMR!systems!in!the!ART;LINC!database!examined!
the!proportion!of!missing!data!on!key!patient!characteristics!and!found!heterogeneity!across!sites,!
with! up! to! 9.9%! missing! age! at! ART! initiation,! 37.2%! missing! clinical! stage! and! 53.0%! missing!
baseline!CD4+! T! cell! count! [102].! The!proportion!of!missing!data!was! found! to! correlate!with! the!
number!of! hours! spent! by! data! clerks! and! the! findings! emphasized! the!need! for!well;trained! and!
competent!staff!to!manage!the!database!and!perform!data!entry.!The!value!of!the!EMR!system!also!
will!depend!on!the!ability!of!users!to!access!the!data.!Many!systems!are!designed!to!readily!produce!





international! donors! has! stalled.! Several! countries! in! sub;Saharan! Africa! have! reported! turning!
patients!away!due!to!deficits!in!both!domestic!and!international!funding![103].!If!the!current!funding!
situation! persists,! rationing! will! negatively! impact! the! successes! pediatric! ART! programs! have!
achieved!in!the!last!ten!years!by!limiting!the!number!of!new!children!initiating!ART!and!the!quality!of!
care!for!children!receiving!ART.!
Establishing!guidelines!as! to!when!ART! should!be! initiated! is! a!way!of! allocating! scarce! resources.!
However,! treatment! guidelines! for! infants! and! children! have! become! progressively! wider.! With!
renewed!efforts!to!diagnose!HIV!infection!in!infants!and!young!children,!the!number!of!children!in!
need! of! ART! will! continue! to! grow.! In! addition,! while! expansion! and! increased! effectiveness! of!
programs!to!prevent!mother;to;child!transmission!will!reduce!the!number!of!children!infected!with!
HIV,! the!number!of!HIV;infected! children!with!prior! exposure! to! antiretroviral! drugs!will! increase,!








and! donor! commitment.! Despite! the!many! barriers! to! implementation! in! such! settings,! programs!
have!demonstrated! they!can!provide!ART! to!HIV;infected!children!and! these!children!have! similar!
treatment!outcomes!as!children! in!high;resource!settings.!Pediatric!ART!programs!have!developed!
innovative! solutions! and!are!demonstrating! they! can! successfully! expand! services! to! increase!ART!
coverage! in! affected! communities! (Panel!1).! As! programs!optimize! care! and! treatment,! and!more!
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This! thesis! presents! data! of! a! collaboration! between! different! partners:! Macha! Research! Trusts!
(previously! called! Malaria! /! Medical! Institute! at! Macha)! and! Macha! Mission! Hospital! in! Macha,!
Zambia;! AIDS! relief! Zambia! and! the! Zambian!Ministry! of! Health;! Erasmus!MC,! University!Medical!





adjacent!research! institute,!all!situated! in!a!rural!village! in!Zambia.! !The!data!of!the!paediatric!HIV!
cohort!group!receiving!care!at!this!rural!Zambian!hospital!provides!the!basis!for!this!thesis.!Although!
most!studies!of!HIV;infected!children!in!sub;Saharan!Africa!are!conducted!in!urban!areas![2],!where!
resources!and! infrastructure!are!greatest,! the!studies!presented! in!this!thesis!were!conducted! in!a!
rural!community!within!the!context!of!the!observational!cohort!study!of!primarily!perinatal!infected!
children!(PART!study)!that!has!been!ongoing!since!2007.!While!conducting!research!in!a!rural!setting!
is! challenging! because! of! limited! resources,! these! studies! provide! insight! into! the! long;term!
consequences! of! HIV! infection! and! treatment! and! the! unique! barriers! and! challenges! associated!
with!providing!care!and!treatment!in!this!setting.!!
!
In! this! final! chapter,! we! will! summarize! the! presented! studies,! highlight! some! of! the! achieved!











the! effectiveness! of! antiretroviral! therapy! among! HIV;infected! children! in! sub;Saharan! African,!
which! places! our! data! in! a! broader! perspective.! This! literature! review,! presented! in! chapter! 2,!
demonstrated!that!short^term!results!of!sub;Saharan!treatment!programs!are!promising.!In!view!of!
the! rate! at! which! ART! program! expansion! has! taken! place! in! the! sub;Saharan! region,! achieving!
similar!program!outcomes!in!sub;Saharan!Africa!to!those!seen!in!developed!countries!is!a!significant!
accomplishment.! However! the! older! age! and! greater! disease! severity! at! the! time! of! treatment!
initiation!in!sub;Saharan!African!HIV;infected!children!hindered!direct!comparisons!with!children!in!
Western!countries.!!
Late! identification!of!clinically! ill!HIV! ;infected!children!supports!the!need!for!earlier!diagnosis!and!
treatment.! Increased! access! to! easy;to;use! technologies! for! diagnosing! HIV! infection! in! children,!
strengthening!of!counseling!and!testing!programs,!as!well!as!PMTCT!programs,!and!revised!criteria!
so!that!children!become!eligible! for!ART!at! less!severe!stages!of! immune!suppression!are!urgently!
needed.!!
More!than!half!of!the!children!reported!were!undernourished!at!treatment!initiation.!!This!calls!for!
integrated! models! of! care! addressing! malnutrition! and! including! both! therapeutic! and!
supplementary!feeding.!!
Suboptimum! antiretroviral! regimens! were! usually! available! for! use,! with! only! 63%! of! the! studies!














commonly! cited!obstacles! to! accessing! the! clinic,! particularly! during! the! rainy! season! [chapter! 3]. 
The!majority!of!caregivers!either!walked!or!used!a!bicycle!and!over!25%!travelled!more!than!5!hours!
to!get!to!the!clinic.!
Disclosure!of!HIV! infection! status! to! children!was! infrequent.! Few!children,!even!among! the!older!










reported! elsewhere! in! sub;Saharan! Africa.! Developing! strategies! to! improve! access! to! care! and!
nutrition! will! be! necessary! to! ensure! optimal,! long;term! treatment! outcomes! for! HIV;infected!
children!residing!in!rural!sub;Saharan!Africa.!
!
To!determine! if! the! limited!access! in! rural! areas,!due! to! the!unique!challenges! faced!by!providers!







with! loss;to;follow;up! being! high! among! children! living! further! away! from! the! clinics,! especially!
among!children!ineligible!for!treatment.!!Both!urban!and!rural!children!responded!well!to!treatment,!













ART! can! effectively! be! delivered! in! a! rural! setting! and! demonstrates! that! children! experienced!
sustainable!immunologic!and!virologic! improvements!after! initiating!ART.!Early!gains!in!CD4+!T;cell!
percentages!were!maintained!throughout!follow;up.!
The! study! also! demonstrates! improvements! in! enrollment! and! treatment! of! children! at! younger!




T;cell! percentages! increased! at! a! slower! rate! of! 0.23! percentage! points! per!month.! The!majority!
(82%)!of!children!achieved!a!CD4!T;cell!percentage!in!the!normal!range!(>25%)!within!the!first!year!
of!ART.!!
Adherence! to! ART! was! high,! with! approximately! 75%! of! children! reporting! >95%! adherence! to!













6]! of! young! HIV;infected! children! in! rural! Zambia!with! good! immunologic! recovery! on! ART,! both!
weight! and! height;for;age! significantly! improved! after! initiation! of! ART.! Differing! patterns! of!
improvement! of! WAZ! and! HAZ! were! associated! with! undernutrition! and! age! at! ART! initiation,!
respectively.!Underweight!children!experienced!a!greater! increase! in!WAZ! in! the! first!6!months!of!
ART,!and!children!older!than!5!years!at!initiation!experienced!significantly!smaller!increases!in!HAZ!
per! month! compared! to! children! younger! than! 2! years! of! age.! However,! a! large! proportion! of!
children!were! underweight! (60%)! and! stunted! (72%)! at! ART! initiation! and! remained! underweight!
(45%)! and! stunted! (46%)! after! two!years!of! treatment,! higher! than!observed!among!HIV;negative!
children! in!the!same!region![3].!Consequently,!successful!treatment!with!ART!was!not!able!to!fully!
reverse!the!effects!of!HIV!and!undernutrition!on!growth.!Partnerships!between!HIV!treatment!and!
nutrition! programs! should! be! explored! so! that! children! receive! an! integrated! care! and! treatment!








ascertainment!of!deaths,! estimates! indicate! that! a! significant!proportion!of! children!entering! care!
are!dying!before!they!initiate!ART.!In!this!study,!the!cumulative!mortality!prior!to!ART!initiation!was!
13.3%!and!was! comparable! to! the! cumulative!mortality!of!14.4%!among!children! initiating!ART! in!
this!paediatric!cohort![chapter!5].!In!addition,!the!mortality!rate!in!the!first!three!months!after!study!
enrollment!among!children!eligible! for!ART!was!comparable!to!the!mortality!rate! in!the!first! three!




HIV! contributes! significantly! to! overall! child! mortality,! especially! in! high;burden! countries.! The!
benefits!for!children!on!ART!should!be!the!same!whether!in!a!resource;poor!or!;rich!setting,!yet!the!






limited! in! resource;constrained! settings! due! to! limited! data! on! the! use! of! efavirenz! (EFV).!
Consequently,! there! is! a! need! for! alternative! treatment! strategies! for! young! children! with!
tuberculosis! and! data! to! support! their! use.! Given! the! limited! antiretroviral! treatment! options! in!
these!settings! for!children!receiving! rifampicin!and!the!need!to! initiate!ART!as!soon!as!possible! to!
avoid! excess! morbidity! and! mortality,! an! EFV! dosing! schedule! extrapolated! from! available!
pharmacokinetic! data! was! developed! for! the! clinical! care! of! young! children! co;infected! with!









high!burden!of! tuberculosis,! the! limited! treatment!options! in! this! region,!and! the! limited!virologic!
efficacy! of! NVP,! use! of! EFV! in! young! children! can! be! considered.! This! is! the! first! study! to!
demonstrate! that! EFV! can! be! used! effectively! in! young! HIV;infected! children! with! tuberculosis.!





antiretroviral! treatment,! and! in! chapter! 9! we! evaluated! such! a! program! comparing! treatment!
outcomes! for! children! receiving! care! in!mobile! and!hospital;based!HIV! clinics! in! rural! Zambia.!We!
found!that,!despite!similar!clinical!and!immunologic!outcomes,!children!in!the!outreach!group!were!




The! disparity! between! paediatric! and! adult! access! to! treatment! is! large! as! provision! of! ART! to!
children! presents! unique! obstacles.! Multiple! challenges! have! been! identified,! and! examples! of!
locally;adapted! strategies! to! overcome! these! have! been! documented.! Chapter! 10! reviews! the!
feasibility! and! effectiveness! of! pediatric! ART! in! sub;Saharan! Africa,! highlighting! some! of! the!
successful! practices! and! developments! in! service! delivery! and! care.! Bottlenecks! that! particularly!
affect! children!and! limit! paediatric! treatment! are!discussed! in! this! chapter,! including! shortages!of!
properly!trained!health!care!providers,!lack!of!laboratory!capacity!for!infant!diagnosis!and!treatment!
monitoring,!adherence,!disclosure!of!HIV!infection!status,!and!retention!in!care.!!
Addressing! shortages! in! human! resources! is! critical! for! paediatric! ART! programs! to! expand,!
particularly! in! rural! areas.! To! increase! access! to! ART,! WHO! promotes! task! shifting! where! non;








to! expand! laboratory! capacity! and! to! develop! simple,! low;cost! point;of;care! assays! for! infant!
diagnosis!and!viral!load!monitoring!has!been!recognized!and!mentioned!in!the!above.!!
Consistent! adherence! to! dosing! guidelines! by! health! care! providers! and! patients! is! essential! to!
reduce! the! likelihood! of! treatment! failure! from!under! dosing! or! drug! toxicity! from!overdosing.! In!
children,! correct! dosing! is!more! challenging! as! it! depends! on! close!monitoring! of! growth! through!
accurate! weight! and! height.!Many! programs! have! implemented! innovative! strategies! to! improve!
pediatric!adherence!beyond!the!recommended!caregiver!education!through!adherence!counseling.!
These! include! the! implementation! of! treatment! supporters;! training! clinic! personnel! in! ways! to!
measure! pediatric! adherence;! identify! reliable! low;technology,! low;cost! methods! of! assessing!
adherence;! implement! family;centered!approaches;!provide!group!and!psychosocial!counseling! for!
caregivers!and!children;!provide!adherence!reminders,!and!provide!training!in!treatment!literacy.!!
The! relationship! between! disclosure! and! adherence! is! recognized! and! WHO! recommends! that!
children!older!than!10!years!participate!in!discussions!regarding!HIV!testing![6].!However,!research!
indicates! that! disclosure! is! not! common! in! sub;Saharan! Africa.! Formal! guidelines! and!





caregiver.! A! family;centered! approach,! decentralized!model! of! care,! and! a! home;based!model! of!
care!are!some!of!the!models!that!have!been!implemented!to!improve!patient!retention.!!
Some! of! the! future! challenges! for! paediatric! programs! that!were! identified! include! integration! of!












The!vast!difference! in!outcomes! is! the! result!of!both!biomedical! and!program! factors!and! include!
having! advanced! disease! upon! diagnosis,! other! co;infections,! malnutrition,! and! delays! in! starting!
ART.!However,!the!challenges!to!curb!the!HIV!epidemic!among!children!in!rural!sub;Saharan!Africa!
are! still! enormous.! Ways! to! further! improve! access! to! care! and! ensure! optimal! and! long;term!
treatment! outcomes! for! HIV! infected! children! residing! in! rural! sub;Saharan! Africa! in! the! (near)!
future,!can!be!divided!into:!!
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to!develop! the!Global!Plan! towards! the!elimination!of!new!HIV! infections!among!children!by!2015!













for! ART! for! their! own! health,! ARV! prophylaxis! option+ B! consists! of! antepartum! daily! triple! ARV!
prophylaxis! until! delivery,! or,!if! breastfeeding,! until! 1! week! after! all! exposure! to! breast! milk! has!
ended.!The!infant!is!to!receive!daily!NPV!prophylaxis!from!birth!to!6!weeks!of!age.!!
The! 2009!WHO! guidelines! in! infant! feeding! for! HIV;infected! women! is! that! all! mothers! who! are!
known! to! be! HIV;infected,! either! on! lifelong! ART! or! not,!who! exclusively! breastfeed! their! infants!
should!do!so! for! the! first!6!months,! introducing!appropriate!complementary! foods!thereafter,!and!
continue! breastfeeding! for! the! first! 12! months! of! life! [10].! An! AFASS! assessment! has! to! be!
performed! before! advising! women! not! to! breastfeed,! to! ensure! that! infant! formula! feeding! is!
Acceptable,!Feasible,!Affordable,!Sustainable,!and!Safe.!!
The!abbreviated!maternal!treatment!period!in!both!option!A!and!B,!contributes!to!the!high!rates!of!
lost;to;follow;up! (LTFU)! in! younger! children! and! consequently! higher! risks! of! paediatric!mortality,!




could! result! in! less! HIV! maternal;to;child! transmission,! especially! in! subsequent! pregnancies,! as!
opposed!to!stop;start!methods!proposed!with!option!A!and!B.!The!total!fertility!rate!in!sub;Saharan!
Africa! is!high,!and! soon!after! the!breastfeeding!period!many!women!become!pregnant!again.!The!
majority! of!women! present! for! antenatal! care! late! in! pregnancy,! and! continuing! prophylaxis!with!
HAART!would!mean!that!the!next!pregnancy!could!be!protected!from!conception.!The!stopping!of!
ART!after!cessation!of!breastfeeding!might!lead!to!viral!rebound,!with!the!risk!of!transmission!to!a!
sexual! partner! or! fetus! being! notably! raised.! In! addition,! the!women! on! life;long! therapy!will! be!
healthier! with! less! risk! of! contracting! opportunistic! infections,! which! can! prevent! the! negative!
paediatric! outcomes! associated! with! the! decline! in! health! or! death! of! primary! caregivers! [14].!
Universal,!lifelong!ART!for!HIV;infected!pregnant!women!will!achieve!maximum!coverage!and!could!
potentially! lead! to! elimination! of! paediatric! HIV/AIDS.! While! studies! on! clinical,! social! [15]! and!








PMTCT! service! points,! with! inexpensive,! portable! and! battery;operated! point^of^care! CD4+! T! cell!
testing! technologies! can!potentially!help! in!avoiding!missed!opportunities! in! choosing! the!optimal!
PMTCT!regimen.!
!
The! first! step! to! getting! a! child!on! treatment! is! diagnosis.!Weak!health! and! laboratory! systems,! a!
limited!number!of!qualified!health!care!workers!skilled!in!paediatric!testing,!and!the!stigma!around!
the! possibility! of! having! an!HIV;positive! child! often!mean! that!many! infants! simply! are! not! being!
tested!for!HIV![16].!Many!African!children!have!their! first!health!care!encounter!at!a!rural!primary!
health!care!center.!Their!access!to!HIV!screening!depends!on!timely!identification!of!being!at!risk!for!








preparedness.!There!are!many!benefits! from!enrolling!children! long!before!ART! is! initiated.! In! the!







miss;reporting! of! certain! indicators.! HIV;infected! pregnant! women! already! on! full! HAART! and!
receiving! care! at! an! HIV! clinic,! do! need! to! bring! their! child! to! a! different!MCH! service! point! for!
testing!and!ART!prophylaxis!if!indicated.!This!does!not!enable!further!integration!of!services!and!can!
result!in!attrition!and!intermittent!service!provision!for!the!mother!and!child.!There!is!a!need!for!the!
development! of! indicators! for! integrated! approaches,! as! well! as! the! integration! of! existing!
monitoring! systems! within! different! health! services,! allowing! for! integration! of! services! with!
accurate!reporting.!
!
HIV! disease! progresses! very! rapidly! in! young! children.!Without! care! and! treatment,! one;third! of!
infants!die!in!the!first!year!and!about!a!half!of!children!by!the!second!year!of!life![18]!(compared!to!a!









more!centralized! laboratory! that!has! the!required!equipment.!The!results!need!to!be!sent!back!to!
sites!and!returned!to!caregivers!in!a!timely!manner.!
















92).! In! summary,! the! longest! delay! in! diagnosis! was! in! the! time! required! to! provide! results! to!
caregivers.! As! the! time! for! transport! and! testing! was! variable,! and! caregivers! had! to! travel! long!
distances! to!get! to! the!clinic,!clinic!appointments!were!often!scheduled!at! three!months! intervals,!





testing,! communicate! results,! and/or! give! adherence!messages.! Across! rural! areas,!mobile! phone!






(2) Supporting! the!expansion!of!ART!programs! into! rural! areas! to! increase!access! to!










in! favor! of! overall! ART! targets.! Furthermore,! the! 2010! WHO! guidelines! [22]! have! expanded! the!
eligibility! criteria! for! children,! including! recommending!ART! initiation! for! all! children! age! two! and!
younger,!but!many! countries!have!yet! to! increase! their! existing!paediatric! targets! to! reflect! these!








effects! of! stigma! and! fear,! services! that! do! not! cater! to! the! entire! family’s! needs,! and! structural!
issues!facing!poor!families,!such!as!transportation![16]. 
Integrating!comprehensive!prevention!and!antiretroviral!services!with!maternal,!neonatal!and!child!
health! services! can! improve! the! efficiency! and! effectiveness! of! all! interventions.! By! packaging!
services,!women! are!more! likely! to! obtain!the! services! they! require! and! service! efficiency!will! be!
enhanced! [23].! Service! integration! can! especially! be! beneficial! in! countries! with! generalized! HIV!
epidemics! since! HIV! care! is! a! substantial! burden! for! already! weak! health! care! systems.! A! more!
integrated!approach!will! strengthen!the!reach!and! impact!of! the!AIDS!response,!will! leverage!HIV;
related!gains!to!generate!broader!health!advances!and!enhance!the!long;term!sustainability!of!HIV!
programs![24].!
According! to!a! four;year! retrospective! review!of!over!200!clinical! sites!within! the!Elizabeth!Glaser!
Pediatric!AIDS!Foundation’s! (EGPAF)! large!multi;country!HIV!care!and!treatment!program! in!Africa!
[25]! the! following!were! associated!with! favorable! paediatric! enrolment! and! a! high! proportion! of!
children! under! two! years! of! age! on! ART:! nutritional! support,! early! infant! diagnosis,! linkages!with!
associations!of!people! living!with!HIV,!and!on;site!PMTCT!services.!These!findings!showing!the! link!
between! certain! services! and! favorable! program! outcomes! for! children! suggest! areas! of! clinical!
activities! that!might! be! expanded! or! strengthened! so! leading! to! improved! paediatric! HIV! service!
utilization!among!similar!resource;limited!country!populations.!
Additionally,! involving! affected! communities,! innovation! and! commitment! will! be! required!to!
alleviate!the!stigma!that!would!deter!women!living!with!HIV!and!vulnerable!women!from!attending!
antenatal! care! and! child! services.! Community! support! programs! that! complement! clinical! services!
and!mentor!mothers,! support! disclosure,! promote! the! involvement! of!men! and! boys! and! reduce!
stigma!and!discrimination!are!all!critical!to!promote!access!to!essential!services!and!retain!families!in!
care![24].!
Recent! improvements! in! early! infant! diagnosis! and! revisions! to! the! WHO! paediatric! treatment!
guidelines! to! broaden! the! eligibility! criteria! for! initiating! ART! [21]! mean! that! more! HIV;infected!
children!will!be! identified,!started!on!ART!and!survive! into!adolescence!and!adulthood.!We!should!
aim!to!provide!the!kind!of!integrated!medical!care!that!is!essential!in!order!to!fully!serve!paediatric!
patients!with!HIV! infection!over! the! long!term.!While! there! is!consensus!about! the!need!for!more!
integrated! systems! health! service! delivery,! a! range! of! factors! at! policy! and! service;delivery! levels!
have! been! identified! as! challenges! to! deliver! integrated! care.! At! the! policy! level,! these! include!
vertical!programming,! lack!of!policy! guidance!on! integrated! care,!under;funding!of! some!program!
areas,! program! territorialism,! and!weak! referral! systems.! At! the! service! level,! factors! can! include!
high! patient! load,! staff! shortages! and! insufficient! training! and! skills! in! certain! program! areas,!
resistance!to!change,!and!inadequate!monitoring!systems!related!to!integration.!Actions!are!needed!
at!both!policy!and!service;delivery!levels!to!develop!an!integrated!approach,!and!national!policies!to!




travel! times! influenced! program! attrition! [chapter! 4],! and! had! a! detrimental! effect! on! virologic!
suppression![chapter!5].!Decentralization!of!care!and!task!shifting,!where!HIV!and!ART!services!are!
relocated!from!hospitals!and!delivered!at!peripheral!clinics,!can!be!an!effective!strategy!to!paediatric!




training,! supporting! simplification! of! paediatric! ART! regimens,! and! advocating! for! task;shifting,!
decentralization!of!paediatric!HIV!care!and!treatment!to!primary!health! facilities!can!be!promoted!
[28].! For!effective!decentralization! to! take!place! into! the! rural!areas,! there! should,! in!addition,!be!
sufficient!resources!for!Primary!Health!Care!Workers!(PHCW)!to!provide!the!necessary!care.! In!the!
absence!of! funds!for!salary! increments,! increasing!knowledge!of!motivational!strategies,!especially!
for! staff! from! remote! centers,! is! necessary! [29].! Stock;taking! and! distribution! of! diagnostics! and!
drugs!need!to!be!worked!out,!and!a!good!relationship!between!communities,!traditional!leaders!and!
local! PHCW! is! needed,! including! acceptance! of! standard! HIV;treatment.! Traditionally,! the! rural!
population!have!less!exposure!to!media!and!thus!also!to!HIV/AIDS!information.!A!lot!of!information,!
Education!and!Communication!(IEC)!material!is!not!adapted!to!the!local!culture!and!is!not!available!
in! the! local! language.! Consequently! there! are! significant! differences! in! HIV/AIDS! knowledge,!
attitudes!and!practices!between!rural!and!urban!population,!which!need!to!be!understood![30].!A!
large! study! comparing! paediatric! enrollment,! ART! initiation! and! early! outcomes! at! primary! (PHF)!
versus! secondary/tertiary!health! facilities! (SHF)!demonstrated! that!pediatric! care!and! treatment! is!
feasible!in!primary!health!facilities!with!equally!or!more!effective!outcomes!than!in!SHF,!highlighting!
the! importance! of! PHF! in! the! context! of! decentralization.! The! low! proportion! of! children! <! 24!
months!initiating!ART!at!PHF!was!concerning,!and!a!multifaceted!approach!is!needed!to!address!this!
if!primary!health!facilities!are!to!support!scale;up!of!paediatric!services![31].!!




increasing! utilization! and! reducing! loss! to! follow;up! [9].! Steps! to! be! taken! towards! effective! task;







Many! studies! have! documented! lower! weight! and! height! and! impaired! growth! of! HIV;infected!
children!compared!to!HIV;uninfected!children!in!both!high;income![32,33]!and!low;income!settings!
[34,35,36].! Reasons! for! HIV;related! delays! in! growth! are! complex! but! include! alterations! in!
gastrointestinal! absorption,! chronic! or! recurrent! infections,! and! endocrine! dysfunction! [37,38].!
Delays!are!generally!more!pronounced! in!children!with!higher!viral! loads! [39,40]!and!more!severe!
disease!progression![41].!!
In!chapter!2,!it!was!shown!that!in!general!there!is!a!high!level!of!malnutrition!at!treatment!initiation!
among! HIV;infected! children! in! sub;Saharan! Africa.! Further! studies! among! the! Zambian! cohort!
demonstrated! that! the! rural! children! initiated!ART!at!a! significant! lower!WAZ! than!urban!children!
[chapter!4].!Severe!undernutrition!was!found!to!be!a!risk!factor!for!mortality!among!children!eligible!
for!ART!as!well!as!for!early!mortality!in!those!receiving!ART![chapter!7].!Treatment!with!ART!resulted!
in!a!significant! improvement! in!growth!parameters! for!at! least!2;3!years!after! initiation![chapter2]!
although!a!high!proportion!of!children!remained!underweight!and!stunted!after!2!years!of!treatment!
[chapter! 6],! and! long;term!effects! on! growth! and! development! are! unknown,! particularly! in! rural!
sub;Saharan!Africa.!
The! large! proportion! of! children! presenting! with! malnutrition! illustrates! the! need! to! develop!
integrated!models!of!care,!combining!both!therapeutic!and!supplementary!feeding!with!treatment!
programs!and! integrate!HIV!programs!with!other! care! at! primary!health! care! level.! In! this! service!
children!would! receive! integrated!disease!management,! including! for!malnutrition,!with! the! same!
counselors!and!caregivers!providing!support!for!ART!and!nutrition.!!
!
Zambia! is! a! relatively! politically! stable! country! with! plenty! of! natural! resources! and! a! vision! of!
poverty!reduction!and!economic!growth;!it! is!therefore!an!ideal!candidate!for!a!country!that!could!
make!a!significant!impact!on!it’s!malnutrition!problem.!Nutrition!has!received!political!attention!and!
is! recognized! in! overarching!development! policies! and! strategies.!However,! political! attention!has!
not!moved!into!concrete!action,!and!each!of!these!strategies,!policies,!and!plans!is!essentially!a!wish!
list!noting!best!practice.!The!strategies!are!mainly!confined!to!the!health!sector,!and!were!created!
with! substantial! input! from! external! actors! but! as! for! now! without! the! backing! of! political!
commitment,!budgetary!or!human!resources,!or!capacity.!Nutrition!is!highlighted!as!a!lower!priority!
area!within!the!health!sector,!and!budgetary!allocation!to!nutrition!is!thus!not!prioritized.!This!hints!













Disclosure! is! an! issue! unique! to! children! as! they! are! not! always!made! aware! of! their! HIV! status.!
Whereas!chapter!3!showed!that!disclosure!among!children!in!our!cohort!was!not!common,!a!more!
recent!analyses!showed!a!considerable!improvement!in!the!child’s!disclosure!status.!Full!disclosure!
for!children!10!years!and!older! increased! from!17%! in! the!2009!cohort! to!48%! in! the!2013!cohort!





are! living! longer,! experience! a! less! symptomatic! early! course! of! the! disease! and! survive! to! older!
ages,!with! improved!quality!of! life.!The!increased!survival!of!children!on!ART!in!sub;Saharan!Africa!









Adherence! to!ART! is!essential! for! continued!viral! suppression!but! is! impacted!by! individual,! family!
and! social! factors! [44].!Non–HIV!disclosure! to! children!has! implications! for! adherence! to! therapy,!
resistance!and!treatment!failure.!Haberer!et!al! in!a!study!in!Zambia![45],!noted!that!older!children!







Sustaining! ART! adherence! requires! accurate,! consistent! monitoring,! a! particular! challenge! for!
resource;limited! countries.! Adherence! measurement! strategies! used! in! low;! and! middle;income!
countries! include! self;! or! proxy;report!measures,! pill! counts,! pharmacy! records,! drug! levels,! clinic!
adherence! and! directly! observed! therapy.! The! optimal! strategy! to! measure! pediatric! adherence!
remains!unclear,!and!adherence!estimates!vary!substantially!between!sites,!but!most!studies! from!
low;!and!middle! income!countries! report!>!75%!paediatric!adherence,!whereas!most! studies! from!
high;income! countries! report! <! 75%! paediatric! adherence! [44].! The! initial! levels! of! adherence! in!




Caregivers! are! requested! to! bring! their! medication! bottles! each! clinic! visit.! Remaining! pills! are!
counted!and!checked!against!the!number!of!pills!prescribed!during!the!time!interval!and!bottles!of!
liquid!medications!are!weighed.!Percent!adherence!is!calculated!as!the!percentage!of!pills!or!liquid!
ingested! for! each!prescribed!drug. The!process! of! conducting! an! accurate! pill! count! and! carefully!
calculating!adherence! in! the!presence!of! child!and!caregiver!may,! in! itself,! reinforce!and!promote!








Research! in! adherence;promotion! strategies! within! the! paediatric! HIV! population! is! limited,! but!
clinical! experience! with! paediatric! populations! is! suggesting! the! benefits! of! initially! determining!
psychological!and!psychosocial!treatment!readiness!of!child!and/or!caregiver.!Intensive,!continuous,!



















second! or! third! line! therapy.! The! number! of! paediatric! options! available! for! global! programs! has!
increased! markedly! in! recent! years! with! the! approval! of! many! new! formulations,! including!
formulations!that!meet!the!unique!administration!needs!of!children,!such!as!dispersible!fixed;dose!
combinations!(FDCs).!Paradoxically,!this!has!not! increased!the!number!of!regimen!options! that!can!
be!given! to! children,!only! the!number!of!dosage! forms!and! strengths!available! to!deliver!any!one!
particular! regimen.! By! 2012,! over! 30! pediatric! ARV! formulations! have! been! WHO! pre;qualified,!
including! 8! unique! pediatric;strength! FDCs! and! 8! dispersible! formulations! [9].! WHO! strongly!
endorses! the! use! of! FDCs! as! a! general! principle! to! simplify! dosing! for! providers! and! patients,! to!
improve! adherence! outcomes,! and! support! decentralizing! services.! In! chapter! 5,!we!were! able! to!
confirm!that!children!taking!ART!regimens!including!FDC!were!more!likely!to!be!adherent.!
!
The!global!demand!for!pediatric!antiretrovirals! (ARVs)! is! low!as!children!account! for!only!7%!of!all!
individuals!on!treatment,!and!when!this!low!demand!is!distributed!over!not!only!the!large!number!of!
products!available!but!the!numerous!dosage!forms!and!strengths!as!well,!demand!for!any!particular!




the!objective! to!achieve!universal!access! for!adults!and!children! living!with!HIV! through!simplified!
HIV! treatment!with! optimized! drug! regimens,! point;of;care! diagnostics,! and! decentralized! service!
delivery.!A!special!paediatric!working!group,!lead!by!WHO,!developed!an!optimized!list!of!paediatric!
ARV! formulations,! determining! the! best! options! for! a! limited! range! of! approved! and! available!
paediatric!ARV!formulations!that!offer!the!highest!quality!of!care!for!children!of!all!ages!and!can!be!
used!to!deliver!all!required!first!and!second!line!ART!regimens![50].!
Meanwhile,! continuous! efforts! to! ensure! that! adapted! treatments! reach! the! children! that! need!
them!are!being!made.!For!example,!the!Drugs!for!Neglected!Diseases!initiative!(DNDi)!is!involved!in!
















have! shown! a! low! sensitivity! of! clinical! and! immunological! criteria! in! identifying! virologic! failure!
[52,53].!This! situation! leads! to!both!delayed!switching! that!could!encourage! further!emergence!of!




Recent! data! supports! less! frequent! CD4! monitoring! in! clinically! stable,! virally! suppressed! adult!
patient! and! suggests! that! routine! CD4! monitoring! for! this! population! may! be! unnecessary! [55].!
Reducing!the!frequency!of!CD4!cell! testing!could!have!benefits!for!both!providers!and!patients,!by!
saving! substantial! sums! of! money! (which! could! be! allocated! to! HIV;RNA! testing),! and! alleviating!
patient! anxiety! from! fluctuations! in! serial! CD4! test! results! due! to! laboratory! and! physiologic!
variability.!Further!research! is!needed!to!see! if! the!primacy!of!viral! load!monitoring! for! individuals!
treated!with!antiretroviral!drugs!is!also!applicable!for!children,!and!if!a!shift!from!CD4(%)!monitoring!






Attrition! occurs! at! all! points! along! the! care! continuum,! and! in! children! this! stretches! from! the!
antenatal!period!through!infancy,!childhood,!adolescence!and,!ultimately,!through!the!transition!to!
adult! HIV! care.! With! ongoing! care! and! treatment! across! these! stages,! the! vast! majority! of! HIV;





differences! among! patient! populations.! It! was! suggested! these! differences! result! from! a!
combination! of! factors! including! national! leadership,! access! to! care,! HIV! prevalence,! patient;
provider! ratios,! caseload! and! decentralization.! Factors! shown! to! reduce! LTFU,! are! for! example!
higher!staff;to;patient!ratios,!shorter!wait!times,!and!active!follow;up.!
When! looking! more! into! personal! and! socio;cultural! factors! associated! with! the! behavior! of!
caregivers! who! take! HIV! infected! and! exposed! children! for! care,! thematic! content! analysis! of!
caregiver’s!perceptions!revealed!that!their!decision!about!routinely!taking!their!children!to!HIV!care!
involved! multiple! levels! of! factors.! The! complexity! and! interconnectedness! of! these! factors!
underlying!retention!of!children!in!HIV!care!by!these!women!caregivers!suggests!that!interventions!
to!reduce!paediatric!LTFU!need!to!be!holistic!and!address!multiple!socio;ecological! levels.!Patient;
centered! care! that! integrates! a! family;centered! approach! to! HIV! paediatric! care! is! therefor!
recommended! [57].! A! qualitative! research! conducted! with! people! with! HIV! in! three! African!
countries! [58],! found! that! missed! clinic! visits! may! be! unintentional! or! intentional,! with! complex!
reasons! that! change! over! time.!While! the! initial,! practical! reasons! for! non;attendance!may! pass,!
people!are!frequently!reluctant!to!return!to!the!clinic,!owing!to!feeling!shame!about!their!absence!
and!in!anticipation!of!negative!responses!from!care!providers,!ultimately!resulting!in!disengagement!
from! care.! The! authors! recommend! that! clinicians! need! to! address! the! reasons! patients! are!




report! a! higher! attrition! [chapter! 5].! Attrition! is! usually! greater! for! children! on! pre;ART! than! for!
those!on!ART![chapter!4],!which!was!also!found!within!the!adult!population!within!the!same!clinic!at!
Macha![59].!
We! suggest! that!our! low!attrition! rates!are!due! to!an! integrated!package!of! care!minimizing! time!
spent!at!the!clinic,!a!family;based!clinic!allowing!guardians!and!children!to!come!at!the!same!review!
date,! a! patient! tracking! system,! and! the! assumption! that! some! children! with! difficult! social!
circumstances!receive!appropriate!(psychosocial)!support!and!motivation!to!remain!in!care.!!
!
Available! evidence! continues! to! highlight! the! urgent! need! to! improve! retention! rates! for! people!




be! late! for! review,! the! next! step! of! actual! tracing! can! be! very! time! and! cost! consuming.! A! large!
survey!of! pediatric!HIV!programs! in!Asia! and! sub;Saharan!Africa! [60]! showed! that,! after! a!missed!
clinic!visit,!83%!of!the!sites!utilized!phone!calls,!21%!home!visits!by!clinic!staff,!and!71%!home!visits!




one!of! the!study!assistants;!an!average!of!2;4!children!could!be! followed!per!day,! travelling!up! to!
155! kilometers,! costing! 120! US$! for! transport! costs! only.! These! efforts! and! costs! would! be!
prohibitive! within! a! normal! clinic! setting.! Using! community! volunteers! or! outreach! workers! for!
contact! tracing! can! be! an! acceptable! alternative! although! this! also! requires! good! communication!
and! feedback! options,! especially! when! dealing! with! a! large! catchment! area! and! low! population!
density.!
!
To! assess! the! long;term! outcomes! of! ART! in! perinatally! infected! children! as! they! age! into!
adolescence,! paediatric! programmes! in! resource;limited! settings! will! need! to! expand! their! focus!
beyond!diagnosis!and!early!monitoring!to!a!chronic!disease!model![60].!Whether!infected!at!birth!or!
later!in!life,!with!prolonged!survival,!HIV;infected!youth,!caregivers,!healthcare!workers!and!teachers!













HIV! has! proven! to! be! a! formidable! challenge,! but! the! tide! is! turning,! also! in! Zambia.! Even! in!
countries!that!have!reached!high!levels!of!service!coverage,!concerted!efforts!are!needed!to!reach!
the!most!marginalized! and! vulnerable! populations.! Children! living!with!HIV! are! some!of! the!most!
vulnerable!members!of!society.!Each!day!that!goes!by!almost!800!HIV;positive!children!die!because!
of! lack! of! access! to! treatment! and! care! [9].! Ensuring! their!well;being! and!protecting! their! human!
rights!is!our!shared!responsibility.!
!
There! are!many! reasons!why!HIV! care! and! treatment! for! infants! and! children! lags! behind! that! of!
adults.!These!challenges!are!complex!and!disparate,!and!can!vary!widely!among!regions,!countries,!
and! even! individual! health! facility! settings.! Bottlenecks! limiting! paediatric! treatment! in! resource;
limited! settings! include! poor! access! to! diagnosis,! weak! systems! for! !linkage! to! care! and! patient!
retention,!few!health!centers!and!providers!equipped!to!deliver!paediatric!ART,!and!!drug!regimens!
that!are!more!complex!to!administer! than!adult! regimens.!Problems!that!are!more!pronounced! in!
rural!areas!include!high!level!of!malnutrition!among!HIV;infected!children,!lack!of!health!personnel,!
difficulties! with! transport! of! clients! to! the! clinic,! but! also! of! drugs! and! diagnostics! to! the! health!
facilities.!!
By! identifying! the! barriers! to! a! durable! ART! scale;up! and! treatment! outcomes!within! a! rural! HIV!
program,!the!current!analysis!does!not!aim!to!provide!an!answer!to!all!the!complexities!of!rural!HIV!
service! delivery.! Instead,! it! urges! researchers! towards! continuous! policy;relevant! assessments! of!
potential! ways! to! overcome! the! cited! barriers,! and! policy! makers! towards! applying! research;
informed! policy!making! and! implementation! in! scaling;up!ART! in! a! high!HIV;prevalence! resource;
limited! setting.!Our! rural! cohort! illustrates! that! paediatric!HIV! service! delivery! in! resource;limited!




to!maintain! viral! suppression,! immunologic! function!and!normal!physiologic!processes,! potentially!
impaired!by!long;term!exposure!to!HIV!and!antiretroviral!drugs.!As!more!than!60%!of!the!population!
in! sub;Saharan! Africa! lives! in! rural! areas! [61],! a! large! proportion! of! these!HIV;infected! youth!will!
receive! care! and! treatment! in! rural! clinics! and! health! centers.! Future! studies! can! provide! critical!
information!on!these!long;term!treatment!outcomes,!as!well!as!susceptibility!to!vaccine;preventable!
diseases,! cognitive! function! and! the! sexual! experiences! of! perinatally;infected! youth,! in! a! rural!
setting!in!sub;Saharan!Africa.!!
!
With! experience! gained! in! implementing! paediatric! ART! programs! in! sub;Saharan! Africa! over! the!
past! decade,! innovative! solutions! to! address! and! overcome! these! barriers! have! been! developed.!
While! these! challenges! impact! most! programs,! the! solutions! are! context;specific.! Even! though!




















6. WHO/UNICEF.!Policy!requirements!for!HIV!testing!and!counseling!of! infants!and!young!children! in!health!
facilities.!Geneva,!Switzerland:!World!Health!Organization!and!UNICEF;!2010.!
7. Tudor!Car!L,!van;Velthoven!MH,!Brusamento!S,!Elmoniry!H,!Car!J,!Majeed!A,!Atun!R.!Integrating!prevention!
of!mother;to;child!HIV! transmission! (PMTCT)! programmes!with! other! health! services! for! preventing!HIV!
infection!and!improving!HIV!outcomes!in!developing!countries.! Cochrane!database!of!systematic!reviews!
Online!(2000).!










11. Thyssen! A,! Lange! JH,! Thyssen! E,! Reddi! A.! Towards! and! AIDS;free! generation! with! Option! B+:!
reconceptualizing! and! integrating! prevention! of! mother! to! child! transmission! (PMTCT)! with! pediatric!
antiretroviral!therapy!initiatives.!JAIDS!2013!Vol!62;!number!2.!
12. Schouten! EJ,! Jahn!A,!Midiani! D,!Makombe! SD,!Mnthambala! A,! Chirwa! Z,! Harries! AD,! van!Oosterhout! JJ,!
Meguid! T,! Ben;Smith! A,! Zachariah! R,! Lynen! L,! Zolfo! M,! Van! Damme! W,! Gilks! CF,! Atun! R,! Shawa! M,!
Chimbwandira! F.! Prevention! of! mother;to;child! transmission! of! HIV! and! the! health;related! Milennium!
Development!Goals:!time!for!a!public!health!approach.!Lancet!2011;!378:282;284.!
13. Granich! RM,!Gilks! CF,!Dye! C,! De! Cock! KM,!Williams!BG.!Universal! voluntary!HIV! testing!with! immediate!
antiretroviral! therapy! as! a! strategy! for! elimination! of! HIV! transmission:! a! mathematical! model.! Lancet!
2009;!373:48;57.!
14. Leeper! SC,! Montague! BT,! Friedman! JF,! Flanigan! TP.! Lessons! learned! from! family;centered! models! of!
















21. G! Bachman.! Demand;side! Barriers! and! Opportunities! for! Uptake! of! Pediatric! HIV! Testing! and! Care.!
Proceedings!of!meeting,!PEPFAR/USAID,!9!May!2011.!
22. WHO.! Antiretroviral! therapy! for! HIV! infection! in! infants! and! children:! Towards! universal! access,!
Recommendations! for! a! public! health! approach,! 2010! revision.! Geneva,! Switzerland:! World! Health!
Organization;!2010.!




















31. Fayorsey! RN,! Saito! S,! Carter! RJ,! Gusmao! E,! Frederix! K,! Koech;Keter! E,! Tene! G,! Panya! M,! Abrams! EJ.!
Decentralization! of! pediatric! HIV! care! and! treatment! in! sub;Saharan! African! countries.! J! Acquir! Immun!
Defic!Syndr.!2013;!DOI:!10.1097/QAI.0b013e3182869558.!
32. Gertner! JM,!Kaufman!FR,!Donfield!SM,!Sleeper!LA,!Shapiro!AD,!Howard!C,!et!al.!Delayed!somatic!growth!
and! pubertal! development! in! human! immunodeficiency! virus;infected! hemophiliac! boys:! Hemophilia!
Growth!and!Development!Study.!J!Pediatr.!1994;!124:!896;902.!
33. Newell! ML,! Borja! MC,! Peckham! C.! Height,! weight,! and! growth! in! children! born! to! mothers! with! HIV;1!
infection!in!Europe.!Pediatrics.!2003;!111:!e52;60.!
34. Bailey!RC,!Kamenga!MC,!Nsuami!MJ,!Nieburg!P,!St!Louis!ME.!Growth!of!children!according!to!maternal!and!





36. Lepage! P,!Msellati! P,! Hitimana! DG,! Bazubagira! A,! Van! Goethem! C,! Simonon! A,! et! al.! Growth! of! human!
immunodeficiency! type!1;infected!and!uninfected!children:!a!prospective!cohort!study! in!Kigali,!Rwanda,!
1988!to!1993.!Pediatr!Infect!Dis!J.!1996;!15:!479;85.!
37. Majaliwa!ES,!Mohn!A,!Chiarelli! F.!Growth!and!puberty! in!children!with!HIV! infection.! J!Endocrinol! Invest.!
2009;!32:!85;90.!
38. 38.!Chiarelli!F,!Verrotti!A,!Galli! L,!Basciani!F,!de!Martino!M.!Endocrine!dysfunction! in!children!with!HIV;1!
infection.!J!Pediatr!Endocrinol!Metab.!1999;!12:!17;26.!








42. Harris! J,! Drimie! S.! International! food! policy! Research! Institute.! Toward! an! integrated! approach! for!
















47. 47.! Mukherjee! JS,! Ivers! L,! Leandre! F,! Farmer! P,! Behforouz! H.! Antiretroviral! therapy! in! resource;poor!
settings:! decreasing! barriers! to! access! and! promoting! adherence.! J! Acquir! Immune!Defic! Syndr! 2006;! 43!
(Suppl!1):!S123–!S126.!!
48. Weigel!R,!Feldacker!C,!Tweya!H,!Gondwe!C,!Chiwoko!J,!Gumulira!J,!Kalulu!M,!Phiri!S.!Managing!HIV;infected!














53. Lynen! L,!Van!Griensven! J,! Elliot! J.!Monitoring! for! treatment! failure! in!patients!on! first;line!antiretroiviral!
treatment!in!resource;constrained!settings.!Curr!Opin!HIV!AIDS.!2010!Jan;!5(1):1;5.!
54. Wilson!D,!Keiluhu!AK,!Kogrum!S,!Reid!T,!Seriratana!N,!Ford!N,!Kyawkyaw!M,!Talangsri!P,!Taochalee!N.!HIV;1!
viral! load!monitoring:! an! opportunity! to! reinforce! treatment! adherence! in! a! resource;limited! setting! in!
Thailand.!Transactions!of!the!Royal!Society!of!Tropical!Medicine!and!Hygiene!(2009)!103,!601;606.!




EJ;! for! the! identifying! optimal! models! of! HIV! care! and! treatment! in! sub;Saharan! Africa! consortium.!
Retention! of! HIV;infected! children! on! antiretroviral! treatment! in! HIV! care! and! treatment! programs! in!
Kenya,!Mozambique,!Rwanda!and!Tanzania.!Advance!online!edition!J!Acquir!Immun!Defic!Syndr.!2012!Oct!
29!doi:!10.1097/QAI.0b013e318278bcb0,!2012.!
57. Wachira! J,! Middlestadt! SE,! Vreeman! R,! Braitstein! P.! Factors! underlying! taking! a! child! to! HIV! care;!





59. vanDijk! JH,! vanTreijen! M,! Janssen! J,! Sitali! J,! Manyani! F,! Nouwen! J.! Low! retention! rate! of! pre;ART! HIV!
infected!patients!after!successful!early!enrolment!in!HIV!care,!a!rural!Zambian!experience.!Proceedings!of!
the!XVIII!International!AIDS!Conference;!18;23!July!2010;!Vienna,!Austria.!Abstract!CDE!1117!
60. IeDEA! Pediatric! Working! Group! –! A! survey! of! paediatric! HIV! programmatic! and! clinical! management!


















In! dit! proefschrift! worden! de! gegevens! van! een! samenwerking! tussen! verschillende! partners!
gepresenteerd:!Macha!Research!Trusts! (voorheen!Malaria!/!Medical! Institute! in!Macha)!en!Macha!
Mission! Hospital! in! Macha,! Zambia;! AIDSrelief! Zambia! en! het! Zambiaanse! ministerie! van!
volksgezondheid;! Erasmus! MC,! Universitair! Medisch! Centrum! Rotterdam,! Nederland;! en! de!
Bloomberg!School!of!Public!Health,!John!Hopkins!University,!Baltimore,!USA.!
Macha!Hospital!is!een!van!de!1,769!HIV/AIDS!centra!in!Zambia![1].!Het!ziekenhuis!is!uniek!vanwege!
de! langdurige! goede! samenwerking! met! de! lokale! gemeenschap! en! het! aangrenzende!
onderzoeksinstituut,!in!ruraal!Zambia.!
De! gegevens! van! het! pediatrische! HIV! cohort! die! hun! zorg! ontvangt! in! dit! ! rurale! Zambiaanse!
ziekenhuis! vormt!de!basis! voor!dit!proefschrift.!Hoewel!de!meeste! studies!naar!HIV;geïnfecteerde!
kinderen! in! sub;Sahara!Afrika!worden!uitgevoerd! in! stedelijke! gebieden! [2],!waar!de!middelen!en!
infrastructuur! het! best! zijn,! werden! de! studies! in! dit! proefschrift! uitgevoerd! in! een! rurale!
gemeenschap! in! het! kader! van! een! observationele! cohort! studie! van! perinataal! geïnfecteerde!
kinderen!(PART!studie,!gestart!in!2007).!Hoewel!onderzoek!in!een!rurale!omgeving!een!uitdaging!is!
vanwege!de!beperkte!middelen,! geven!deze! studies! inzicht! in!de!gevolgen!en!de!behandeling!van!
HIV! bij! kinderen! op! lange! termijn! en! de! unieke! barrières! en! uitdagingen! met! betrekking! tot! het!
verstrekken!van!zorg!en!behandeling!in!deze!situatie.!
In! dit! laatste! hoofdstuk! geven! we! een! samenvatting! van! de! gepresenteerde! studies,! inclusief! de!
behaalde!successen!en!resterende!uitdagingen!met!betrekking!tot!pediatrische!HIV;zorg!in!gebieden!








Sahara! Afrika,! hetgeen! onze! gegevens! in! een! breder! perspectief! plaatst.! Deze! literatuurstudie,!
gepresenteerd! in! hoofdstuk! 2,! toont! aan! dat! korte;termijn! resultaten! van! HIV/ART!
behandelprogramma’s! in! sub;Sahara! Afrika! veelbelovend! zijn.! Gezien! de! snelheid! waarmee! de!
uitbreiding!van!HIV/ART!programma’s!heeft!plaatsgevonden!in!de!sub;Sahara!regio,!is!het!verkrijgen!
van!gelijkwaardige! resultaten! in! sub;Sahara!Afrika!programma’s!en!Westerse! landen!een!prestatie!
van! formaat.!De!oudere! leeftijd! en! verder! gevorderd! ziektestadium!op!het!moment! van! start! van!





Late! identificatie! van!HIV;geïnfecteerde! kinderen!ondersteunt!de!behoefte! aan! vroegere!diagnose!
en!behandeling.!Betere!toegang!tot!eenvoudig!te!gebruiken!technologieën!voor!het!diagnosticeren!
van! HIV! bij! kinderen,! het! versterken! van! counseling! en! diagnostiek! programma’s,! evenals! PMTCT!
programma's,! en! herziene! criteria,! zodat! kinderen! in! aanmerking! komen! voor! ART! in! minder!
vergevorderde!stadia!van!immuundeficïentie,!zijn!dringend!nodig.!
Meer!dan!de!helft!van!de!kinderen!waren!ondervoed!bij!aanvang!van!de!behandeling.!Dit!vraagt!om!
integrale! modellen! van! zorg! welke! ondervoeding! adresseren! en! zowel! therapeutische! en!
supplementaire!voeding!includeren.!
Suboptimale! antiretrovirale! behandelingen! waren! gewoonlijk! beschikbaar,! slechts! 63%! van! de!
studies!meldde!het! gebruik! van!protease;remmers.! Er! is! een!duidelijke!noodzaak!voor!een!betere!
toegang! tot! pediatrische! geneesmiddelen,! inclusief! vaste;dosis! combinaties,! en! betere!
beschikbaarheid!van!effectieve!tweedelijns!medicijnen!voor!kinderen!in!sub;Sahara!Afrika.!!
Gerapporteerde!resultaten!waren!van!behandelprogramma's!geïmplementeerd!in!stedelijke!centra.!
Continue! belangenbehartiging! is! nodig! voor! betere! toegang! tot! zorg! voor!HIV;besmette! kinderen,!
met! name! in! de! rurale! bevolking,! met! de! noodzaak! om! deze! programma's! te! monitoren! en!
evalueren.!
De!literatuurstudie!levert!het!bewijs!dat!behandelprogramma’s!in!sub;Sahara!Afrika!effectief!zijn!in!
het! leveren!van!virale!suppressie,!retentie!van!patiënten! in!zorg,! !en!overleving,!hetgeen!bevestigt!
dat!universele! toegang! tot!behandeling!een!haalbare!en!essentiële!prioriteit! is.!Aanvankelijke!ART!





toegankelijkheid! tot! gezondheidsinstanties.! Gebrek! aan! vervoer! (54%),! onvoldoende! financiële!
middelen! (60%)! en! slechte! wegen! (32%)! waren! vaak! genoemde! obstakels! tot! de! toegang! tot! de!
kliniek,! in! deze! rurale! omgeving,! in! het! bijzonder! tijdens! het! regenseizoen! [hoofdstuk! 3].! De!
meerderheid! van! de! zorgverleners! liepen! of! fietsten! naar! de! kliniek,! en! meer! dan! 25%! van! hen!
reisde!meer!dan!5!uur.!




meerderheid!van!de! zorgverleners! vonden!dat!hun!kind! te! jong!was!om!hun!HIV;status! te!weten,!
terwijl!anderen!bang!waren!om!het!hun!kinderen!te!vertellen!of!niet!wisten!hoe!dat!te!doen.!Deze!
informatie!werd!gerapporteerd!door!de!verzorger!in!plaats!van!het!kind!en!kan!een!onderschatting!
zijn! van! het! aantal! kinderen! met! ware! kennis! van! hun! status,! maar! in! ieder! geval! toont! het! de!
beperkte!betrokkenheid!van!de!zorgverlener!in!het!proces!van!onthulling!op!dat!moment.!





verbeteren! om! zeker! te! stellen! dat! er! optimale,! langdurige! behandelingsresultaten! zijn! voor! HIV;
geïnfecteerde!kinderen!die!woonachtig!zijn!in!ruraal!sub;Sahara!Afrika.!
!









Lange! reisafstanden! in! de! rurale! gebieden! zijn! van! invloed! op! de! timing! van! kliniek! bezoeken,!
evenals! het! beloop! /attritie! binnen! het! programma,! met! een! hoog! verlies;aan;follow;up! onder!
kinderen! die! verder! weg! van! de! klinieken! wonen,! vooral! onder! kinderen! die! niet! in! aanmerking!
komen! voor! een! behandeling.! Zowel! stedelijke! als! rurale! kinderen! reageerden! goed! op! de!
behandeling,! in! overeenstemming! met! andere! studies! [hoofdstuk! 2].! Het! niveau! van! de!
immunologische!en!klinische!respons!werd!beïnvloed!door!hun!uiteenlopende!uitgangskenmerken.!
Factoren! die! geassocieerd! worden!met! een! hoger! risico! op! sterfte! waren! het! bezoeken! van! een!!
rurale! kliniek,! een! jongere! leeftijd,! lagere! WAZ,! WHO! graad! 3! of! 4,! en! lage! (<5%)! CD4! T;cel;
percentage! bij! heb! begin! van! ART.! Echter,! in! een!multivariate! analyse! bleek! het! bezoek! aan! een!
rurale!kliniek!niet!langer!significant!geassocieerd!met!sterfte,!terwijl!de!andere!genoemde!baseline;
kenmerken!dit!nog!wel!waren.!Mortaliteit!was!consistent!hoger! in! rurale!klinieken,!mede!door!de!
jongere! leeftijd! en! sterke!mate! van! ondervoeding.! Verlies! in! follow;up!was! hoger! in! de! stedelijke!










De! studie! toont! ook! verbeteringen! aan! in! de! registratie! en! behandeling! van! kinderen! op! jongere!




verminderde! de! toename! in! CD4! T;cel! percentages! zich! tot! 0,23! procentpunt! per! maand.! De!













hetgeen!zowel!hun!vermogen!om! in!de! zorg! te!blijven!en!de! response!op!de!behandeling!kunnen!
beïnvloeden.!
! !
Zoals! in! de! eerdere! analyse! [hoofdstuk! 4],! in! de! rurale! populatie! werd! een! grotere! mate! van!
ondervoeding!waargenomen! in!vergelijking!met!andere! studies.! In!de! studie!die!de!groeipatronen!
[hoofdstuk!6]!evalueerde!van! jonge!HIV;geïnfecteerde!kinderen!met!goede! immunologisch!herstel!
door! ART! in! ruraal! Zambia,! is! er! een! significante! verbetering! van! zowel! gewicht! en! lengte;voor;
leeftijd!na!aanvang!van!ART.!!Verschillende!patronen!van!de!verbetering!in!de!WAZ!en!HAZ!werden!
gerelateerd!aan! respectievelijk!ondervoeding!en!de! leeftijd!bij!de!aanvang!van!ART.!Kinderen!met!
ondergewicht! ervoeren! een! grotere! toename! van! de!WAZ! in! de! eerste! 6! maanden! van! ART,! en!
kinderen!ouder!dan!5!jaar!bij!aanvang!ervoeren!significant!kleinere!stijgingen!van!de!HAZ!per!maand!
in! vergelijking! met! kinderen! jonger! dan! 2! jaar.! Echter,! een! groot! deel! van! de! kinderen! hadden!
ondergewicht! (60%)! en! waren! onvolgroeid! (72%)! bij! het! begin! van! ART! en! bleven! ondergewicht!
behouden! (45%)! en! onvolgroeid! zijn(46%)! na! twee! jaar! behandeling,! hoger! dan!waargenomen! bij!
HIV;negatieve!kinderen!in!dezelfde!regio![3].!!!
Dientengevolge,! succesvolle! behandeling! met! ART! was! niet! in! staat! de! effecten! van! HIV! en!
ondervoeding! op! de! groei! volledig! om! te! keren.! Een! samenwerking! tussen! HIV;behandeling! en!
voedings! programma's! moet! worden! onderzocht,! zodat! kinderen! een! geïntegreerde! zorg! en!




De! meerderheid! van! de! kinderen! die! bij! de! HIV! zorg! en! behandeling! programma’s! aangemeld!
worden!komen!reeds!in!aanmerking!voor!ART!op!het!moment!van!de!registratie![hoofdstuk!4],!zoals!
60%!van!de!kinderen!in!de!studie,!waar!gekeken!werd!naar!sterftecijfers!en!klinische!indicatoren!van!




mortaliteit! voor!ART! initiatie!13,3%!hetgeen!vergelijkbaar!was!met!de!cumulatieve!mortaliteit! van!
14,4%! onder! kinderen! na! ART! initiatie! in! deze! pediatrische! cohort! [hoofdstuk! 5].! Daarnaast! is! de!
sterfte! in! de! eerste! drie!maanden! na! start! in! de! studie! onder! kinderen! die! in! aanmerking! komen!
voor!ART!vergelijkbaar!met!de!sterfte! in!de!eerste!drie!maanden!na!ART!initiatie!(ongepubliceerde!





voordelen! voor! kinderen! op! ART! moet! dezelfde! zijn! in! een! onbemiddelde! als! in! bemiddelde!
omgeving,!maar!het!sterftecijfer!onder!de!eerste! is!acht!keer!hoger!dan!die!van!de! laatste! [4].!Dit!






Antiretrovirale!behandeling! (ART)! opties! voor! jonge! kinderen!met! gelijktijdige! infectie!met!HIV!en!
tuberculose!zijn!beperkt!in!omgevingen!met!weinig!hulpmiddelen!vanwege!beperkte!gegevens!over!
het! gebruik! van! efavirenz! (EFV).! Bijgevolg! is! er! een! behoefte! aan! alternatieve!
behandelingsstrategieën! voor! jonge! kinderen! met! tuberculose! en! gegevens! om! deze! te!
ondersteunen.!Gezien!de!beperkte!antiretrovirale!behandeling!opties!in!deze!settings!voor!kinderen!
die! rifampicine! ontvangen,! en! de! noodzaak! om! ART! zo! spoedig! te! starten! om! een! toename! van!
ziekte! en! sterfte! te! voorkomen,!werd! er! een! EFV! doseringsschema!ontwikkelt,! geëxtrapoleerd! uit!
beschikbare!farmacokinetische!gegevens,!voor!de!klinische!zorg!van!jonge!kinderen!co;besmet!met!
tuberculose.! Dit! doseringsschema! werd! geïmplementeerd! als! de! standaard! van! zorg! bij! Macha!
Hospital! in!de!Zuiderlijke!Provincie!van!Zambia!en!was!onafhankelijk!van!de!observationele!cohort!
studie.!Behandelingsresultaten!van!kinderen!jonger!dan!3!jaar!of!die!minder!wegen!dan!10!kg,!die!of!
EFV;based! ART! plus! anti;tuberculeuze! behandeling! of! nevirapine;based! (NVP)! ART! ontvingen!
werden!vergeleken![hoofdstuk!8].!
Ondanks!de!slechtere!gezondheid!tijdens!de!initiatie!van!ART,!vertoonden!kinderen!jonger!dan!3!jaar!
die! werden! behandeld! voor! tuberculose! en! een! EFV;based! ART! regiment! kregen! significante!
verbeteringen! in!de!klinische,! immunologische!en!virologische!resultaten,! in!vergelijking!met! jonge!
kinderen! die! een! NVP;gebaseerd! regiment! ontvingen.! Gezien! het! toenemende! aantal! jonge! HIV;
geïnfecteerde! kinderen! die! beginnen! met! ART! in! sub;Sahara! Afrika,! de! hoge! ziektelast! van!
tuberculose,! de! beperkte! behandelingsmogelijkheden! in! deze! regio,! en! de! beperkte! virologische!
effectiviteit! van!NVP,! kan! gebruik! van! EFV!bij! jonge! kinderen!worden!overwogen.!Dit! is! de! eerste!
studie!die! toont!dat!EFV!effectief!kan!worden!toegepast!bij! jonge!HIV;geïnfecteerde!kinderen!met!




voor! HIV;besmette! kinderen! in! onbemiddelde! omgevingen.! Decentralisatie! wordt! voorgesteld! als!
zijnde! een! van! de! sleutels! tot! het! opschalen! van! toegang! tot! antiretrovirale! behandeling,! en! in!
hoofdstuk! 9! hebben!we!een!dergelijk!programma!geevalueerd!door!de!behandelingsresultaten! te!
vergelijken! voor! kinderen! die! zorg! ontvangen! middels! mobiele! en! ziekenhuis;gebaseerde! HIV;
klinieken! in! ruraal! Zambia.! We! zagen! dat,! ondanks! vergelijkbare! klinische! en! immunologische!
resultaten,!kinderen!in!de!outreach;groep!minder!kans!toonden!op!virologische!onderdrukking.!Dit!
zou! kunnen! komen! door! een! lagere! therapietrouw.! Continue! aandacht! voor! de! kwaliteit! van! de!
geleverde! diensten! en! het! belang! van! therapietrouw! is! van! cruciaal! belang! voor! het! succes! van!
decentrale!zorg.!
!
De! ongelijkheid! in! toegang! tot! behandeling! voor! kinderen! en! volwassenen! is! groot! aangezien! de!
verstrekking! van! ART! voor! kinderen! unieke! obstakels! heeft.! Meerdere! uitdagingen! zijn!
geïdentificeerd,! en! voorbeelden! van! lokaal! aangepaste! strategieën! om! deze! te! overwinnen! zijn!
gedocumenteerd.!Hoofdstuk!10!beoordeelt!de!haalbaarheid!en!effectiviteit!van!pediatrische!ART!in!
sub;Sahara! Afrika,! en! toont! enkele! van! de! succesvolle! manieren! en! ontwikkelingen! in! de!




behandeling!beperken!worden! in!dit! hoofdstuk!besproken,!met! inbegrip! van!een! tekort! aan! goed!
opgeleide! zorgverleners,! onvoldoende! laboratoriumcapaciteit! voor! diagnose! en! monitoren! van!
behandeling! bij! kinderen,! therapietrouw,! kennis! van! HIV;infectie! status! en! retentie! in! de! zorg.!
Het! adresseren! van! personeels! tekorten! is! essentieel! voor! de! uitbreiding! van! pediatrisch! ART;
programma's,!met!name!in!rurale!gebieden.!Om!de!toegang!tot!ART!te!vergroten,!beveelt!WHO!aan!
tot! het! verschuiven! van! taken,! waarbij! een! niet;gespecialiseerd! kader! verantwoordelijkheden! op!
zich! neemt! in! ART!management[5].! Veel! programma's! implementeerden! een! of! andere! vorm! van!
taakverschuiving,! resulterend! in!een!vermindering!van!de!programma!kosten!en!het!verhogen!van!
de! efficiency! van! het! programma.! Echter,! supervisie! en! begeleiding! zijn! van! belang! om! een! hoge!
kwaliteit!van!zorg!te!waarborgen!(zie!ook!hoofdstuk!9).!
Klinische! laboratoria! spelen! een! cruciale! rol! in! de! zorg! en! behandeling! van! HIV;geïnfecteerde!
kinderen.! De! noodzaak! om! laboratorium! capaciteit! uit! te! breiden! en! om! eenvoudige,! goedkope!
point;of;care! testen! voor! diagnose! bij! kinderen! en! het!monitoren! van! viral;load! te! ontwikkelen! is!
erkend!en!hierboven!beschreven.!!
Consistente!toepassing!van!doseringsrichtlijnen!door!zorgverleners!en!patiënten!is!essentieel!om!de!
kans! op! falen! van! de! behandeling! te! verminderen! door! onderdosering! of! van! toxiciteit! door!
overdosering.!Bij!kinderen!is!het!juist!doseren!moeilijker!aangezien!het!afhangt!van!monitoren!van!
de! groei! door! middel! van! accurate! gewicht! en! lengte! bepaling.! Veel! programma's! hebben!
innovatieve! strategieën! geïmplementeerd! voor! de! verbetering! van! pediatrische! therapietrouw,! in!
additie! tot! de! aanbevolen! informatie! verstrekking! voor! verzorgers! door! middel! van! compliance;
counseling.! Dit! omvat! het! inschakelen! van! behandeling! supporters;! trainen! van! personeel! in! het!
meten!van!pediatrische!therapietrouw;!het!identificeren!van!betrouwbare,!eenvoudige!technologie!
en!betaalbare!methoden!ter!beoordeling!de!therapietrouw;!implementeren!van!een!gezinsgerichte!





Formele! richtlijnen! en! aanbevelingen! inzake! de! informatieverstrekking! aan! kinderen,! alsmede!
opleiding! van! zorgverleners!en! counselors!die!dit! proces!begeleiden! zijn!nodig!om!het!niveau! van!
openbaarmaking!onder!kinderen!in!sub;Sahara!Afrika!te!verhogen.!
Zoals! voor! de! therapietrouw! is! retentie! in! de! zorg! ingewikkelder! voor! kinderen! dan! voor!
volwassenen.! Bijgevolg! moeten! strategieën! om! retentie! te! verbeteren! rekening! houden! met! de!
behoeften!en!motivatie!van!zowel!het!kind!als!de!verzorger.!Een!familie;gecentreerde!benadering,!
gedecentraliseerd! model! van! de! zorg,! en! een! home;based! model! van! zorg! zijn! enkele! van! de!
modellen!die!zijn!geïmplementeerd!om!retentie!van!de!patiënt!te!verbeteren.!
Een! deel! van! de! toekomstige! uitdagingen! voor! de! peadiatrische! programma's! die! werden!












Kinderen! in! sub;Sahara!Afrika! reageren!even!goed!op!de!behandeling!als! kinderen! in!het!Westen.!
Het!grote!verschil!in!de!uitkomsten!is!het!gevolg!van!zowel!biomedische!als!programma!factoren!en!
omvat! een! ernstiger! ziektestadia! bij! diagnose,! andere! co;infecties,! ondervoeding! en! uitstel! in! het!
starten!van!ART.!
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Abbreviations!
!
ABC! ! Abacavir!
AIDS! ! Acquired!Immune!deficiency!syndrome!
ALT! ! Alanine!Aminotransferase!
ART! ! Antiretroviral!Treatment!
ARV! ! Antiretroviral!!
AZT! ! Zidovudine!
CD4! ! Cluster!of!differentiation!4!
CDC! ! Centers!for!Disease!Control!and!prevention!
CI! ! Confidence!interval!
D4T! ! Stavudine!
DBS! ! Dried!blood!spots!
DNA! ! Deoxyribonucleic!acid!
EFV! ! Efavirenz!
EID! ! Early!Infant!Diagnosis!
EDTA! ! Ethylenediaminetetraacetic!acid!
FDC! ! Fixed;dose!combination!
HAART! ! Highly!active!antiretroviral!therapy!
HAZ! ! Height;for;age!z;score!
HIV! ! Human!Immunodeficiency!Virus!
HR! Hazard!ratio!
IQR! ! Interquartile!range!
LPV/r! ! Lopinavir/ritonavir!!
LTFU! ! Lost!to!follow!up!
MCH! ! Maternal!and!Child!Health!
NRTI! ! Nucleoside!reverse!transcriptase!inhibitors!
NVP! ! Nevirapine!
PEPFAR!! President’s!Emergency!Plan!for!AIDS!Relief!
PCR! ! Polymerase!chain!reaction!
PMTCT! ! Prevention!of!Mother!to!Child!Transmission!
PY! ! Person;years!
RNA! ! Ribonucleic!acid!
SAS! ! Statistical!analysis!system!
Sd! ! Single!dose!
SD! ! Standard!deviation!
SES! ! Socio;economic!status!
SSA! ! Sub;saharan!Africa!
3TC! ! Lamivudine!
UNAIDS! United!Nations!program!on!HIV/AIDS!
USD! ! United!States!dollar!
WAZ! ! Weight;for;age!z;score!
WHO! ! World!Health!Organization!
ZMK! ! Zambian!Kwacha!
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